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PREFACE 
Many drugs exhibit poor and/or erratic absorption from 
the gastro-intestinal tract. Reports in the literature have 
suggested that under certain conditions drug absorption may be 
enhanced by co-administration with a lipid. The physiological 
and physicochemical mechanisms activated by the presence of the 
lipid within the gut are poorly understood. A knowledge of 
these mechanisms may enable a rational approach to drug 
formulation in lipid vehicles to be adopted, leading to 
exploitation of a hitherto little used dosage form. 
The aim of the present study was to investigate the 
physiological and physicochemical factors governing oral drug 
absorption from lipid vehicles and thus to evaluate the 
potential of lipids as an oral drug delivery system • 
• 
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SUMl1ARY 
Oil and emulsion vehicles have been shown to alter the 
oral absorption of many drugs. This may be due to enhanced 
lymph flow and/or altered gastro-intestinal motility in the 
presence of the oils. 
The oral absorption of a model compound (DOT) in the 
presence of three chemically different oils, arachis oil, 
Miglyol 812 and liquid paraffin was investigated in rats, the 
influence of lymphatic absorption and gastro-intestinal 
motility being determined. The findings were applied to the 
for.mulation of the'steroid prednisolone, in an attempt to 
produce elevated more uniform plasma drug levels by enhancing 
lymphatic absorption. 
The rank order for total DOT absorption from 1m! volumes 
of different vehicles was arachis oil > Miglyol 812= water 
containing 6% Tween 80 > liquid paraffin. The concentration of 
nOT in lymph collected via thoracic duct cannblae in 
anaesthetised rats was greatest in the presence of arachis oil, 
there being no difference between Miglyol 812 and liquid 
paraffin. Using a gamma camera the gastric emptying rate and 
total intestinal transit of 9 ~ c - s u l p h u r r colloid, an oil phase 
marker, was shown to be faster in the presence of 1m! liquid 
paraffin than the other two oils. 
The oral absorption of 3H-prednisolone was independent 
of the nature of the oily vehicle (30pl volumes) and was not 
selectively absorbed into the lymph. Esterification to 
3H-prednisolone-21-palmitate increased the lipophilicity of the 
- 1 ~ ~
drug but did not stimulate selective lymphatic absorption and 
reduced oral absorption following administration in arachis 
oil. Lymphatic absorption of the ester was not promoted by 
administration in 1ml arachis oil. 
Only the lymphatic absorption of compounds exhibiting 
selective uptake into the lymph may be enhanced by the presence 
of a suitable lipid vehicle. Altered gastro-intestinal motility 
in the presence of lipids may have greater potential for 
enhancing the absorption of a wider variety of compounds . 
• 
-2-
CHAPTER 1 
INTRODUCTION 
Oral administration in lipid vehicles has often been 
investigated as a potential means of overcoming the variable 
and incomplete bioavailability associated with poorly water 
soluble drugs. Although the absorption of a variety of drugs 
has been shown to be altered in the presence of oils and 
emulsions, few studies into the underlying mechanisms causing 
this change have been conducted. The influence of the 
physiological processes stimulated by lipids and their 
digestion products, on drug absorption are therefore not well . 
understood. The aim of the present investigation was to 
determine the affect of these processes on oral drug 
absorption. From the results obtained it was anticipated that a 
rational approach to drug formulation in oily vehicles could be 
adopted. 
• 
1.1 Oral Drug Absorption in the Presence of Lipids. 
Although there are many reports in the literature of 
altered oral drug absorption following co-administration of 
oils, the approach has not been systematic since each study 
differs with respect to the drug, oil, formulation and species 
investigated. The formulation details of these studies are 
summarised in Table 1.1. 
The oral absorption of griseofulvin, an antifungal 
agent, fram lipid vehicles has been extensively studied as a 
-3-
Drug + Dose 
Table 1.1 -Examples of Altered Oral Drug Absorption in the Presence of Lipids 
(Formulation (1) is compared with formulation (2). o/w = oil-in-water 
emulsions) 
Formulation Effect of Lipid 
Griseofulvin 1.Co-administration with a high fat meal. 
2.Co-administration with a high protein or 
carbohydrate meal 
Plasma levels doubled 
Gr iseoful vi n 
50mg/kg 
1. o /w containing 10mg polsorbate 60 + 10mg 
digycerides of edible fats per ml 
2a)Corn oil suspension containing 10mg 
polysorbate 60 per ml 
b)Aqueous suspension containing 10mg 
polysorbate 60 per ml 
2.5 fold increase in 
bioavailability 
Species Reference 
Human Crounse 
(1961 ) 
Rat Carrigan & 
Bates (1973) 
Griseofulvin 
500mg/kg 
Anticonvulsant 
Piperazi ne 21 
derivative 
1.Corn oil o/w + 300mg polysorbate 80 
per 30g 
2a)Aqueous suspension + 300mg 
b)Commercial tablets 
1.Corn oil solution 
2a)Corn 'oil o/w ; 20%v/v oil+0.8% 
pluronic F-87 
8mg/kg in 0.1ml/kgl b)Suspension in normal saline 
Chlormethiazole 1.Arachis oil s u s p e n s i o n ~ 6 4 0 m g g oil in 
640mg soft gelatin capsules 
2.Chlormethiazole base in soft gelatin 
capsules 
Peak plasma levels Human Bates & 
increased 3-4 fold Sequeira 
Two fold increase in ( 1975) 
bioavailability 
I ncreased ED 50 Mice ~ a n v o r d e k e e r 
Decreasd pharmacological & Bloss 
activity and duration (1977) 
50% increase in peak Human Fischler et 
plasma leve Is al.(1973) 
Hydrophobic 1.Soft gelatin capsules-20%w/w drug base Increased bioavailability Dogs Stella et 
antimalarial amine in oleic acid solution ale (1978) 
250mg 2.Hard gelatin capsules-hydrochloride salt 
Flufenarnic acid 1.Soft gelatin capsule-100mg vegetable oil, Increased plasma levels Dogs Angelucci et 
200mg 40mg hydrogenated vegetable oil, '34% increase in total al.(1976). 
8mg beeswax and 5mg soya lecithin drug absorbed 
2.Hard gelatin capsule-20mg magnesium stearate 
• 
Sulphanilamide 1.0live oil suspension Mice Increased therapeutic Feinstone et 
acyl derivatives 2.Aqueous"accacia suspension activity & blood levels al.(1940) 
Acetyl 
sulphasoxazole 
118mg/0.5ml rat 
118mg/2g human 
Sulphisoxazole 
I 
Micronised 
Phenytoin 
20mg/kg 
Ephedrine 
20mg 
1. o /w - 50% vegetable oils+emulsifiers 
2.Commercial aqueous suspension 
As above 
1a)Corn oil suspension 
b)Corn oil o/w = 0.4g oil/ml 
2.Aqueous suspension + 0.5% methyl 
cellulose 
All formulations contain 10mg polysorbate 
polysorbate 80 per ml 
1.Mineral oil solution 19 in 99g 
2.Aqueous solution 
Plasma levels increased Rat 
0-4h. Human 
Svenson et 
al. ( 1956) 
INO. change 
Rate of absorption reduced I Rat Chakrabarti 
Peak plasma levels 1.5 to & Belpaire 
1.9 fold increase ( 1978) 
Decreased % drug recovered I Dogs Lin et ale 
in urine over 48h. ( 1970) 
Theophy lli ne 
=15mg anhydrous 
theophylli ne 
Nitroglycerin 
3.5mg/kg 
Lampren 
THC 
5mg in 10ml/kg 
1.°/'t1 = 50ml peanut oil, 4ml 
polyoxyethylene (4) lauryl ether & 
2ml sorbitan trioleate per 100ml 
2.Aqueous solution 550mg/100ml 
1 .0 hi = sesame oil 40% v /v, 
polysorbate 80 0.4%v/v 
2.Aqueous solution 
1.0ily suspension 
2.Micronised drug 
1.Corn oil suspension 
2.10% Tween 80 in saline suspension 
Increased rate of 
absorption 
Reduced peak plasma level 
Unchanged bioavailability 
50-85% increase in 
absorption 
Reduced plasma levels 
Rabbits 
Human 
Human 
Mice 
Diamond 
( 1970) 
Ogata & 
Fung (1980) 
Vishl'r 
(1969) 
Mantilla -Plat d 
&Harbi son ( 1975) 
THe 
3Smg 
Androstendione 
cyclopentyl enol 
1.0.8Sml sesame oil solution 
2. o /w = 0.8Sml sesame oil+Tween 80 
1.Sesame oil solution in soft 
gelatin capsules 
ether 123.6mg/Sml I 2.Aqueous suspension of varying 
Quingestrone 
100mg 
Ethynylestradiol 
- 3-cyc lopenty 1 
ether O.Sml 
particle size +0.15% disodium phosphate 
1a)Sesame oil suspension 
b)Sesame oil solution in 3ml 
2.Micronised powder - particle size 10um 
1.Sesame oil solution + 2S%w/v 
glycerol mono-oleate 
2a)Sesame oil solution 
b)Aqueous suspension 
Increased peak plasma 
levels and rate of 
absorption 
Increased urinary 
excretion 
Increased urinary 
excretion 
Increased lymphatic 
absorption 
Human 
Human 
Human 
Rat 
Perez-Reyes 
et al.(1973) 
Bruni et 
ale ( 1966) 
Bruni & 
Galletti( 1970) 
Gianina et 
al.(1966) 
Urogastrone 
20mg 
Heparin 
100mg/kg in 
5.0 or 10ml/kg 
1. 0 hi = trioctanoin or olive oil 
2a)Aqueous solution 
b)O.2%w/v Tween 80 in aqueous 
solution 
c)o/w= liquid paraffin or 
diethylphthalate 
All o/w formulations contain 5%v/v 
oil+p.2%w/v Tween 80 
1. o /w =-trioctanoin, corn oil or 
peanut oil 
2a)aqueous solution + sodium 
taurocholate 
b)o/w=mineral oil 
All emulsions = 4.5ml oil, 31.5ml water 
and sodium taurocholate 0.035M 
Increased actvity Rat Hori et 
al.(1977) 
Increased plasma Rat Engel & 
levels Gerbil I Fahrenbach 
( 1968) 
Indoxole 1a)Lipomul-oral emulsion Increased Human 
Wagner et 
b)Soft gelatin capsule containing bioavailability 
ale ( 1966) 
polysorbate 80 
2a)Aqueous suspension +0.1% pluronic F68, 
50% sucrose,reservatives and 
flavouring agent 
b)Hard gelatin capsules=dioctyl sodium 
succinate sodium benzoate & magnesium 
stearate 
SL512 1.Mer solution Increased plasma Rat Yamahira et 
0.5mg/kg in 20ul I 2a)Corn oil suspension levels ale ( 1978) 
b)MBLA solution 
-
-
Dicoumarol 1.Triolein suspension Increased Rat Bloedow & 
10mg/kg 2.0.5% methyl celluolse aqueous bioavailability Hayton (1976) 
in 5ml/kg suspension 
Sulphisoxazole 1a)Triolein suspension Increased Rat Bloedow & 
i 
acetyl 100mg/kg b)Trioctanoin suspension bioavailability Hayton ( 1976) 
in 5ml/kg 2.0:5% methyl cellulose aqueous 
suspension 
• 
means of improving the slow, erratic and incomplete 
gastro-intestinal absorption normally associated with this 
drug. Crounse (1961) reported a two fold increase in the serum 
griseofulvin levels after single or multiple dosing to human 
subjects following a high fat meal compared with fasting 
conditions or a high protein or carbohydrate meal. It was 
demonstrated that the elevated serum levels were due to 
increased drug absorption rather than slowed clearance fram the 
'serum. Following a study demonstrating an enhancing effect of 
corn oil on griseofulvin absorption in rats (Carrigan 
1974,Carrigan & Bates 1973) similar experiments were conducted 
in fasted human subjects (Bates & Sequeira 1975). Each subject 
was dosed with griseofulvin formulated as a)commercial tablet, 
b)an aqueous suspension or c)in suspension in a corn oil, 
oil-in-water emulsion. Urinary analysis of 
6-desmethylgriseofulvin, the major metabolite of the 
antibiotic, showed the emulsion to have produced peak drug 
levels 3 to 4 times those of the other f o r . m u ~ t i o n s s and a total 
drug absorption twice that of the other preparations. It was 
suggested that the underlying mechanism was similar to that 
demonstrated in the rat (Carrigan 1974,Carrigan & Bates 1973), 
i.e. that the products of corn oil hydrolysis (linoleic acid 
and oleic acid) inhibited gastric emptyinq and proximal 
intestinal motility, allowing time for more complete drug 
dissolution and a b s o ~ t i o n . . In human subjects bile secretion 
stimulated by administration of the oil possibly further 
enhanced griseofulvin dissolution. Varyinq the proportion of 
oil in the emulsion from 0-12q showed maximal a b s o ~ t i o n n of a 
-13-
250mg dose of the drug to be achieved with 6-12g oil, 6g being 
comparable to that necessary for initiation of the reflexes 
reducing gastric motility (Bates et al.1977). Although 
unemulsified corn oil also enhanced absorption the effect was 
less marked, 12g oil having the same effect as only 3g 
emulsified corn oil (Bates & Sequeira 1975). Bloedow & Hayton 
(1976) found that the bioavailability of griseofulvin in rats 
was reduced by administration of the drug as a suspension in 
triolein. It was suggested that differences in the rat strain, 
lipid volume and drug particle size might account for this 
unexpected result compared with that obtained with corn oil. 
Further investigations by Grisafe & Hayton (1978a) using an in 
situ rat intestine model and a perfusate containing monolein 
(3mM), oleic acid (6mM), triolein (2g/100ml) and/or sodium 
taurodeoxycholate (8roM), suggested that following dissolution 
g r i s e o ~ u l v i n n concentrates in the micellar and oil intra-luminal 
phases from which there is negligible absorption, absorption 
occuring mainly from the aqueous phase. Thus ~ h e e ability of a 
triglyceride to enhance the oral absorption of griseofulvin is 
apparently due solely to enhanced dissolution and not enhanced 
absorption of dissolved drug. 
The effects of lipid vehicles on drugs other than 
qriseofulvin have been far less extensively investigated. 
The therapeutic activity of a series of acyl derivatives 
of sulphanilamide aqainst streptococcal, pneumococcal and 
influenza virus infections in mice was enhanced by oral 
administration of the druqs in olive oil rather than 
suspensions in accacia (Feinstone et al.1940), and blood level 
-14-
determinations showed that drug absorption had been increased. 
A study with another sulphonamide, acetyl sulphisoxazole, 
showed an oil-in-water emulsion formulation to increase the 
plasma drug levels during the first four hours after 
administration in both rats and humans, and to be 3 to. 5 times 
more active against streptococcal and pneumococcal infections 
in mice than the corresponding aqueous suspension (Svenson et 
al.1956). Absorption of the parent drug, sulphisoxazole, was 
unaltered by formulation as an emulsion. It was not established 
whether acetyl sulphisoxazole absorption was altered by the 
presence of the oil or the emulsifiers. 
Intra-gastric administration of micronised phenytoin to 
rats, in corn oil suspension and in corn oil emulsion yielded 
peak plasma levels 1.89 and 1.47 times that obtained with the 
equivalent aqueous suspension, and significantly higher total 
drug absorption as determined from the AUC O- 12h (Chakrabarti & 
Belpaire 1978). It was suggested that reduced gastro-intestinal 
motility in the presence of the corn oil may pave contributed 
to these effects, the time to the peak plasma concentration 
being slower with the oil formulations. However, the oral 
absorption of the anticonvulsant, 1-diphenyl-
4 - [ ( 6 - m e t h y l - 2 - p y r i d y l ~ ~ methyleneamino]piperazine, was reduced 
in the presence of corn oil (Sanvordeker & Bloss 1977). 
Intra-gastric adDdnistration to mice of the drug in corn oil 
solution resulted in total arrest of anticonvulsant activity 
and, although administration in a corn oil emulsion restored 
activity, it was not to the same level attained fram an aqueous 
suspension. The authors suggested that as the drug is very 
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lipophilic transfer from the corn oil to the intestinal fluid 
was insignificant, but that following emulsification the 
available surface area was increased allowing greater drug 
transfer into the intestinal fluid and hence greater 
absorption. 
Oral administration of drugs in oily vehicles has been 
achieved by several workers using soft gelatin capsules. A 
comparison was made in human subjects of chlormethiazole 
administered in capsules containing chlormethiazole base and in 
capsules containing the base in arachis oil. The presence of 
the oil increased the peak plasma level by approximately 50%, 
although the time to the maximum plasma concentration was 
unaltered (Fischler et al.1973). This effect was shown to be 
dependant on the weight ratio of the arachis oil and 
ch+ormethiazole administered, chlormethiazole (384mg) plus 
arachis oil (384mg) yielded plasma levels equal to the base 
alone whereas chlormethiazole (384mg) plus arachis oil (758mg) 
produced plasma levels twice that of the base alone. As in 
. .,--
vitro results showed that the arachis oil did not enhance 
c h l o ~ e t h i a z o l e e dissolution it was suggested that adsorption of 
arachis oil to the stomach wall resulted in an enlarged contact 
surface, which facilitated diffusion of the drug across the 
gastric mucosa. Stella et al.(1978) investigated the effect of 
oleic acid in a soft gelatin capsule formulation on the 
bioavailability of a hydrophobic amine antimalarial, 
d!butylamdnomethyl 6 , 8 - d i c h l o r o - 2 - ( 3 , 4 - d i p h e ~ 1 ~ 4 4
quinolinemethanol, nor.mally adDdnistered as the hydrochloride 
in hard gelatin capsules. Female Beaqle dogs were each dosed 
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with either the hard gelatin capsule or three soft gelatin 
capsules containing the drug in solution in oleic acid. A 
significantly higher total drug absorption, as determined from 
the AUC O_12h ' was produced by the soft gelatin capSules. It was 
postulated that the oleic acid formulation allowed the poorly 
water soluble drug to enter the gastro-intestinal tract in a 
readily dispersible form facilitating more rapid and complete 
drug absorption. I t is possible that the oil served only to 
form a solution of the drug and had no physiological effect on 
drug absorption; further investigations with a control drug 
solution are therefore needed to determine the effect of the 
oleic acid. The oral absorption of flufenamic acid, an 
analgesic and anti-inflammatory agent, was enhanced in dogs by 
administration of the drug in a soft gelatin capsule containing 
vegetable oils, beeswax and soya lecithin, rather than in a 
hard gelatin capsule containing magnesium stearate (Angelucci 
et al.1976). Higher plasma levels were achieved, except after 
30 minutes, and the mean total drug absorption, as determined 
• 
by the AUC O_12h ' was increased by 34%. However, in human 
subjects higher plasma levels were only attained after 90 
minutes, although it was suggested that the sampling regimen 
had not been optimised and further investigations were therfore 
required. Ephedrine absorption in dogs was not enhanced by 
administration in a mineral oil solution contained in a soft 
gelatin capsule {Lin et al.1974}, approximately half of the 
dose from the soft gelatin capsule being excreted in the urine 
over the first 48 hours compared with three-quarters fram the 
aqueous solution. Unfortunately absorption fran a digestible 
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oily solution was not investigated. Human absorption studies 
with Lampren, an antileprotic agent, showed that for a standard 
dose absorption from coarse crystals was about 20%, from 
micronised crystals about 50% and from oily suspension about 
85%. For clinical purposes the drug was therefore suspended in 
an oil-wax base and administered in a capsule, resulting in an 
absorption of about 70% (Vischer 1969). Although the mechanism 
for absorption is not clear the drug is very lipophilic (log 
octanol:water partition coefficient of approximately 6.0) and 
it is possible that it remained with the oil and was absorbed 
into the lymph. 
Higher plasma levels during the first 20 minutes after 
administration of theophylline to rabbits, were achieved by 
administering the drug in a peanut oil-in-water emulsion rather 
than an aqueous solution (Diamond 1970). It was suggested that 
the fine dispersion of emulsion droplets facilitated rapid drug 
absorption and that the presence of oil stimulated mesenteric 
blood flow via hormonal pathways. 
• 
Nitroglycerin when formulated in a sesame oil emulsion 
and intra-gastrically administered to rats was found to yield 
lower, later peak plasma levels than the equivalent aqueous 
solution (Ogata & Fung 1980). However, the total drug 
absorption was the same .from the two formulations indicating 
. . 
the potential of the emulsion as a sustained release 
preparation. The delay in drug absorption was attributed to the 
time required for drug movement fraa the oil phase to the water 
phase prior to absor.ption, and to gastric emptying effects of 
the oil. 
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Solutions of 14C-A-9-tetrahydrocannabinol (THC) in corn 
oil reduced drug absorption in mice compared with absorption 
from a 1% polysorbate 80 in saline formulation (Mantilla-Plata 
& Harbison 1975). Further studies showed a decrease in 
absorption in laboratory animals when oily solutions of THC 
were compared with emulsions containing Tween 80. However, in 
human studies the rate of THC absorption and the resulting 
plasma levels were higher with a sesame oil solution than with 
a sesame oil emulsion containing Tween 80 (Perez-Reyes et 
al.1973). 
The absorption of a number of steroids has been shown to 
be altered by administration in oily vehicles. Alibrandi and 
his co-workers (1960) investigated the biological activity in 
rats, of testosterone, androstanolone (dihydrotestosterone), 17 
~ - m e t h y l l testosterone, prednisone, prednisolone and a number of 
short chain fatty acid esters, administered in sesame oil 
solution and in aqueous suspension. Following repeated daily, 
intra-gastric dosing, nearly all the test compounds of the 
• 
androgen series and some of the cortical series exhibited an 
increase in specific activity when in solution in the sesame 
, 
oil. A number of possible physiological mechanisms were 
suggested to explain the results. However it is possible that 
improved absorption was observed with the sesame oil solution 
simply because uhe drug was in solution and a dissolution step 
was not required as with the suspension. This possibility was 
further discussed by Bruni et al.(1966). They showed that as 
lonq as the particle size of an androstendione aqueous 
suspension was sufficiently small (4 to 30pm) the absorption, 
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as determined by urinary analysis, was the same as from a 
sesame oil solution of the drug. These results are in 
disagreement with those of Alibrandi et al.(1960), although the 
experimental protocol was different in the two investigations. 
The cyclopentyl enol ether of androstendione administered in a 
sesame oil solution resulted in higher steroidal urinary 
excretion than administration in an aqueous suspension of 
particle size 4 to 8pm. Although this result may again be due 
to the difference in the physical form of the drUg, it was 
suggested that the particle size was sufficiently small for 
this not to be a problem, and that some other mechanism such as 
lymphatic absorption was involved (Bruni et al.1966). A similar 
study was conducted with progesterone 3-cyclopentyl enol ether 
(Quingesterone), 100mg being administered to one human patient 
either as micronised powder (particle size <10pm), a suspension 
in sesame oil or a solution in sesame oil. In the fasted 
patient the oily formulations gave better absorption than the 
aqueous suspension, but when the drug was taken after a meal 
• 
excretion levels from the aqueous suspension approached those 
observed after ingestion of the oily solution. Thus, there 
would appear to be little difference in the therapeutic 
effectiveness of Quingestrone given in oily solution and in 
solid form taken at meal times (Bruni & Galletti 1970). The 
absorption of ethynylestradiol was enhanced by administration 
of the cyclopentyl ether derivative in sesame oil solution, and 
further enhanced by administration of the cyclopentyl ether 
derivative in sesame oil containing 2S\w/v q1ycery1 monoleate 
(Giannina et a1.1966). 
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Preliminary investigations in two adult male subjects 
showed that higher serum concentrations of indoxole were 
achieved by administration of the drug in cottonseed oil 
solution or Lipomul Oral emulsion (cottonseed oil-in-water 
emulsion) than as a very fine powder in hard gelatin capsules. 
Further studies (Wagner et al.1966) showed that the 
bioavailability of indoxole in man decreased in the following 
order of formulations, emulsions=soft gelatin capsules 
(containing drug dissolved in polysorbate 80»aqueous 
suspension)powder in capsule. The relative potency estimates 
were 1.00, 1.10, 0.47, 0.16 following a single dose and 1.00, 
0.72, 0.27 and 0.16 following the sixth dose of the drug 
administered on a multiple dose regimen. On the basis of these 
results and those in the dog which indicated that indoxole is 
excreted,into the bile, it was postulated that joint 
enterohepatic recycling of the drug and oil resulted in 
increased absorption from the emulsion. Both Carrigan (1974) 
and S e q u ~ i r a a (1976) suggested ~ h a t t this in fact was not the 
• 
underlying mechanism since the serum level-time curves did not 
exhibit the characteristic multiple peaks and parallel 
decreases in serum concentration associated with enterohepatic 
recycling. In addition there was no s u p p o r t i n g ~ v i d e n c e e which 
would explain how the drug and lipid continued to associate 
with each other followinq absorption from the gut. It seems 
more likely that indoxole absorption is dissolution rate 
limited and that any solution dosaqe form would therefore 
'. 
increase the bioavailability of the druq relative to a 
suspension, as was seen with both the emulsion and polysorbate 
~ 2 1 1
80 solution, there being no difference between these two 
formulations. Similar results were obtained by Kaiser et 
al.(1967) in the rat. 
As the glycoprotein urogastrone inhibits gastric acid 
secretion its plasma levels may be determined by monitoring 
gastric acid output. Intra-jejunal administration of 
urogastrone in aqueous solution, 0.2%w/v Tween 80 solution, 
liquid paraffin emulsion and diethylphthalate emulsion was 
s ~ o w n n not to alter gastric acid output in rats, whereas 
administration in trioctanoin and in olive oil emulsions 
significantly inhibited gastric acid secretion (Hori et 
al.1977). This suggests that the digestibility of a lipid 
vehicle is an important consideration. The inhibitory action of 
the trioctanoin emulsion on gastric acid output was shown to be 
dependant on the oil volume, 5%v/v trioctanoin giving the 
maximum inhibition. 
Whilst investigating the physicochemical and 
physiological properties of lipids which may affect the 
• 
bioavailability of poorly water soluble drugs, Bloedow and 
Hayton (1976) showed that in rats the bioavailability of 
dicoumarol in was increased by administration in suspension in 
triolein or polysorbate 80, and the bioavailability of 
sulphisoxazole acetyl was increased by administration in 
suspension in triolein, polysorbate 80 and trioctanoin. The 
results of these studies indicated that whilst polar, 
digestible lipids increased the bioavailability of lipophilic, 
poorly water soluble drugs without increasing the absorption 
rate; nonpolar, nondigestible lipids generally did not affect 
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the bioavailability of these drugs, although they did appear to 
reduce the absorption rate. 
Engel and Fahrenbach (1968) showed that the oral 
absorption of heparin was insignificant in rats and gerbils 
following intra-duodenal administration in an aqueous solution, 
in micellar solutions of monoolein or sodium taurocholate, or 
in sodium taurocholate stabilised mineral oil emulsion. 
However, significant absorption was achieved by administration 
in trioctanoin, corn oil or peanut oil emulsions stabilised 
with sodium taurocholate. These results would again suggest the 
importance of oil digestibility for enhanced drug absorption. 
The mechanism by which absorption of this lipid insoluble drug 
was enhanced was not determined. 
Yamahira and co-workers (1978,1979a,1979b) investigated 
the effect of oil volume and oil digestibility on the 
gastro-intestinal absorption of· the poorly water soluble 
antinflammatory agent, 
1 - c y c l o p r o p y l - 4 - p h e n y l - 6 - c h l o r o ~ 2 ( 1 H ) - q u i n a z o l i n o n e e <SL512) in 
• 
the rat. It was suggested that previous animal experiments had 
utilised large oil volumes that were beyond reasonable 
comparison with a human dose, distorting the characteristics of 
the dosage forms, and that an oil volume of 20ul/rat was more 
. 
comparable to a human clinical dose volume. Serum levels of 
SL512 1 hour after administration in 20ul volmes of a MeT 
(medium chain triglyceride) solution, a corn oil suspension, a 
MCM (medium chain monoglyceride) solution, a MBLA ( N - ~ ~
-methyl-benzyllinoleamide, a poorly digestible lipid) solution 
and an aqueous suspension, were determined and shown to be in 
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, 
good agreement with the gastric emptying rate of each 
preparation, with the exception of the MBLA formulation. It was 
suggested that as SL512 was readily absorbed from the 
intestine, the gastric emptying step was rate determining for 
digestible oils, whereas the rate of MBLA digestion was 
p r ~ b a b l y y the rate limiting step for drug absorption from this 
oil. The serum levels of SL512 had the rank order MBLh(corn 
oil(MCT in intact animals but in rats with ligated bile ducts 
and in in situ recirculation experiments where no oil digestion 
occured, SL512 absorption was virtually equal for all three 
preparations. This again demonstrates the requirement for oil 
digestion. However, at a dose level of 2ul, the absorption of 
SL512 was shown to be less dependant on dosage form factors of 
the lipid formulation such as drug concentration or intestinal 
digestibility of the lipid vehicle, suggesting that 
physiological factors might be relatively more important. 
Results for the MCT formulation at a range of oil volumes 
indicated that for 10-100pl/rat the decrease in SL512 
• 
absorption rate with increasing oil volume was mainly 
attributable to a decrease in the rate of digestion of the 
lipid after g a ~ t r i c c emptying, but that above 200pl/rat various 
factors such as depression of the gastric emptying rate or 
. 
i n t e s t ~ n a l l motility, in addition to a decrease in lipid 
digestion rate, may be involved in the decreased absorption 
rate of the drug. 
Talbot & Meade (1971) reported that the ingestion of 
potato chips containing small amounts of methyl polysiloxane, a 
lipid like agent that enhances crispness, apparently 
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significantly reduced the absorption of warfarin and 
phenindione in patients taking these drugs. 
Few generalised conclusions can be drawn from these 
investigations due to the large variation in the experimental 
conditions and protocol. However it does appear that oil 
digestibility and oil volume may be important considerations. 
In addition it is evident that suitable control studies have to 
be conducted to ensure that changes in drug absorption are due 
to the presence of the oil and not due to such factors as 
particle size or the presence of emulsifiers. 
This literature review has been limited to simple oil 
and oil-in-water emulsion systems. Other more complex lipid 
formulations which have been used to enhance oral drug 
absorptionoinclude:-
a)liposomes (Ryman & Tyrrell 1979) 
b)multiple emulsions (Engel et al.1968) 
c)water-in-oil emulsions (Nakamoto et al.1979) 
• 
Various physiological mechanisms affecting oral drug 
absorption in the presence of lipids have been proposed:-
a)Altered gastro-intestinal motility changing the residence 
time of the drug at the site of absorption (Bates & Sequeira 
1975). 
b)Enhanced mesenteric lymph flow increasing the capacity for 
lymphatic absorption (DeMarco & Levine 1969). 
c)stimulated bile flow increasing drug dissolution and 
solubilisation (Bates & sequeira 1975). 
d)Altered intestinal mucosal membrane p e ~ e a b i l i t y y caused by 
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reversible combination of fatty acids with the membrane 
structure (Muranushi e ~ ~ al.1980). 
The present study was limited to an investigation of the 
influence of lymphatic absorption and gastro-intestinal 
motility on oral drug absorption. To understand these potential 
mechanisms a knowledge of the process of lipid digestion and 
the effect of lipids on lymph flow and gastro-intestinal 
motility is essential. 
1.2 Lipid Digestion. 
Triglycerides are fatty acid esters of glycerol and form 
the major portion of dietary lipids. Digestion and absorption 
of these molecules is dependant on the hydrocarbon chain length 
and the degree of unsaturation of the fatty acid moiety. 
The digestion process is initiated by pharyngeal lipase 
in man, or by lingual lipase in rats (Hamosh et al.1975) which 
is mixed with the food as it is swallowed and starts the 
• 
hydrolysis of the triglyceride molecules within the stomach. 
The fatty acids liberated stabilise the coarse triglyceride 
emulsion formed in the stomach from the shear forces generated 
by gastric motility (Lindhorst et al.1977), and following 
g ~ s t r i c c emptying stimulate the release of the hormones secretin 
and cholecystokinin (CCK), leading to gall bladder contraction 
and s e ~ r e t i o n n of pancreatic juice. 
Pancreatic juice contains several lipolytic enzymes. 
"Classical" pancreatic lipase rapidly hydrolyses both tri- and 
41- glycerides, as it is specific for the primary (1,3) ester 
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bonds, to produce an equilibrium mixture of tri-, di- and 
monoglycerides and fatty acids (Borgstrom 1974,Hofman 1966). 
This enzyme has a greater affinity for long chain and for 
unsaturat'ed fatty acids (Morely et al.1974). Lipolytic activi ty 
depends on the adsorption of the water soluble enzyme to the 
oil-water interface, enabling binding of the substrate ester 
bond to the active site. Bile salts at their critical micellar 
concentration (CMC) h a v ~ ~ been shown to inhibit lipase activity 
by removing the enzyme from the oil-water interface, the 
mechanisms involved are discussed by Borgstrom (1977). However, 
co-lipase, a polypeptide co-factor for lipase present in 
pancreatic juice, effects the binding of lipase to the 
substrate in the presence of bile salts probably by forming a 
1:1 complex with the enzyme (Borgstrom & Erlanson 1973). 
Co-li'pase also has a binding site for bile salt micelles so 
bringing the micelles close to the oil-water interface allowing 
rapid solubilisation of the lipolytic products. A second 
lipolytic enzyme present in pancreatic juice is known by a 
• 
variety of names due to its broad spectrum of action, lipase A, 
non-specific lipase, sterol-ester hydrolase and carboxylic 
ester hydrolase. It hydrolyses 2-monoglycerides and generally 
compliments the action of "classical" lipase so that together 
they diqest most t r i q l y c ~ r i ~ e s s present in the diet. 
Lipolysis is facilitated by increasinq the available oil 
surface area for enzymic action and by rapid removal of 
hydrolysis products from the substrate surface (Bennzonana & 
Desnuelle 1965). Bile salts perform both these functions. 
Initially bile salts are synthesised in the liver from 
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cholesterol although the major fraction of bile is derived from 
bile salts that have been re-absorbed in the ileum by an active 
transport mechanism, and then transported to the liver in the 
portal vein where they are reconjugated. In humans, bile is 
stored in the gall bladder until ejected into the intestinal 
lumen after hormonal stimulation of the gall bladder following 
gastric emptying of food. There is no gall bladder in the rat, 
v i r t u a l l ~ ~ the entire bile salt pool is present in the intestine 
(Norman & Sjovall 1958). 
Adsorption of bile salts at the oil-water interface 
reduces the surface tension of the oil droplets thereby 
increasing the stability of the emulsion. Experiments by 
Lindhorst et al.(1977) indicated that at the usual 
intra-luminal pH of approximately 6.5, monoglyceride, fatty 
acid and bile salt monomers interact to reduce the interfacial 
tension of oil droplets sufficiently to allow emulsification 
during the introduction of low intensity shear forces, such as 
are produced by gastro-intestinal movement. The formation of 
• 
emulsions of high stability is relatively unimportant as fat 
digestion normally occurs rapidly. 
Within the intestinal lumen bile salts are usually above 
their CMC and therefore form micelles. The importance of 
micellar solubilisation of the lipolysis products varies 
greatly for different fats. The soaps of short chain fatty 
acids (SCFA) are sufficiently water soluble to give a 
reasonabie rate of absorption even in the absence of bile salt 
micelles. For less water soluble fatty acids a dynamic 
equilibrium i8 established between the fatty acids in the oil 
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phase, in the micellar phase and in the aqueous phase. 
Absorption of fatty acids causes a shift in the equilibrium 
drawing fatty acids and monoglycerides out of the oil phase 
into the micellar or aqueous phases. For long chain fatty acids 
(LCFA) the rate of absorption from the micellar phase is faster 
than from the aqueous phases as they partition in favour of the 
bile salt micelles, the reverse being true for short and medium 
chain fatty acids. The absorption surface of the intestinal 
mucosal cells is considered to be covered by a layer of 
unstirred water through which the digestion products have to 
diffuse prior to absorption. As the rate of diffusion is 
inversely related to the square root of the molecular weight, 
the micelle diffuses across the unstirred layer at a rate about 
a tenth of that of the molecule. However, the concentration of 
the water insoluble lipids in the micellar phase is considered 
to be 100 times that in the molecular lipid phase. Thus the 
presence,of a micellar phase favours transport of these lipids 
through the unstirred water layer by a factor of ten. When the 
• 
micelles have delivered their content of lipid they diffuse 
back into the bulk phase (Borgstrom 1974,Wilson & Dietschy 
1972) • 
The mechanism by which fatty acids and monoglycerides 
enter the mucosal cells remains obscure, although the initial 
uptake is not energy dependant as it occurs in the absence of 
oxygen, at low temperatures and in the presence of metabolic 
inhibitors (Mishkin et al.1972,Johnston & Borgstrom 1964). As 
uptake is a passive process the rate depends on the 
concentration'of free unbound fatty acid external to the cell. 
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It is possible that there are specific receptor sites for fatty 
acids in the mucosal membrane but they have not yet been shown 
to be present. It seems likely that some facilitating mechanism 
within the cell accounts for the fact that after uptake LCFA 
rapidly leave the lipoidal membrane to enter the aqueous 
cytosol of the cell. This movement of fatty acids through the 
cell has been observed during electron microscopy studies 
(Ohshima 1977). Ockner and Manning ( 1 9 ~ 4 ) ) found that ~ ~ protein 
constituent of the mucosal cell, which they called fatty acid 
binding protein (FABP), was capable of binding to LCFA and that 
its concentration responded to the fat content of the diet. In 
addition it was found to have a greater affinity for 
unsaturated rather than saturated fatty acids. 
Short and medium chain fatty acids (less than C10 ) are 
sufficiently ~ w a t e r r soluble to move through the m u c o s a ~ ~ cell 
into the hepatic portal vein, by diffusion alone. Fatty acids 
having a longer chain lengths are re-esterified within the 
mucosal cell, incorporated into chylomicra and transported into 
• 
~ h e e lymph (see figure 1.1). The distribution of fatty acids 
between these two a b s o r p t i ~ n n pathways is discussed in section 
1.5.1. Two pathways for the re-esterification of LCFA are 
recognised (Isselbacher 1967), the synthetic enzyme system 
responsible being located in the smooth endoplasmic r e t i ~ l u m m
(Ohshima 1977,Sabesin & Frase 1977). Intra-cellular 
triglyceride formation is promoted by an increased rate of 
fatty acid delivary to the mucosa, mucosal penetration being 
the rate-limiting step in fatty acid absorption. 
The mechanism by which re-synthesised triglycerides are 
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formed into chylomicra is not clearly understood. Chylomicra 
consist of an oil droplet of liquid triglyceride containing 
small amounts of dissolved, esterified cholesterol, and a 
stabilising layer of more polar lipid (phospholipid) together 
with protein lying at the interface between the oil and aqueous 
medium (Johnston 1968). It is possible that the oil droplets 
are formed in a proteinaceous medium within the membrane bound 
cisternae (smooth ,endoplasmic reticulum) of the cell so that a 
layer of lipophilic protein forms around each drop (Cardell et 
al.1967). The proteins are probably formed in the ribosomes of 
the rough endoplasmic reticulum passing through communications 
between the cisternae of the rough and smooth endoplasmic 
reticulum to associate with re-synthesised triglycerides 
forming the chylomicra. Inhibition of protein synthesis using 
puromycin (Yousef et al.1976,Friedman & Cardell 1972,Kayden & 
Medick 1969,Redgrave 1969,Redgrave & Zilversmitt 1969) and 
acetoxycycloheximide (Glickman et al.1972) has shown that 
lipoprotein synthesis has a marked influence on the absorption 
• 
and transport of long chain triglycerides. However, the 
reliabiliy of this technique has been questioned (Barrowman 
1978). 
During fat absorption chylamicra can be seen to 
accumulate in Golgi. vacuoles in the cytoplasm close to the 
lateral borders of the epithelial cells and in enlarged 
intracellular spaces between neighbouring cells at the level of 
their nuclei (Cardell et ale 1967). Polay and Karlin (1959) 
proposed that chylomicra leave the cell by reverse pinocytosis, 
and B.M. studies (Ohshtma 1977,Sabeisin & Frase 1977) have 
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shown Golgi vacuoles containing lipid droplets fused with the 
lateral cell membrane following absorption of LCFA. Recent 
studies by Glickman et al.(1976) using colchicine have 
indicated that microtubules may be involved in the extrusion 
process. From the intercellular spaces chylomicra appear to 
pass through the basement membrane of the epithelial cells into 
the lamina propria of the villus and thence gain access to the 
lymphatic vessels. Chylamicra enter the terminal lymphatics by 
passing between the epithelial cells (Casley-Smith 1962, 
Sabesin 1976), or by passing through the cells in vesicles 
(Casley-Smith 1962,Dobbins 1971,Dobbins & Rollins 1970). 
Triglycerides may also enter mesenteric lymph in the 
form of very low density lipoproteins (VLDL). The mechanism by 
which resynthesised triglycerides are assigned to one of these 
carrier proteins appears to be specific and dependant on the 
degree of unsaturation of the constituent fatty acids (Ockner 
et al.1969,Leat & Harrison 1974). Caselli et al.(1979) 
administered corn oil, peanut oil, rapeseed oil and canbra oil 
• 
to rats and found that the higher the proportion of unsaturated 
fatty acid ingested the more numerous and the greater the size 
of the chylomicra, whereas absorption of saturated fatty acids 
gave rise to numerous VLDL like particles and small chylomicra. 
The size of chylomicra also varies with the fat load in the 
intestine, the mean size of fat particles in the lymph 
increases during absorption and their phospholipid content 
decreases (Borgstrom & Laurell 1953,Fraser et 
al.1968,Bouqui1lon et al.1974). Glickman et a1.(1972) showed 
that the size of chy1amicra ia dependant on the rate of mucosal 
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protein synthesis, ~ n h i b i t i o n n of protein synthesis caused a 
marked, sustained increase in chylomicra size following 
intra-duodenal lipid infusion in rats, in an attempt to 
"package" lipid more efficiently. Shepherd and Simmonds (1959) 
suggested that there is a limit to the rate at which fat can be 
transfered to lymph. 
Upon release of chylomicra and VLDL particles into the 
vascular system the triglyceride is hydrolysed by lipoprotein 
lipase bound to the luminal surface of capillaries. The fatty 
acids released bind to albumin and remain in circulation or are 
taken up by the liver. The other fractions of chylomicra are 
also taken up by the liver (Scow et al.1980). 
Several workers (Knoebel 1972,Sabesin et al.1975,Noguchi 
et al.1977) have shown that the proximal region of the 
intestine is the principal site for fat absorption, although 
absorption 'in the distal region may occur in adverse 
conditions. The rate of fatty acid re-esterification is greater 
in the proximal region (Kotler et al.1980) and Wu et al.(1980) 
• 
concluded that the distal intestine is defective in utilising 
phospholipid for chylomicra synthesis. Under conditions of high 
lipid infusion absorption of triglyceride may occur at a low 
rate in the distal intestine. 
1.3 Effect of Fat on Gastro-Intestinal Transit. 
The gastro-intestinal smooth ,muscle cells are 
characterised by spontaneous activity and autorhythmicity. 
External factors such as mechanical or chemical sttmulation of 
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the mucosal receptors, extrinsic or intrinsic nerve impulses 
and hormones modulate this spontaneous actvity to give rise to 
the different movements of the gut. Inhibition of 
gastro-intestinal transit by fats has been observed by many 
workers, one of the earliest being Roberts (1931) who showed 
gastric motility in humans to be inhibited by a variety of 
natural triglycerides. The precise mechanism by which fats 
exert this effect is unclear. 
Distention of the stomach stimulates gastric emptying 
but as soon as fresh food enters the duodenum it initiates the 
responses that then inhibit further emptying (Wiepkema et 
al.1972). Aberdeen et al.(1960) found that in rats, 15-20\ of a 
test meal containing emulsified coconut oil, PEG. and saline was 
immediately recoverable from the small intestine but that no 
further material left the stomach during the first hour. Once 
gastric emptying re-started it proceeded at a steady rate which 
was slower in the presence of 1.0m! oil than with either 0.5m! 
or 0.25m! oil present. 
• 
Exit of chyme from the stomach is associated with antral 
peristaltic waves moving all the way to the pyloric sphincter. 
Upon approaching the pylorus the contraction produces a 
pressure q r ~ ~ e n t t of 2-4mmHg in humans, which is sufficient to 
. 
initate passage of chyme through the pylorus into the d u o d e n ~ . .
. . 
The pylorus then begins to contract increasing the resistance 
to the outlet and causing a sharp rise in pressure in the 
antrum. Evacuation is stopped when the closure of the pylorus 
i8 complete. Peristaltic action in the first portion of the 
duodenum is cloaely associated with that of the antral stomach 
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(Jacobson & Shanbour 1974,Cohen et al.1979) and the evacuated 
contents are rapidly propelled into the second portion of the 
duodenum while the pylorus remains closed preventing reflux. 
The role of the pyloric sphincter in the regulation of gastric 
emptying is not clear, there being evidence to suggest that it 
may have a role in the emptying of solids only. This is 
discussed in a review by Cooke (1975). 
Usually gastric emptying is slowed by a depression or 
abolition of the propulsive antral pumping activity, affected 
by neural and humoral mechanisms ( T h o m a ~ ~ 1957). Hunt and Knox 
(1968a) have defined three types of receptors in the duodenum 
which respond to acid, osmotic pressure and lipids present in 
. 
the intestinal contents by indirectly inhibiting gastric 
emptying. Neural inhibition is transmitted by the vagus, 
stimulation of the receptors influences the vagal nucleus which 
in turn co-ordinates gastric motility (Thomas & Baldwin 1968). 
This is discussed at greater length by Cohen et al.(1979). In 
the presence of fat humoral inhibition is mediated via the 
• 
enterogastrone hormones CCK and secretin, released from the 
mucosa of the upper intestine in response to fatty acids in the 
lumen. It is not known whether hormone-release is by direct 
action of the'fatty acids on the endocrine cells, or at another 
site via a neural-hormonal reflex. Secretin inhibits both 
gastric and intestinal motiliy as well as gastric emptying 
(Chey et al.1970), whereas CCK inhibits gastric emptying but 
stimulates gastric and intestinal motility at physiological 
concentrations (Oebas et al.1975). Yamaqishi and Oebas (1978) 
investigated the effectiveness of the C-terminal octapeptide of 
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CCK in inhibiting the emptying of 300ml saline in dogs, and 
concluded that CCK inhibits gastric emptying by relaxation of 
the proximal stomach and contraction of the pyloric sphincter. 
Again this is discussed at greater length by Cohen et 
al.(1979). The pyloric shincter has also been shown to contract 
in response to acid, fat, amino acids and glucose preventing 
emptying (Fischer & Cohen 1973). 
Biliary and pancreatic secretions are essential for the 
inhibiton of gastric motility by fat, as fatty acids are 
required for receptor stimulation having a much lower threshold 
for inhibition than triglycerides (Quingley & Meschan 
1941,Menguy 1960,Long & Weiss 1974). The chemical structure of 
. 
the fatty acid is important in determining the extent of the 
inhibition of gastric emptying. Hunt and Knox (1968b) 
investigated the effect of straight chain fatty acids on 
gastric emptying and found that from acetic (C2 ) to octanoic 
acid (Ca ) there was little difference in the effect on gastric 
emptying, from C10 to C14 fatty acids there was a significant 
• 
increase in the ability to delay gastric emptying, but C16 
(palmitic) and C1a (stearic) acids were not as effective as C14 
(myristic) acid. Unsaturated fatty acids delay gastric emptying 
more than saturated fatty acids of the same chain length 
(Cooperman & Cook 1976). 
Upon arrival in the descending duodenum the chyme is 
subjected to the action of a complicated series of 
contractions, relaxations and tonus changes, resulting from 
segmentation (stationary ring contractions) and peristalSis 
(moving rin9 contractions) of the intestinal muscles that 
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affects mixing and then propulsion. The occurence and force of 
contraction at a given point depends on the inter-relationship 
among several factors; intrinsic and extrinsic nerve reflexes, 
activity of the autonomic nervous system and various locally 
released chemical agents (serotonin, histamine, prostaglandins, 
etc. ). Simmonds (1957) observed that pressure patterns 
associated with propulsive motility are decreased in the 
proximal jejunum by fat feeding whilst non-propulsive motility 
is increased. 
The amount of food transported per unit time through the 
intestine and the speed of overall progression along the gut 
are greatly influenced by the rate of gastric emptying 
(Derbloom et al.1966,Pirk 1967). Thus inhibition of gastric 
emptying produced by contact of food with the intestinal 
mucosa, contributes to slower progression through the gut. 
Investigations into the influence of fats on intestinal transit 
have suggested that gastric emptying and not intestinal 
motility is the determdning factor in gastro-intestinal transit 
• (Aberdeen et al.19DD,Derbloom et al.1966,Yamahira et al.1978). 
Thus fats slow gastric emptying through a complex 
response, mediated by neural and humoral mechanisms, to the 
stimulation of duodenal receptors by fatty acids in the 
intestinal lumen. Propulsive intestinal motility is also slowed 
by fatty acids although intestinal transit is largely dependant 
on the rate of gastric emptyinq-
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1.4 Lymphagogue Effect of Fats. 
A number of authors have discounted lymph as a major 
route of drug transport due to its low flow compared to blood; 
blood flow being 500-700 times that of lymph under normal 
conditions (Bollman et al.1948,Reininger & Sapirstein 1957). 
Lowrimore (1977) suggested that any drug not exclusively 
absorbed by the lymph would therefore be taken up tO,a greater 
extent by the portal system. It follows that the percentage of 
drug absorbed via the lymphatic route may be increased by 
stimUlation of lymph flow. 
Water and fats are the only dietary materials that have 
been shown to stimulate lymph flow iSimmonds 1954,Gallo-Torres 
& Muller 1969a) although there is a distinct difference in the 
underlying mechanisms causing this change. Borgstrom and 
Laurell (1953) studied lymph and lymph proteins during fat and 
saline absorption in rats. Both materials caused an increase in 
lymph flow but.with saline there was a corresponding decrease 
• in lymph protein concentration, whereas this was increased by 
fat. In addition, optimal water flow was reached two hours 
earlier than optimal lipid flow following fat administration. 
It was suqgested that the increase in lymph flow following 
saline administration was due merely to increased fluid 
absorption fram the intestinal lumen, whereas increased lymph 
flow and protein levels followinq fat feedinq was due to 
increased blood filtration followinq a rise in blood flow 
through the mesenteric vessels. It is possible to visualise 
plasma protein escape from the vascular system by bindinq Evans 
- ~ ~
Blue dye to plasma albumin. Using this technique Wollin and 
Jacques (1973) showed that following intra-gastric 
administration of olive oil (2mg/kg) or glucose solution 
(O.5g/ml) to rats, far higher concentrations of extravascular 
dye were found in the fat-fed rats. These observations were in 
agreement with the findings of Simmonds (1957) who suggested 
that the lymph flow changes following fat feeding are mediated 
by some humoral effect on the mucosal blood flow or motility or 
both. 
Studies by Fara et al.(1969,1972) in the cat showed that 
intra-duodenal administration of fat caused an increase in 
mesenteric blood flow, inhibited gastric and duodenal motility 
and increased gallbladder pressure and pancreatic secretion. In 
addition intravenous administration of hormones which are 
released during fat digestion (CCK or secretin) was found to 
have a significant vasodi·lator effect on the superior 
mesenteric vascular bed. CCK was also found to increase gut 
motility but this required a cholinergic link. Further 
• 
investigations using anaesthetised cats showed that 
pentagastrin and CCK induced motor contraction of the small 
intestine and a transient increase in regional blood flow, 
whilst secretin had no effect on motility but caused a 
sustained increase in blood flow "(Fasth et al.1973). Secretin 
appears to increase submucosal blood flow while CCK enhances 
mucosal blood flow (Fara , Madden 1975). Following this work in 
c a ~ s , , Turner and Barrowman (1977) showed that intravenous 
administration of CCK and its synthetic C-terminal octapeptide 
cau.ed a transient augmentation of intestinal lymph flow in 
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rats which was suggested to be a result of the effect of these 
agents on mesenteric blood flow. 
Biber et al.(1973} proposed that vasodilatation in the 
gut depends partly on the release of intestinal hormones and 
partly on local mechanisms evoked by mechanical and possibly 
, 
chemical stimulation. They showed that intra-arterial 
administration of 5-hydroxytryptamine produces a similar 
vascular response in the small intestine to that of CCK and 
secretin. In addition, studies by Wollin and Jacques 
(1974,1976) implicated histamine in the mechanisms increasing 
intestinal capillary permeability. They were able to prevent 
the increase in lymph flow and plasma protein escape in the rat 
following intra-gastric administration of olive oil, by 
blockage of H1 and H2 receptors or by stimulation of diamine 
oxidase (DAD) release by prior injection of heparin. They 
proposed that histamine was released locally after olive oil 
feeding and that this increased the permeability of the 
intestinal capillaries to plasma proteins. DAO levels in lymph 
• 
were found to be elevated during fat feeding again suggesting 
histamine release; DAO is released to limit the biological 
response to histamine when it is liberated in large quantities 
(Buffoni 1966). Charbon et al.(1980) showed that histamine and 
2-methyl-histamine also increase blood flow in the vascular 
beds of the superior mesenteric artery, left gastric artery and 
canmon hepatic artery of dogs. 
It has been suggested that intestinal blood flow may be 
increased by increased gut motility following CCK release 
(Frank and Kern 1968,Lee 1965). However, Simmonds (1957) had 
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shown by in vivo experiments with anaesthetised rats, that gut 
motility is not essential for the propulsion of lymph, and that 
the increase in the formation and propulsion of lymph during 
fat absorption was not dependant on a high level of intestinal 
motility. Depression of intestinal motility in rats by 
intra-duodenal infusion of atropine had no effect on the 
ability of the intestine to absorb and transport fat (Bennett & 
Simmonds 1962). Glucagon has a vasodilator action on splanchnic 
circulation but inhibits intestinal motility. Barrowman et 
al.(1978) found that glucagon caused a rapid but transient 
increase in lymph flow again suggesting that intestinal 
motility is unimportant in the lymphagogue effect of fat. 
It can be seen therefore that the increase in lymph flow 
following fat feeding is due to a complex mechanism of humoral 
and local effects causing vasodilatation and increased 
capillary permeability, giving rise to increased plasma 
filtration. The precise manner in which these mechanisms 
interact is as yet not ~ u l l y y understood. 
• 
1.5 Intestinal Lymphatic Absorption. 
Although few, studies have been performed a number of 
isolated reports in the literature suggest that under certain 
conditions some foreign compounds can exhibit significant 
lymphatic absorption. LCFA and some dietary compounds are 
absorbed primarily into the intestinal lymph. A knowledge of 
the factors affecting the absorption of these compounds will 
help in determining the criteria for lymphatic absorption and 
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the potential for enhanced lymphatic drug absorption in the 
presence of fats. 
1.5.1 Lypmhatic Absorption of Fatty Acids. 
A number of studies (Powell 1932, Hughes & Wimmer 1935, 
Bloom et al.1950, Reiser & Bryson 1951, Bloom et al.1951, 
Chaikoff et al.1951, Kiyasu et al.1952, Bergstrom et al.1954, 
Bloamstrand 1954) have shown that following intestinal 
absorption fatty acid molecules of greater than C14 chain 
length are transported primarily as fatty acid esters in the 
chylomicra of the mesenteric lymph, whereas medium chain fatty 
acids (MCFA) with a chain length of CS-C 12 , are carried 
primarily as free fatty acids in the portal vein. 
A small proportion of LCFA will normally partition into 
the portal vein during absorption and be transported by this 
route (Bloom et al.1950, Blomstrand 1954). This partitioning 
into the portal vein appears to be dependant on the chemical 
structure and on the quantity of fatty acid administered. 
McDonald et al.(1977,19S0) showed that for linoleic acid the 
• , 
percentage absorbed into the lymph of rats was directly related 
to the intra-duodenal infusion rate of the oil. From a similar 
study with a variety of fatty acids it was concluded that at 
physiological concentrations of fatty acids in the intestinal 
lumen the portal pathway accounts for more LCFA transport than 
previosly realised, especially for unsaturated fatty acids. 
However, this system is saturable at a level that varies for 
each fatty acid and then the remainder has to be transported in 
the lyJll)h. Failure in the digestive mechanisms for LCFA at any 
stage will increase the partitioning into the portal vein. 
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Several workers have shown that a deficiency of bile salts 
within the gut lumen reduces re-esterification of fatty acids 
in the mucosal cells leading to greater transport of LCFA 
through the portal vein (Gallagher et al.1965, Dawson & 
Isselbacher 1960, Saunders & Dawson 1963, Borgstrom 1953). 
Kayden & Medick (1969) found that inhibition of protein 
syntheSis by puromycin reduced chylomicra formation, again 
resulting in an increase in LCFA absorption into the portal 
vein. 
Absorption of MCFA into the lymph does not occur as 
readily as absorption of LCFA into the portal vein. Borgstrom 
(1955) suggested that the route by which fatty acids are 
transported following absorption is determined by the extent of 
their re-esterification within the mucosal cell. It has been 
shown that within these cells the re-esterifyingenzymes (see 
section 1.2) are specific for LCFA (Brindley & Hubscher 1966) 
and that there are also short and medium chain glyceride 
hydrolases present (Borgstrom 1974). Formation of short or 
• 
medium chain triglycerides within the mucosal cell does not 
readily occur therefore, with the result that only a small 
proportion of MCFA is transported in the lymph, as illustrated 
by Hyun et al.(1967). They found that follOWing administration 
of 150mq 1 4 C - ~ c t a n o 1 c c acid (Ca ) ~ r r 292mq 14C-oleic acid (C 1a ) 
in 3mls emulsion ~ o o rats with lymph and portal vein cannulae, 
as, of the absorbed oleic acid was transported by the lymphatic 
system but as much as 15' was transported directly by the 
portal vein. 5o, of the oleic acid detected in the portal blood 
was as free, unesterified fatty acid. However after 
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administration of octanoic acid 95% of the absorbed fatty acid 
was transported by the portal system and the small amount 
present in the lymph was predominantly as free fatty acid. It 
is possible that this small amount of 14C-activity was 
transferred from the blood to the lymph during general 
circulation. 
It would appear that MCFA absorption is restricted 
almost totally to the portal route whereas LCFA absorption is 
primarily via the mesenteric lymph but a small proportion is 
also absorbed into the portal vein. During abnormal conditions 
the portal system may f o ~ ~ the primary route of absorption for 
LCFA. 
The degree of unsaturation of the hydrocarbon chain also 
affects fatty acid absorption. Unsaturated fatty acid have been 
shown to be more rapidly absorbed into the mucosal c ~ l l s , , more 
readily bound to fatty acid binding protein and more easily 
esterified than saturated acids of equal chain length (Ockner 
et al.1972,Gangl et al.1980,Simmonds et a l . 1 9 6 8 , C h o ~ ~ & 
• 
Hollander 1979). 
Thus the rate and route of absorption of fatty acids is 
dependant on:-
a)the lipophilicity of the molecule as determined by the 
hydrocarbon chain length and the degree of unsaturation, 
b)the fatty acid load within the intestinal lumen, 
c)the affinity of the fatty acid for the enzymes and carrier 
prot,eins involved in the digestion ,process. 
1.5.2 Lymphatic Absorption of Dietary COmpounds. 
Cholesterol is the major sterol found in animal tissue 
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being an important structural component of cell membranes and a 
precursor for the formation of bile salts and steroidal 
hormones. It is almost totally absorbed via the lymphatic 
system both in rats (Sylven & Borqstram 1968) and humans 
(Hellman 1960). Sieber et al.(1974) showed in rats that all of 
the absorbed activity from a labelled 0.72pmol/kg dose of 
cholesterol was recovered in the lymph, almost all in the form 
of cholesterol esters in the chylomicron fraction. As a result 
of this property cholesterol has been used in some absorption 
studies to assess the degree to which a test compound is 
transported by the lymph. 
The fat soluble vitamins, A,D,E and K, all exhibit 
significant, if not total a b s o ~ t i o n n via the lymphatic route. 
Absorption of vitamin A can occur via the portal route in rats 
(Murray & Grince 1961,Yeung & Veen-Baigent 1972) especially in 
abnormal conditions such as diverted bile flow (Gagnon & Dawson 
1968, Hollander 1980) but normally it p ~ r t i t i o n s s between the 
lymph and the blood in favour of the lymph. Schachter et 
• 
al.(1963,1964) demonstrated in the rat that vitamin D is 
absorbed maximally in the jejunum and transferred chiefly to 
the lymph as the free biologically active sterol. The 
tocopherols (vitamins E) are absorbed from the gut unchanged 
and the intestinal lymph acts as the major route of absorption 
(Peake et a1.1972,Johnson & Pover 1962,MacMahon et al.1971). 
Using 14c-1abel1ed vitamin K preparations Jacques et al.(1954) 
found that approximately 50% of a dose of vitamin ~ 1 1 and all of 
a dose of vitamin X3 was absorbed by rats. Vitamin K1 appeared 
to be transported mainly via the intestinal lymphatics and 
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vitamin K3 by the portal venous route. These results were later 
confirmed by Mezick et al.(1968). 
The presence of bile salts has been found to be 
essential for the lymphatic absorption of cholesterol (Chaikoff 
et al.1952) and the fat soluble vitamins D (Schachater et 
al.1963,1964) and E (Gallo-Torres 1970). Due to the low water 
solubility of these materials solubilisation by bile salt 
micelles is required to enable movement of the xoolecule through 
the aqueous envirament of the gut lumen to the mucosal 
membrane. It has also been suggested that bile salts may be 
essential for the hydrolysis of cholesterol and vitamin esters 
that is necessary prior to absorption, and may aid penetration 
of the molecules into the mucosal cell itself (Gallo-Torres 
1970). Vitamin A is sufficiently water soluble to be absorbed 
directly into the portal vein in the absence of bile (Gagnon & 
Dawson 1968). 
Co-administration with long chain triglcerides (LCT) has 
been shown to enhance the lymphatic absorption of cholescerol 
• 
and vitamins D and E by a variety of mechanisms. Incorporation 
of fatty acids and monoglycerides into the bile salt micelle 
increases the solubility of the cholesterol in the hydrophobic 
micellar centre giving rise to increased absorption (Hofman & 
. 
Small 1967,Treadwell & Vahouny 1968). In addition,· LCT 
stimulate chylomicra synthesis t h e r e ~ ~ increasing the capacity 
of the lymph to transport cholesterol (see section 1. 2) • 
Thompson et al.(1969) ascribed the enhanced absorption of 
cholesterol and vitamin 0 following co-administration with LCT 
to increased tran8port of the ccmpounds out of the mucosal cell 
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into the lymphatics. The enhanced absorption of vitamin E in 
the presence.of LCT was attributed to stimulation of bile flow 
giving rise to increased solubilisation of the poorly water 
soluble vitamin (Gallo-Torres et al.1971,MacMahon & Thompson 
1970). All these proposed mechanisms are feasible and it is 
likely that it is a combination of these effects that results 
in increased lymphatic absorption. The effectiveness of this 
triglyceride stimulation is related to the chain length of the 
constituent fatty acids, only LCT enhance absorption as only 
LCFA are absorbed via the lymphatic pathway. In addition, if 
cholesterol is administered in a hydrocarbon oil, absorption is 
decreased almost to zero (Sylven & Borgstrom 1969,Mattson et 
al.1976) because cholesterol partitions in favour of the oil 
which is not absorbed and the cholesterol is therefore retained 
within the intestinal lumen. 
Thus the presence of bile salts is essential for the 
lymphatic transport of cholesterol and vitamins 0 and E due to 
their low solubility in the aqueous enviroment of the gut 
• 
lumen. Co-administration with LCT enhances the absorption of 
these compounds by increasing their solubility in the bile salt 
micelles, by stimulating chylomicra synthesis and/or increasing 
the transport out of the mucosal cells into the lymph • 
. 
1.5.3 Lymphatic Absorption of FOreign COmpounds. 
Robbins (1929) found that in the presence of dietary fat 
(cream) there was a marked increase in the absorption of carbon 
tetrachloride in the doq. I t was suggested that this may be due 
to absorption of the drug with the fat t h e r e ~ ~ avoiding 
first-pass metabolism. Analysis of lymph samples showed that 
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carbon tetrachloride was only present following 
co-administration of cream. 
The lymphatic absorption of the steroid ethynylestradiol 
(EE) in rats was found to be enhanced by the addition of a 
lipophilic grouping and by administration in an oily vehicle 
(Gianna et al.1966). Only 0.4-0.6% EE was recovered in the 
lymph when given in aqueous or oily vehicles, whereas 1.4% of a 
dose of ethynylestradiol cyclopentylether was recovered in the 
lymph following administration in aqueous suspension, 7.5% 
following administration in sesame oil solution and 15.7% 
following administration in sesame oil containing 25%w/v 
glyceryl mono-oleate. Similarly Coert et al.(1975) showed that 
the androgenic activity of testosterone in rats over 7 days was 
greatly improved by esterification to the apolar testosterone 
undecanoate. This effect was further augmented by dissolving 
the ester in arachis oil. It was demonstrated that the 
absorption of testosterone undecanoate occured via the 
lymphatic route. These findings were confirmed in human 
• 
patients (Horst et al.1976). This suggests that both the 
lipophilicity of the compound and the nature of the vehicle are 
important in determininig the extent of lymphatic absorption. 
In 1969 DeMarco and Levine reported an attempt at a more 
systematic investigation into the role of the lymphatics in 
intestinal absorption and distribution of drugs. They 
considered the absorption in rats of intra-duodenal doses of 
para-aminosalicylic acid (PAS) ( 4 0 m ~ ~ in 2ml water) and 
tetracycline hydrochloride (20mg in 1ml water) and concluded 
that under normal conditions the lymphatic route contributes 
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little to the overall absorption of the two drugs. It was 
suggested that as there was no selective uptake into the lymph 
the major route of absorption would be the blood due to its far 
higher flow rate. Pre-dosing with tripalmitin to increase the 
lymph flow was found to increase the level of both drugs in the 
lymph (Levine 1970), and ligation of the superior mesenteric 
vein to decrease the blood flow also increased PAS lymph 
levels. Thus for compounds not selectively absorbed into the 
lymph co-administration of lipid may increase the lymphatic 
absorption by stimulation of lymph flow. 
Lowrimore (1977) performed a series of investigations in 
order to elucidate the relationship between the physicochemical 
properties of drugs and their absorption and distribution by 
the lymphatic system. Lymph levels following intra-gastric 
injections of aqueous, radiolabelled solutions of the acidic 
drugs phenobarbital and thiopental, the basic drugs 
d-amphetamine and imipramine, and the neutral compounds ethanol 
and prednisolone, were determined in anaesthetised, female 
• 
mongrel dogs. Only prednisolone appeared in significantly 
greater concentrations in the lymph than in the portal blood 
during the absorptive phase. It was suggested that the ability 
of a compound to be absorbed by the lymph rather than the 
portal venous system is significantly, but not exclusively 
governed by the lipid solubility of the compound. A correlation 
was observed between the relatively selective lymphatic 
absorption of compounds and their ability to become 
incorporated into the lipid phase of the lymph. 
Similar criteria for lymphatic a b s o ~ t i o n n were suggested 
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by Sieber et al.(1974). They studied the lymphatic transport of 
a large series of radiolabelled foreign and natural compounds 
intra-duodenally administered in ethanol/water solution to rats 
with thoracic duct fistulae. In most cases the activity 
recovered in the lymph over 24 hours was only a small 
percentage of the total amount absorbed. The portal route 
appeared to be more important in the intestinal absorption of 
benzene, benzoic acid, aniline, p-aminosalicylic acid, 
salicylic acid, phenanthrene, oestradiol, testosterone, 
d i g o x i n ~ ~ hexanoic acid, hexylamine, hexanol, antipyrine, 
isoniazid and caffeine. Only a few compounds appeared to be 
. selectively absorbed via the intestinal lymphatics, -namely 
octadecanol, cholesterol and p,pDDT, all of which are highly 
lipid soluble. It was shown that for compounds poorly absorbed 
into the lymph most of the radioactvity was carried in the 
infranatant phase of the lymph, whereas for those compounds 
more readily absorbed the radioactivty was present in the 
chylomicra. This suggests that the lipid fraction of the lymph 
• 
is important in carrying compounds well absorbed into the 
lymphatics and it could be that the extent of absorption is a 
function of lipid solubility. However, a further study by 
Sieber (1976) on the lymphatic absorption of DDT and some 
structurally related compounds which varied markedly in 
lipophilicity, suggested that there was not a strict parallel 
between lipophilicity and lymphatic absorption. Kamp and 
Neurmann (1975) concluded that while lipid solublity appeared 
to be a major pre-requisite, specific structural requirements 
contributed to deter.mininq the extent to which compounds are 
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lymphatically absorbed. 
In a series of investigations with rats, into the 
absorption of 17-methyl-14C-oestradiol (Blockage et al.1953), 
17«methyl-14C-testosterone (Hyde et al.1954) and 
cortisone-4- 14C-acetate (Blockage et al.1955), it was concluded 
that the lymphatic absorption of these steroids was 
insignificant with respect to the total absorption. Only 0.2 to 
0.4% of a 0.2mq dose of 1 7 ~ m e t h y l - 1 4 C - t e s t o s t e r o n e e was 
recovered in the lymph over 24 hours reqardless of whether it 
was administered in a 50% ethanol solution or in corn oil. 
Similarly with a 0.2mq dose of cortisone-4- 14C-acetate, none 
was recovered in the lymph although 46% of the dose was 
absorbed. It was suggested that in the former case the small 
amount of steroid detected in the thoracic duct lymph could 
have been derived from the plasma. Following oral 
administration of labelled hydrocortisone and testosterone in 
human patients Hellman et al.(1956) also concluded that these 
compounds were not transported to a significant degree in the 
• 
thoracic duct lymph'. These results are in general agreement 
with those reported by Sieber et al.(1974) in which it was 
suggested that these steroids were not sufficiently lipid 
soluble to be selectively absorbed into the lymph. 
The same conclusion can be applied to the cardiac 
glcosides. Porth et al.(1969) studied the intestinal absorption 
of aqueous solutions of tritium labelled digoxin, dig! toxin and 
oubain in the intestinal loops of anaesthetised cats. Drug 
concentrations always remained below those in the portal blood, 
the amount of glycoside passing into the lymph during one hour 
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being only 0.006 to 0.02% of the administered dose, with oubain 
displaying the highest lymph levels followed by digitoxin and 
digoxin. Administration of digtoxin as an olive oil emulsion 
failed to increase the lymphatic absorption and it was 
concluded that these glycosides appear in the lymph indirectly 
by way of the blood. These findings for digoxin and digitoxin 
were confir.med by Oliver et al.(1971) and Beerman & Hellstrom 
(1971). In addition only trivial amounts of proscillaridin A, a 
cardiac glycoside derived from squill, were found in human 
thoracic duct lymph after oral dosing of the drug as a tablet 
to two patients (Anderson 1977). 
A major criterion for lymphatic absorption would 
therefore appear to be high lipid solubility such that the 
material is carried in the chylomicra of lymph. Increasing 
lipophilicity by structural modification such as 
esterification, and stimulation of lymph flow by 
co-administration with oils, may enhance lymphatic absorption • 
• 
1.6 Objectives and Proposals. 
In summary it has been suggested that drug absorption in 
the presence of lipids may be affected by 4 main physiological 
. 
factors a)gastro-intestinal motility, b)lymph flow, c)bile flow 
and d)memhrane p e ~ e a b i l i t y , , associated with fat digestion. 
Inhibition of gastric emptying and intestinal motility 
stimulated by fatty acids via neural-humoral pathways (see 
section 1.3), prolongs the time of the drug at the site of 
dissolution and absorption which may result in enhanced 
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absozption. 
Stimulation of mesenteric lymph flow by fatty acids 
increases the potential for drug absozption via this route (see 
sections 1.4 & 1.5.). The lymphatic absorption of drugs offers 
a number of advantages. First, it may be possible to divert 
drug absorption from the portal system, reducing first-pass 
metabolism. Second, the absorption of lipophilic agents showing 
irregular absorption might be enhanced. Finally, if the 
absorption of a drug into the mesenteric lymph can be promoted 
it may be possible to deliver high concentrations of cytotoxic 
drugs into the lymphatic circulation. 
Bile flow is stimulated by fat hydrolysis. In the 
presence of an increased bile salt concentration both drug 
dissolution and absozption may be enhanced. Solubilisation of 
drug in bile salt micelles will aid the dissolution process and 
incozporation of drug into mixed bile salt micelles may enhance 
absorption (see below). 
Several workers have attributed enhanced drug absorption 
• 
in the presence of fatty acids to changes in the mucosal 
membrane permeability (Hori et al.1977,Grisafe & Hayton 
1978b,Inui et al.1976,Muranushi et al.1980).Grisafe & Hayton 
(1978b) suqgested that short and medium chain fatty acids 
present in the intestinal epithellal cell membranes may induce 
a phase transition in the lipid bilayers from organised gel to 
a randamised liquid crystalline phase, and the associated 
change in membrane fluidi ty results in a change in membrane 
permeability. A similar hypothesis was proposed by Muranushi et 
al.(1980) who suggested that mixed bile salt micelles enhance 
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r 
the intestinal absorption of poorly absorbed drugs by 
facilitating the incorporation of the lipid component of the 
mixed micelle into the mucosal membrane. This then interacts 
with the polar region of the membrane phospholipids and 
increases the fluidity and the permeability of the membrane. 
Such a change in permeability is reversible. No conclusive 
evidence has yet been reported to substantiate these theories. 
The aim of the present study was to determine the 
potential for enhancing oral drug absorption by stimulating 
lymphatic absorption" in the presence of a suitable oily 
vehicle. The effect of different oily vehicles on the oral 
absorption of a model compound (DDT) was investigated, the 
influence of lymphatic absorption and gastro-intestinal transit 
being determined. The results from this study were applied to 
the formulation of the steroid prednisolone, in an attempt to 
produce elevated more uniform plasma levels of the drug by 
enhancing the lymphatic absorption. 
• 
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CHAPTER 2. 
ORAL ABSORPTION OF DDT. 
2.1 Introduction. 
The selection of a model compound to determine the 
possiblityof enhancing lymphatic absorption by oral 
administration in an oily vehicle is determined by several 
factors. First that co-administration of the compound with oils 
enhances its oral absorption, second that it exhibits a degree 
of lymphatic absorption, and third that it is readily assayed 
in biological fluids. 
DDT (2,2,-bis(p-chlorqphenyl)1,1,1-trichloroethane) was 
first synthesised by Zeilder in 1874 but attracted little 
interest until the early 1940's when its insecticidal 
properties were discovered. Toxicity studies at this time 
indicated that DDT orally administered as an oily solution was 
more toxic than the corresponding aqueous suspension. Konst and 
• 
Plummer (1946) found that in rats the tremor and the mortality 
ratio induced by DDT was ten times higher following 
admdnistration as a corn oil solution than as an aqueous 
suspension at concentrations of 2%, 5% and 20%w/v • In a similar 
study Woodward et al.(1944) showed the mortality ratio of rats 
followinq adDdnistration of DDT in increasinq doses 
(140-300mq/kq) to be higher with a corn oil solution than with 
an aqueous suspension. However in both sets of experiments it 
is po.sible that the difference between the aqueous and oily 
vehicles was due onl¥ to the difference in the physical for.m in 
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which the DDT was administered, i.e. a suspension compared with 
a solution. Sieber et al.(1974) orally administered to rats DDT 
(0.64mg/kg) in solution in 0.5ml 50% ethanol and in 1ml olive 
oil and found that 82% of the dose was absorbed from ethanol 
compared with 79% from olive oil. However, only 20% of the 
absorbed dose was recovered in the lymph following dosing with 
ethanol whereas 33% of the absorbed dose was recovered in the 
lymph following dosing in olive oil. This suggests that the 
I 
presence of an oil may alter the route, but not the extent of 
DDT absorption. 
Several groups of workers have shown that following oral 
administration to rats, DDT is largely absorbed via the 
lymphatic.pathway, incorporated in the triglyceride core of the 
chylomicra (Pocock & vost 1974,Sieber et al.1974,Rothe et 
al.1957). There is, however, some discrepancy between these 
investigators as to the proportion of DDT absorbed via this 
route. Pocock and Vost (1974) recovered 62\ of a 100nM dose of 
DDT dissolved in sunflower seed oil, from the lymph within 12 
• 
hours, whereas Sieber et al.(1974) recoverea only 33\ of the 
absorbed dose (=26\ original dose) in the lymph in 24 hours 
following oral administration at a dose level of 0.64mg/kg in 
1.0ml olive oil. Rothe et al.(1957) administered DDT (10mg/kg) 
to rats i n . O . ~ m l l emulsion containing 15% peanut oil and 
recovered 4 7 ~ \ \ of the dose, 60\ of this being recovered from 
the lymph. As different doses of DDT in different vehicles were 
used in these experiments it is not possible to compare the 
results directly, although they do suggest that following oral 
administration a proportion of DDT is absorbed into the lymph. 
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Hayes (1959) in a review article suggested that the nature of 
the oily vehicle was important in determining the extent of DDT 
absorption, he stated that "the formulation in which DDT is 
applied is more important than the purity of the compound in 
determining the toxicity and often depends on the amount and 
character of the oil in the formulation". It is possible that 
the chemical composition of the oil is important in determining 
the lymphatic absorption of DDT. 
Early investigators had to rely on relatively 
insensitive analytical methods to determine DDT levels in 
biological fluids. One widely used technique is based on the 
titration of the chlorine in the DDT molecule with silver 
nitrate (Smith & Stohlman 1944). Other techniques include 
spectrophotometry following a complex chemical reaction (Ofner 
& Calvery 1945,Judah 1949) and a biological assay based on the 
toxic response of the housefly to DDT contaminated material 
(Laug 1946). More recently the development of GLC and the 
electron capture detector has provided an accurate analytical 
• 
method for determining trace levels (nanogram quantities) of 
DDT in biological fluids (Dale et al.1970). 
DDT would therefore seem to be a suitable model compound 
for the present investigation. It is highly lipophilic having a 
water solubility of the order of 1-5ppb and an octanol:water 
partition coefficient of 1.6 K106 (Chiou et al.1977). It shows 
some dependance on for.mulation as to the extent of oral 
toxicity and is in part absorbed via the lymphatic route. In 
addition a sensitve analytical technique is available for the 
determination of DDT in biological fluids and tissues. 
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Three oils that are used in pharmaceutical preparations 
but which have chemically different structures were selected as 
vehicles for oral administration of DDT to rats:-
a)Arachis oil B.P.I (peanut oil), a natural oil consisting of 
triglycerides the fatty acid constituents of which are chiefly 
oleic acid (C 18 containing one double bond) and linoleic acid 
(C 18 containing two double bonds) with smaller amounts of 
palmitic, arachidic, lignoceric and stearic acids. 
b)Miglyol 812, a synthetic oil produced by hydrolysis, 
fractionation and re-esterification of coconut oil, consisting 
of a mixture of triglycerides of saturated fatty acids of 
medium chain length (C8 - C12 ). 
c)Liquid paraffin B.P., a mineral oil consisting of a mixture 
of liquid hydrocarbons. 
The oral absorption of DDT from solution in each oil was 
investigated in rats, to determine whether DDT absorption could 
be altered by the presence of an oily vehicle and whether the 
nature of the oil used was an important consideration • 
• 
1.2 Materials and Apparatus. 
2.2.1 Materials. 
a)p,pDDT and p,pDDE - Aldrich Chemicals Co.Ltd.,Gillingham, 
Dorset. 
b)Miglyol 812 - Dynamit Nobel, Slough, Berks. 
c)Liquid paraffin B.P.- Shell. Ltd., London. 
d)Arachis oil B.P. - Evans Ltd., Liver.pool. 
e)Tween 80 - Sigma (London) Chemicals Co.Ltd., Poole, Dorset. 
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f)Amethocaine h Y d r o c h l o r i d ~ ~ 1% B.P. Minims, Metoclopramide and 
Propantheline bromide - Pharmacy Dept., University Hospital, 
Nottingham. 
g)n-Hexane SLR and Formic acid AR 97% - Fisons, Loughborough, 
Leices. 
h)Heptachlorepoxide - Vesicol Chemicals Corporation, Chicago, 
USA. 
2.2.2 Apparatus. 
a)Silverson Blender - Silverson Machines Ltd., Waterside, 
Chesham, Bucks. 
b)QPR hand Homogeniser - Omerod Engineers Ltd., Rochdale, 
Lancs. 
c)Coulter counter model TA 
- Coulter·Electronics Ltd., 
Harpenden, Herts. 
d)Heparinised haematocrit capillary tubes - Gelman Hawsksley 
Ltd., Brackmills, Northhants. 
e)Haematocrit centrifuge - MSE Scientific Instruments, Crawley, 
Sussex. 
• 
f)Dreyer's tubes - R.B.Radleys & Co.Ltd., Sawbridgeworth, 
Herts. 
g)Dosing needles - for.med from a curved syringe needle (Size 
199X2") with a smoothed rounded piece of silver solder at the 
end. 
h)Gas chranatograph - Perkin Elmer Series Model F17 fitted with 
an electron capture detector 6 ~ i i foil source. Operating 
conditions - injector temperature 275°, oven temperature 225°, 
nitrogen carrier gas inlet pressure 170kN/m2 and flow rate 
78ml/Ddn, pulse settinq 6, range 10. 
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i) Rheometer - Deer Variable S tress Rheometer, London. 
2.3 Methods. 
2.3.1 Assay Procedures. 
a)Standard solutions - a stock solution of the internal 
standard (heptachloepoxide) in n-hexane (70ng/ml) was prepared. 
Approximately 100mg DDT was accurately weighed into a 10ml 
flask and made up to volume with the internal standard 
solution. By serial dilution a range of standard DDT solutions 
fram 50-400ng/ml were prepared which were run at intervals 
during the analysis. 
b)Extraction procedure - plasma samples were mixed for one 
minute on the vortex mixer with an equal volume 97% formic acid 
saturated with n-hexane. Two volumes of internal standard stock 
solution were added to each sample which were mixed for a 
further f i v ~ ~ minutes. The aqueous and organic phases were then 
• 
separated by centrifugation at 3,000 rpm for five minutes. 
Samples of the hexane layer were either injected directly onto 
the column or diluted as necessary with stock internal standard 
solution prior to injection. 
c)Efficiency of the extraction procedure - rat plasma samples 
(1ml) were spiked with a concentrated ethanolic solution of DOT 
to qive final concentrations of 50, 100, 200, 300 and 400 
nq/ml. The plasma was shaken overnight and six 50pl aliquots 
from each plasma sample were analysed to determine the 
percentage extraction 'Of O.O.T •• Aliquots (3)(.50fll) of a plasma 
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sample taken by cardiac puncture from a rat dosed 24 hours 
previously with DDT (100mg/kg), were analysed on three 
different days at weekly intervals and the coefficient of 
variation determined. 
d)Cleaning of glassware - due to the sensitivity of the assay, 
glassware had to be thoroughly washed to remove all traces of 
D.D.T •• Glassware was cleaned with acetone and water, allowed 
to stand overnight in aqueous Decon and then re-washed in 
acetone and then n-hexane using an ultra-sonic bath. 
2.3.2 Preparation of Dosage Forms. 
a)Oily solutions - in all experiments in which at least 1ml oil 
was administered the same dose of DDT (100mg/kg) was used. Oily 
solutions containing this dose in 2ml and in 1ml of each oil 
were prepared. To determine the effect of 30pl oil on DDT 
absorption oily solutions containing 7.5mg/kg DDT in 30pl were 
prepared. 
b)Emulsions - oil-in-water emulsions were prepared from each 
oil using the Silverson blender and the QPR hand homogenisor 
• 
and the same basic formula:-
Oil (containing 20mg/ml DDT) 
Tween 80 
water to 100% 
Each rat was dosed with 2mls emulsion. Prior to 
administration the droplet size distribution and viscosity of 
the emulsion was determined using the Coulter Counter and 
rheometer, and the total surface area of the emulsion 
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calculated. Preparations containing (oil + DDT and 6% Tween 80) 
in a volume of 2mls were made to determine the effect of the 
surfactant on DDT absorption. 
c)Control - a fine suspension of DDT (20mg/ml) in water was 
prepared by dissolving DDT in 6% Tween 80 and making up to 
volume with warm water. The particle size distribution of the 
suspension was determined using the Coulter Counter. The dose 
micellised in the aqueous phase was calculated by allowing the 
suspension to settle and then analysing an aliquot of the clear 
supernatant. 
2.3.3 Plasma Level Determinations. 
Groups (n=4 per group) of male Wi star rats, weight range 
180-200g, received a single formulation cotaining D.D.T. 
Immediately after oral administration of the dose each 
rat was restrained to allow blood to be taken from the tail 
tip. 1% amethocaine hydrochloride (O.OSml) was injected 
subcutaneously into the lower half of the tail five minutes 
prior to excision of the last millimetre of the tail. To 
• 
encourage bleeding the tail was gently stroked along its length 
towards the tip. Duplicate blood samples were then collected 
into SOul heparinised capillazy tubes. Each capillary tube was 
approximately three-quarters filled and the end sealed in a 
flame before centrifuging. The haematocrit value of each blood 
sample was noted in the attempt to monitor any haemodynamic 
changes due to repeated sampling. The capillary tubes were 
broken at the plasma/red blood cell, boundary and the plasma 
collected into Dreyer's tubes. Repeated sampling was carried 
out in the same manner; bleeding was re-started by wipinq the 
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tail tip with a damp cloth. Between sampling the rats were 
returned to the cage containing the other rats of the group. 
This general procedure was used to determine the plasma 
concentration of DDT in rats dosed with the following 
formulations:-
1. 2ml oil 
2. 1ml oil 
3. 2ml emulsion 
4. 2ml (oil + 6% Tween 80) 
5. 30ul oil 
6. 1ml (water ~ ~ 6% Tween 80) 
7. 1ml arachis oil or Miglyol 812 orally administered 
two hours after intra-peritoneal injection of an aqueous 
solution metoclopramide (10mg/kg) 
8. 1ml liquid paraffin or Miglyol 812 orally 
administered two hours after intra-peritoneal injection of an 
aqueous solution of propantheline bromide (Smg/kg) • 
• 
2.4 Results. 
2.4.1 Assay Procedure. 
The linear sensitivity range of the electron capture 
detector for DDT was SO-400ng/ml (see figures 2.1 & 2.2). As 
the response of the detector tended to vary standard solutions 
were xun at various time intervals during the day. 
The mean efficiency of the plasma extraction procedure 
. for the range 100-400nq/ml was 90.6%2.4% (see table 2.1) with a 
daily coefficient of variation of 6.1%. 
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FIGURE 2.1 
GAS CHROMATOGRAM FOLLOWING INJECTION OF 
EXTRACTED PLASMA SAMPLE. 
A 
B 
c 
A ~ S o f v e n t t Peak 
B= I nternaf Standard 
(Heptach lorepoxide 
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FIGURE 2.2 REGRESS ION LINE FOR STANDARD SOLUTIONS OF D. D. T. (100 - 400 ng/mB 
AND FOR EXTRACTED PLASMA SAMPLES SPIKED WITH DDT. 
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2.S 
2.0 
1.5 1 /./ ~ ~ Standard Solutions 
l.OJ / ~ / / .to Extracted Plasma Samples 
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Table 2.1 -Efficiency of the Plasma Extraction Procedure for 
DDT Over the Concentration Range 400 to 100 ng/ml.(n=6 per 
sample group). 
D.D.T. Peak height Percentage 
concentration ratio extraction 
ng/ml (mean±S .0. ) % 
std.soln. 400 2.58 ± 0.09 
plasma sample 2.21 ± 0.09 89.0 
std.soln. 300 1. 74 ± 0.08 
plasma sample 1.62 .± 0.05 88.3 
• 
std.soln. 200 1.18 ± 0.04 
plasma sample 1.09 ± 0.05 91 .9 
std.soln. 100 0.59 ± 0.05 
plasma sample 0.50 .:t 0.05 93.4 
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2.4.2 Absorption Studies. 
For each dosage form the plasma DDT concentration versus 
time profile was constructed (see figures 2.3-2.10). From the 
data the maximum plasma concentration (Cp ) and the time of max 
the CPmax (Tmax) were determined, and the total drug absorption 
~ s s determined from the area under the curve between 0 and 24 
hours (AUC O- 24h )' was calculated using the trapezoidal method 
(see table 2.2). Comparison of these parameters for the 
different formulations was made using the Student's"t"test or 
the Mann Whitney"U"test. 
The droplet size distribution, total oil surface area 
and viscosity of the emulsions were not significantly different 
(p>0.05) (see table 2.3), therefore the differences in DDT 
absorption from the emulsions could not be attributed to these 
physical parameters. 
The aqueous suspension of DDT had a particle size 
distribution of 5 . 4 ~ . 7 u m m (geometric mean diameter ~ ~ geometric 
standard ·deviation) and only 0.32mg/ml DDT w ~ s s micellised by 
the Tween 80 in the aqueous phase. 
During the animal experimentation it was observed that 
certain groups of rats became hyperexcitable. Initially they 
over-reacted to external stimuli and then they began to shake 
and when excited would exhibit characteristic "shadow boxing". 
The severity of the symptoms was directly related to the plasma 
concentration of DDT. 
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FIGURE 2.3 
THE EFFECT OF DIFFERENT VEHICLES ( 1 ml volumes) 
ON THE ABSORPTION OF ORALLY ADMINISTERED 
DD T (100 mg/ kg) I N RATS (Mean + S. E.M., n= 4 per group). 
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FIGURE 2.4 
THE EFFECT OF DIFFERENT ARACHIS Oil FORMULATIONS ON 
THE ABSORPTION OF ORAllY ADMINISTERED DDT (lOa mglkg) 
IN RATS (Mean + S.E.M., n=4 per group). 
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FIGURE 2.5 
THE EFFECT OF DIFFERENT MIGlYOl812 FORMULATIONS 
ON THE ABSORPTION OF ORAllY ADMINISTERED DDT 
(l00 mg/kg) I N RATS (Mean + S. E. M., n= 4 per group) 
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Plasma 
FIGURE 2.6 
THE EFFECT OF DIFFERENT LI QU I D PARAFFI N FORMUlATIONS 
ON THE ABSORPTION OF ORALLY ADMINISTERED DDT 
(100 mg/kg) IN RATS (Mean + S. E. M., n= 4 per group) 
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FIGURE 2.7 
THE EFFECT OF DIFFERENT OILS (30 ut volumes) ON THE 
ABSORPTION OF ORALLY ADMINISTERED DDT (7.5 mg/ kg) 
I N RATS ( Mean + S. E. M., n= 4 per group). 
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Plasma 
Figure 2.8 
THE EFFECT OF METOCLOPRAMI DE (lOmgikg) ON THE 
ABSORPTION IN RATS OF ORALLY ADMINISTERED 
DDT (lOOmg/kg) IN ARACHIS OIL Urn!) 
(Mean + S. E. M. n=4per group). 
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Figure 2.9 
THE EFFECT OF PROPANTHELI NE (Smg Ikg) AND METOCLOPRAMI DE 
(lOmg/kg) ON THE ABSORPTION IN RATS OF ORALLY 
ADMINISTERED DDT UOOmg/kg) IN MIGLYOL 812 Urn!) 
(Mean + S. E. M., n=4 per group). 
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Figure 2.10 
THE EFFECT OF PROPANTHELI NE (Smgikg) ON THE ABSORPTION 
IN RATS OF ORALLY ADMINISTERED DDT nOOmglkg) IN 
LIQUID PARAFFIN nml)(Mean + S.E.M., n=4per group). 
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Table 2.2 - Absorption Data Following Oral Administration of DDT in Different Vehicles to Rats 
(Mean -t S.D., n=4 per group). 
Arachis Oil Miglyol 812 
C Tmax AUC O- 24h Cpmax Tmax AUC O- 24h • C pmax pmax 
ug/ml h. mg ml/h. ug/ml h. mg ml/h. ug/ml 
1ml oil 11 .08 7.0 118.3 4.67 6.0 57.91 1. 72 
+1.95 +2.0 +6.6 +0.74 +0.0 +10.22 ±0.05 
2ml oil 10.24 10.0 112.17 4.21 11.5 54.52 1.39 
.±3.62 +2.3 +14.74 +1 .88 +1.0 ±23.61 ±0.59 
2ml emulsion 9.18 4.0 105.81 3.61 5.5 54.52 4.25 
.±2.07 +0.0 +12.54 :to.59 +5.5 +3.42 ±0.42 
2ml oil 9.99 7.0 112.21 3.67 9.0 55.97 1.87 
(containing .:t2 .52 ±1 .41 +26. 11 ±0.99 ±3.46 ±19.02 to.38, 
. 
6% Tween 80) 
Predosing with / / / 3.56 10.0 46.08 1.99 
Propantheline to.73 to.O ±15.44 t o .52 
Predosing with 5.52 5.75 76.76 / / / I Metoclopramide ±1.58 ±O .5 ±12.23 
Control C pmax = 2.88±0.37ug/ml 
Tmax = 10.0±2.0h. AUC O- 24h 44.59±5.32mg ml/h. 
Liquid Paraffin 
Tmax AUC O- 24h • 
h. mg ml/h. 
4.0 23.90 
+0.0 +4.23 
-
6.5 13.25 
±3.4 ±7.36 
5.0 54.27 
+2.0 +8.20 
-
8.0 27.11 
±1.63 +5.25 
9.0 31.80 
+ 1 • 16 +6 ~ ~ 15 
/ / 
Table 2.3 -Physical Properties of the Emulsion Formulations 
Containing DDT. (n=3) 
Oil Droplet geometric Surface Area Viscosity 
diameter (m2 /ml ) (poise) 
(mean:tS.D. ) 
Arachis oil 7. 1 + 2.5 0.537 0.00440 
Miglyol 812 6.6 + 1.5 0.525 0.00436 
L,iquid paraffin 7.0 + 2.6 0.608 0.00410 
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2.S Discussion. 
The results of these studies showed clearly that the 
oral absorption of DOT is dependant on the nature and the 
formulation of the vehicle in which it is administered. 
The plasma DOT concentration versus time profiles for 
DDT administered in 1m! volumes of arachis oil, Miglyol 812, 
liquid paraffin and water containing 6% T ~ e e n n 80, exhibit 
significant differences (see figure 2.3). Whilst arachis oil 
promoted absorption ( ~ . O S S for CPmax and AUC O- 24h values) 
liquid paraffin gave rise to a shorter absorption phase 
resulting in lower total drug absorption and earlier peak 
plasma concentrations than for the other vehicles (P(O.OS for 
Tmax and AUC O- 24h values). Comparison of DOT absorption from 
Miglyol 812 and water showed that although a higher peak plasma 
level occured with Miglyol 812 (p<P.OS) there was no difference 
( ~ O . O S ) ) in total DOT absorption over 24 hours as determined 
from the AUCO_24h • However, one hour after d ~ s i n g g the plasma 
concentration of DOT following administration in Miglyol 812 
was less than after administration in any other vehicle 
(P(O.OS). This difference no longer existed after 2 hours 
Cg>o. OS') suggestinq that there is an initial time lag prior to 
DDT absorption from Miqlyol 812. 
Ideally, an aqueous solution of D.D.T. would have formed 
the control for.mulation for this set of e x p e r ~ e n t s . . However, 
as DOT ia highly insoluble in water,'and also in SO\ aqueous, 
ethanol, which is often used in such circumstances, an aqueous 
au.pension of DOT was used. A fine suspension suitable for 
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administration was formed by dissolving the DDT in Tween 80 
(6%) prior to the addition of water. Although it is possible 
that the surfactant itself may have altered the absorption of 
DDT studies using oil containing 6% Tween 80 in a volume of 
2mls suggested that this did not occur (see below). 
Increasing the volume of the vehicle administered to 2ml 
changed the plasma DDT profiles for the individual oils but did 
not alter the differences between the oils (see Figures 2.4,2.5 
& 2.6). Whereas 2ml arachis oil and Miglyol 812 only slowed the 
rate of absorption (P(O.05 for Tmax values), with 2m2 liquid 
paraffin the total absorption and the peak plasma concentration 
of DDT were also reduced (P(O.05 for AUCO-24h,CPmax and Tmax 
values) compared to the 1ml volumes of oil. Thus doubling the 
oil volume increased the time to peak plasma concentration and, 
in the case of liquid paraffin, the total drug absorption and 
peak plasma concentration. 
Administration of DDT in oil-in-water emulsions altered 
the absorption in different ways with each oil. With arachis 
• 
oil emulsification increased the rate (P(O.05 for Tmax values) 
but not the extent of absorption compared with 1m2 and 2m2 
volumes of the oil (see Figure 2.4). Although with Miglyol 812 
emulsification increased the initial rate of DDT absorption, 
the 2 hour plasma concentration being higher (p(P.05), the Tmax 
value was unchanged (see Figure 2.5). Administering the oil as 
a preformed emulsion by-passes the emulsification step in the 
digestion process (see introduction) enabling absorption to 
commence more rapidly. 
DDT absorption from liquid paraffin was greatly enhanced 
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by emulsification, the total drug absorption and peak plasma 
levels being higher (P(O.OS) than for 1ml or 2m! volumes of oil 
(see Figure 2.6). Liquid paraffin is not readily absorbed but 
when it is presented to the mucosal membrane as a preformed 
emulsion of mean droplet diameter <O.Sum it is absorbed as 
easily as olive oil (Frazer et al.1944,McWeeny 1957). As the 
mean particle size of the liquid paraffin emulsion in which DDT 
was administered was larger than O.Sum it is unlikely that the 
liquid paraffin was absorbed as easily as these authors 
suggest, but it is probable that absorption of the smaller 
emulsion droplets readily occured. 
There were no differences (p>O.OS) between the plasma 
DDT concentration time profiles for 2ml oil and 2ml oil 
containinq 6% Tween 80, suqgestinq that Tween 80 was not 
exertinq any influence on DDT absoption from the emulsions (see 
Table 2.2). 
DDT was administered in 30pl volumes of oil 
(approximately equivalent to a 10ml dose for a 70kg man on a 
• 
body weiqht basis) to determine whether the differences in 
absorption from the different oils were still observed at low 
oil volumes (see figure 2.7). The total absorption of DDT over 
24 hours was still less (P(O.OS) from liquid paraffin than from 
arachis oil or Miqlyol 812 but there was no longer a difference 
( ~ . O S ) ) between the latter two oils. The peak plasma level was 
still higher ( ~ . O S ) ) followinq administration in arachis oil 
than with the other two oils, but the time to peak plasma 
concentration was now longer with Miqlyol 812 than with arachis 
011 or liquid paraffin. The profiles of the plasma DDT 
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concentration with 3 0 ~ 1 1 volumes of liquid paraffin and arachis 
oil are similar in that there is a rapid rise in the plasma DDT 
levels followed by a steady fall, although absorption from 
arachis oil was greater, as evidenced by the higher plasma DDT 
concentration at any given time. With Miglyol 812 the profile 
was f l a t ~ e r r the peak plasma levels being lower and achieved 
after a longer time period but sustained for longer. Reducing 
the oil volume therefore had a Significant effect on DDT 
absorption in the presence of all three oils but maintained 
characteristic differences in absorption between them. 
The influence of metoclopramide and propantheline 
bromide on the absorption of DDT from 1ml volumes of oil was 
investigated to determine whether gastro-intestinal motility 
was an influencing factor in the present studies. 
Metoclopramide increases gastro-intestinal motility by 
increasing the size of antral contractions (Johnson 1971), 
whereas propantheline bromide slows gastro-intestinal motility 
by its anticholinergic properties (Hurwitz et al.1977,Brodie 
• 
1966). Jamali and Axelson (1977) investigated the effect of 
intra-peritoneal doses of metoclopramide (10mg/kg) and 
prqpantheline (Smg/kg) on the gastro-intestinal absorption of 
qriseofulvin in rats when given as an aqueous suspension in 
O.S\ polysorbate 80 or as a solution in polyethylene glycol 
600. Metoclopramide preadministration was shown to increase the 
qastric emptying rate of the for.mulations whereas propantheline 
retarded it. The effect on griseofulvin absorption induced by 
the two druqs was dependant on the dosaqe for.m of the 
griseofulvin a ~ n i s t e r e d . . Predosinq with metoclopramide 
-82-
increased the bioavailability of the PEG formulation but 
decreased the bioavailability of the griseofulvin suspension; 
propantheline had the opposite effect to metoclopramide in both 
instances. This showed that griseofulvin absorption was 
dependant on both the formulation and on gastro-intestinal 
motility. The same experimental protocol that was used for this 
qriseofulvin study was adopted in the present investiqation. 
Pretreatment with metoclopramide reduced total DDT 
absorption and the peak plasma concentrations from 1ml arachis 
oil (P(O.OS) although durinq the first four hours there was no 
difference (p>O.OS) in the plasma levels (see Fiqure 2.8). This 
s u q g e ~ t s s that the effect of the druq on gastric emptyinq was 
insiqnificant compared to that of the oil but then, under 
influence of the druq the transit of the oil through the upper 
qastro-intestinal tract was increased reducinq the time 
available for DDT absorption. However with Miqlyol 812 
pretreatment with metoclopramide appeared to increase DDT 
absorption and the laq-time prior to absorption (see Fiqure 
• 
Total absorption of DDT from liquid paraffin followinq 
~ r e t r e a t m e n t t with propantheline bromide was increased (p(P.1) 
as was the time to the p e ~ ~ plasma level ( ~ . O S ) ) although 
there was no change in.the actual plasma levels of D.D.T.(see 
Piqure 2.10). This suggests that slowing the gastro-intestinal 
transit of liquid paraffin allowed absorption of DDT to occur 
ovar a longer time period. Figure 2.9 shows the effect of 
. 
pre-treatment with propantheline on the absorption of DDT from 
MiCJlyol 812. 
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Whatever the underlying mechanisms these studies showed 
that changes in gastro-intestinal motility can alter DDT 
absorption from these oils. It is therefore possible that the 
effect of the individual oils on gastro-intestinal motility_ 
contributes to the differences in DDT absorption from the three 
oils. 
In most studies a large variation in the plasma levels 
of DDT wi thin the same group of animals was observed, and this 
may be attributed to slow, incomplete absorption of DDT Judah 
(1949) found that 72-80% of a 125mg intra-gastric dose of DDT 
in nut oil could be recovered from the rat gut three hours 
after administration. Smith & Stohlman (1945) dosed rabbits 
with 300mg/kg DDT in olive oil and recovered 5-50% of the dose 
in the faeces and in addition, they found that the relative 
elimination of DDT in the faeces as compared to the urine was 
greater with larger doses. Using male Sprague-Dawley rats 
orally dosed with 10mg DDT in 0.5ml peanut oil, Bishara et 
al.(1972) found that 40% of the dose was eliminated in the 
• 
faeces in 24 hours yet only 0.9% of the same dose was excreted 
in rats dosed intra-peritoneally. It was concluded that a large 
percentage of the orally a ~ n i s t e r e d d dose was not absorbed. 
DDT absorption from the gut would seem to be slCM, and a 
relatively large fraction of an oral dose is excreted in the 
faeces as a result of not being absorbed or possibly biliary 
excretion (see below). It may be anticipated that such factors 
, 
would contribute to large intra-group variation in DDT 
amozption such as obeerved in the present study. 
The hyperexcitability of the rats observed durinq some 
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of the experiments is characteristic of DDT poisoning (Cameron 
1945,Domenjoz 1944). Experiments by Dale et al.(1963) with rats 
suggested that the severity of the symptoms of poisoning after 
\ 
a single oral dose of DDT are directly proportional to the 
concentration of the compound in the brain, which in turn is in 
equilibrium with the plasma DDT levels (Radmoski 1970). Thus, 
the observed symptoms are directly related to the plasma 
concentration of DDT as determined in the present experiment. 
The pharmacological action of DDT on the brain does not seem to 
be clearly understood, although it is thought to be due to a 
reduction in brain acetylcholine (Martin & Nigar 1979,Judah 
1949,Colhourn 1959,S t.Omer & Ecobichon 1971). 
PharmacOkinetic analysis of the plasma profiles of DDT 
was not attempted as it was difficult to determine the most 
suitable compartmental model to apply. Semilogarithmic plots of 
the plasma DDT concentration versus time for arachis oil 
suggested that a one compartment model was applicable, whereas 
the plots for liquid paraffin suggested that a two compartment 
• 
model was more suitable. As DDT accumulates in the adipose 
tissue (Gillette 1973) a two compartment open model is possibly 
the more suitable. However, the plasma profiles for DDT 
administration in Miglyol 812 and to a lesser extent in arachis 
- . 
oil, exhibited two peak plasma levels as is characteristic of 
biliary recycling. High concentrations of DDT in the bile have 
been found in rats killed after acute oral dosinq with DDT 
(Smith 1944,1945). More recently Jensen et al.(1957) have 
demonstrated small quantities of DDT present in the bile and 
shown that biliary excretion is responsible for almost all of 
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the DDT metabolites in faeces. The pharmacokinetic picture for 
DDT following oral administration to rats is therefore complex 
and there was insufficient data from the present study to 
attempt any such analysis. 
An increase in the height of peak C (see Figure 2.1) was 
observed in the chromatograms for sequential plasma samples 
following dosing of DDT. Further investigation showed that 
peak C had similar chromatographic properties to p,pD.D E , 
2,2-bis(p-chlorophenyl)-1,1-dichloroethylene, which is known to 
be a major metabolite of p,pD 0 T.-
The present studies have shown that the vehicle in which 
DDT is orally administered is critical in determining the oral 
toxicity of the compound. In addition it was shown that 
• 
altering gastro-intestinal motility, using the drugs 
metoclopramide and propantheline bromide, alters the plasma 
levels of DDT. The lymphatic absorption of DDT in the 
presence of arachis oil, Miglyol 812 and liquid paraffin was 
investigated to determine whether this factor was contributing 
• 
to the observed differences in oral DDT absorption. 
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CHAPI'ER 3. 
LYMPHATIC ABSORPI'ION OF DDT. 
3.1 Introduction. 
From literature reports it was anticipated that the 
partitioning of DDT between the portal and lymphatic absorption 
pathways could be affected by the presence of lipids of 
different chemical structure (see sections 1.5 and 2.1). The 
lymphatic absorption of DDT in the presence of Miglyol 812, 
arachis oil and liquid paraffin was therefore investigated to 
determine whether this was a factor in the differences observed 
in the plasma DDT profiles following administration in t ~ e e
three oils. 
3.1.1 Investigative Techniques. 
Investigations into the role of the lymphatic system in 
the transport of absorbed material from the intestine are 
dependant on cannulation of the lymph vessels •. I t is preferable 
to cannulate the main intestinal lymph vessel, tying off the 
accessory trunk which lies close to it, but as this is a 
difficult surgical procedure the thoracic duct is often 
cannulated immediately above the cisternae chyli. In small 
animals such as the rat, it may be difficult to be certain 
whether or not the liver lymph is included in this drainage and 
therefore whether metabolic derivatives of the test substance 
are being sampled. Mezick et al.(1968) whilst investigating the 
lymphatic transport of 14C-menadione (vitamin K) in the dog, 
determined the contribution of hepatic lymph to the thoracic 
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duct lymph. They found that in almost every case all the 
radioactivity in the thoracic duct lymph represented transport 
from the intestine, total recovery in the thoracic lymph over 
90 minutes being unchanged when the hepatic lymphatics were 
ligated. The hepatic lymph transport was only important during 
the initial period of intestinal absorption and transport; the 
initial lymphatic transport being decreased in animals with 
closed hepatic lymphatics. Noguchi et ale (19'77) suggested that 
the concentration of compounds absorbed via the intestinal 
lymphatics is always lower in the thoracic lymph than in 
mesenteric lymph due to lymph drainage from other vessels into 
the cisternae chyli. 
In recent years the availability of fine flexible 
plastic tubing has made possible the preparation of chronic 
lymphatic fistulae in conscious animals. Prior to this fine 
glass cannulae were used which only allowed acute studies in 
anaesthetised animals. Virtually all the studies that have been 
conducted to determine the contribution of t h ~ · i n t e s t i n a l l lymph 
to the absorption of compounds from the gastro-intestinal tract 
have used the chronic cannnulation procedure described by 
Bollman et al.(1948), for either the thoracic lymph duct or 
small intestinal lymph vessel. Slight modifications to this 
procedure have been descibed by Warshaw (1972) and Gallo-Torres 
& Muller (1969b). There are several major problems associated 
with this method; 
a)Securing the cannula. 
b)Clot formation within the cannula. 
c)Metabolic disturbances due to removal of body fluid. 
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d)Opening of lymphatico-venous anastomoses. 
It is difficult to secure the cannula in poSition in the 
thoracic duct so that there is no leakage of lymph and its 
position is not disturbed by animal movement. Initially the 
cannula was tied in position by means of a ligature around the 
duct but this is a difficult surgical procedure and more 
recently biological glues such as cyanoacrylic cements, have 
been used to glue the cannula in place. 
Due to the low lymph flow rate there is a tendancy for 
clots to form within the cannula either hindering or stopping 
further flow. This can sometimes be avoided by heparinisation 
0; the cannula prior to use and by the addition of heparin to 
the infusion fluid. 
Metabolic disturbances may be caused by drainage of 
lymph over long periods of time, resulting in loss of body 
fluid· and plasma proteins and phospholipids. Body fluid may be 
teplenished by intra-venous infusion of a suitable buffer 
solution. • 
It is likely that the communications which exist between 
intestinal lymph vessels and the portal veins are not normally 
functionary but exist as potential routes which open when 
subjected to increased lymphatic. pressure such as may occur 
when a cannula is partially obstructed, or when lymph flow is 
particularly high. Therefore, when investiqa tions are beinq 
made to define the relative importance of portal venous and 
lymphatic routes in the transport of absorbed material from the 
intestine, the presence of these lymphatico-venous anastomoses 
has to be considered. 
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In an attempt to overcome the latter two problems 
Giradet and Beninghoff (1977) developed two alternative 
procedures to allow continuous circulation of lymph within the 
body whilst removing small samples as required, these are the 
thoracic duct to duct shunt and the t-tube-side thoracic duct 
fistula, for use in rat or man. 
In the present study the lymph levels of DDT were 
determined in rats following intra-gastric administration of 
DDT (100mg/kg) in 1ml arachis oil, Miglyol 812 or liquid 
paraffin. Owing to the technical problems associated with 
recovery operations with thoracic duct cannulated rats, lymph 
was collected from anaesthetised animals. Corresponding lymph 
flow and plasma DDT levels were determined. 
3.2 Marterials and Apparatus. 
• 
a)Sugical implements - forceps, coarse scissors, fine scissors, 
iris scissors (J.Weiss & Son Ltd., 11, Wigmore St., London) 
Spencer-Wells forceps, glass disectors (home-made by drawing 
out, bending and fire polishing ~ . S m m m glass r?d),·surgical 
needle (1/2 circular triangular pointed no.1S, Aseptic, Leeds), 
trochar (able to accomodate PPSO tubing), sterile gauze, cotton 
buds, iris retractor (Weiss, modified to take an extra rounded 
flange 13mm wide by 17mm depth on one side, dimensions 70mm for 
each arm, 22mm across the base, 36mm between the tips when 
relaxed) • 
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b)Cannulas - i)thoracic duct- Portex poythene tubing (PP50) 
about 50cm bent into a 12-14mm diameter semicircle at one end 
and with that end bevelled at about 45°. Portex Ltd., Hythe, 
Kent. 
ii)jugular vein- Portex flex nylon 00 tubing. 
c)Slow infusion pump - Scientic Research Instruments Ltd., 
Croydon, Surrey. 
d)Dulbecco's"A+B solution - Oxoid Ltd.,Basingstoke, Hants. 
e)Heparinised capillary tubes - Gelman Hawksley Ltd., 
Brackmills, Northants. 
f)Dreyer's tubes - R.B.Radleys&Co.Ltd., Sawbridgeworth, Herts. 
g)Miglyol 812- Dynamit Nobel, Slough, Berks. 
h)Arachis oil B.P. - Evans Ltd., Liverpool. 
ilLiquid paraffin B ~ P . . Shell Ltd., London. 
k)p,p D.D.T.-Aldrich Chemicals Co.Ltd., Gillingham, Dorset. 
3.3 Methods. 
• 
3.3.1 Thoracic Duct Cannulation. 
( The experimental procedure is represented 
diaqramatically in figure 3.,1). 
Each rat (200g male Wistar) was orally dosed w i t ~ ~ 1m! or 
30pl oil containing 20mg or 1.5mg DDT respectively. Rats dosed 
with 1ml oil volumes were then left for 45 minutes before 
proceeding- This allowed time for the oil to be swallowed and 
to beqin emptying from the stauach. Each rat was anaesthetised 
with pentobarbital sodium (Saqatal 90mq/ml) approximately O. 3m! 
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FIGURE 3.1 
CANNULATION OF THE RAT THORAC IC DUCT ( Acute Preparation). 
.. 
.. 
I nfusion of Dulbecco's solution (AtB) 
+ heparin (l unitlml) at 2 mllhr through 
a jugular vein cannula 
+ 
bdominal incision below 
the costal margin 
'l .... ---Exteriorised 
Thoracic duct cannula 
ollection of thoracic duct 
lymph 
Blood tamPling from 
tail-tip 
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intra-peritoneally, and a maintainance dose of 15mg/kg was 
adndnistered intra-peritoneally at approximately half hourly 
intervals to maintain the animal in a state of deep anaesthesia 
throughout the experiment. The left jugular vein was cannulated 
at the level of the anterior and posterior facial branches and 
Dulbecco's solution (A+B) containing heparin (1 unit/ml) was 
infused at a rate of 2ml/hr to restore the body fluid loss due 
to drainage of the thoracic duct lymph. The abdominal thoracic 
duct was cannulated immediately above the cisternae chyli using 
the method described by Ford & Hunt (1967). As the animal 
remained anaesthetised the incision was not closed merely 
covered with saline moistened gauze. Lymph"was collected 
continuously fram the cannula through heparinised capillary 
tubes into Dreyer's tubes. Samples of lymph were taken for 
analysis at half-hourly intervals between 2 and 6 hours after 
dosing and the lymph flow rate was determined by weighing the 
lymph collected. Tail tip blood samples were taken at 2, 2.5, 
3, 3.5, 4, 5 and 6 hours' after dosing. Lymph ~ n d d plasma levels 
of DDT were determined by G.L.C. analysis. The normal lymph 
flow in anaesthetised animals under these conditions was 
determined using the above procedure with undosed animals. 
3.3.2 Plasma Levels in Anaesthetised Rats. 
Rats were orally dosed with 1ml oil containing DDT 
(20mg) and then left for 45 minutes before being anaesthetised 
as in the previous section •• An abdominal incision was made and 
the organs overlying the thoracic duct were packed to one side 
as in the cannulation procedure. The state of anaesthesia was 
maintained for six hours after dosing. Tail tip blood samples 
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were taken at 2, 2.5, 3, 4, 5 and 6 hours after dosing and the 
plasma levels of DDT determined by G.L.C. analysis. 
3.4 Results. 
Statistical comparison of parameters was made using the 
Student's "t" test or the Mann Whitney "U" test. 
Insufficient DDT was absorbed 'from the 30pl oil volumes 
to be accurately detected in either the lymph or plasma 
samples. A comparison of the different formulations could not 
therefore be made. 
Anaesthesia and "sham" operation procedure significantly 
(P(O.05) reduced plasma DDT levels in rats dosed with 1ml 
arachis oil and Miglyol 812 at the three data points available 
for comparison with unanaesthetised rats i.e. 2, 4 and 6 hours 
after dOSing (see figures 3.2 & 3.3). However in those rats 
dosed with D.D.T.in liquid paraffin, the reduction was only 
significant (P(O.OS) 4 hours after dosing (see figure 3.2 & 
3.3). 
The plasma DDT levels in anaesthetised rats dosed with 
Miglyol 812 rose steadily .from O . ~ 3 ± O . 0 2 u g / m l l at 2 hours to 
1.76±O.08ug/ml at the end of the experimental period. This 
reflected the steady increase in lymph flow from O.36±O.04 
ml/hr to O.67±O.07 ml/hr, that was observed over the same time 
period in the thoracic duct cannulated rats, a characteristic 
which was not observed following dosing with arachis oil or 
liquid paraffin. In the former case, the lymph flow remained 
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Figure 3. 2 
THE EFFECT OF DIFFERENT VEHICLES (lml volumes) ON THE 
ABSORPTION OF ORALLY ADMINISTERED DDT (lOOmglkg) 
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FIGURE 3. 3 
THE EFFECT OF DIFFERENT OILS (l ml volumes) ON THE 
ABSORPTION OF ORALLY ADMINISTERED DDT (100 mg/kg) 
IN ANAESTHETISED RATS (Mean + S.E.M., n= 4 per group) 
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relatively constant at approximately 1.0ml/hr until it began to 
fall 4 hours after dosing, and in the latter case although the 
lymph flow was slightly less and more erratic, it was not 
different (p 0.05) to that found with arachis oil. The lymph 
flow in the control group ranged from 0.58±0 .06ml/hr initially 
to 0.65±0.067ml/hr 4 hours later (see figure 3.4). 
In each experiment the plasma level of DDT following 
thoracic duct cannulation was less than 1pg/ml (see figure 
3.5). These levels are virtually negligble in comparison to the 
corresponding concentrations of DDT in the lymph. This was also 
observed in those rats dosed with 30pl oil volumes in which 
sufficient DDT was absorbed to be detected. 
To show the comparative effects of the different oils on 
DDT uptake into the lymph it was necessazy to allow for the 
differences in lymph flow in each rat caused by the different 
oils. Thus, the concentration of DDT (pg/hr) at the thoracic 
duct end of the cannula was calculated fram the flow rate, the 
volume of the cannula and the DDT concentrattpn in the lymph, 
and plotted against time. By interpolation from this graph the 
concentration of DDT (pg/hr) at the same time intervals after 
dosing with 1ml oil volumes for each rat was determined, and 
the mean and standard deviation for each group calculated (see 
figure 3.6). 
Oral administration of DDT dissolved in 1m! arachis oil 
gave higher (p<O.OS) peak concentrations of DDT in the lymph 
than in either Miglyol 812 or liquid paraffin. There was no 
difference ( p ~ . O S ) ) between the DDT concentrations in the lymph 
following a ~ n i s t r a t i o n n in these two oils. However the time to 
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FIGURE 3.4 
THORACIC DUCT LYMPH FLOW IN ANAESTHETISED RATS 
FOLLOWING ORAL ADMINISTRATION OF DIFFERENT OILS 
(l ml volumes) CONTAINING DDT (lOa mglkg) 
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FIGURE 3. 5 
THE EFFECT OF DIFFERENT OILS (1 ml volumes) ON THE ABSORPTION 
OF ORALLY ADMINISTERED DDT (100 mg/kg) INTO LYMPH AND INTO 
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reach the peak concentration was faster (P(O.OS) following 
administration in liquid paraffin than in either Miglyol 812 or 
arachis oil (see figure 3.6). 
3.S.Discussion. 
The data in this set of experiments were obtained using , 
anaesthetised animals in order to minimise the technical 
procedures required. It is necessary to consider the effect the 
anaesthesia may have had on the physiological mechanisms being 
investigated. 
As pentobarbitone anaesthesia is known to reduce blood 
flow in the splanchnic bed and reduce gut motility (Lee 
1965,Green 1979), it was anticipated that drug absorption in 
the anaesthetised animals would be different to that in the 
conscious animals. This was shown to be true in those rats 
dosed with DDT in 1ml arachis oil or Miglyol ~ 1 2 , , the plasma 
levels being higher (P(O.OS) in the unanaesthetised animals 
(see figures 3.1 & 3.2). However, in rats dosed with DDT in 
liquid paraffin the plasma levels were only higher (P(O.OS) in 
the conscious animals 4 hours after dosing (see figures 3.1 & 
3.2). It is likely that slower intestinal transit of liquid 
paraffin in anaesthetised rats allowed more time for DDT 
absorption, therebf compensating for reduced absorption 
resulting from other physiological changes. 
General anaesthesia has also been shown to alter lymph 
flow and. composition, with each anaesthetic having its own 
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particular effect (Lowrimore 1977). Polderman et al.(1943} 
investigated the effect of ether and pentobarbital sodium on 
lymph flow in mongrel dogs by cannulation of the cervical 
lymphatics. Barbiturate anaesthesia was found to reduce flow by 
50% from that under local anaesthesia, with an associated rise 
in lymph protein concentration, whereas ether anaesthesia had 
the reverse effect. It was suggested that the barbiturate 
caused a shift of fluid from the tissue to the blood stream and 
that the reverse occured with ether. These findings were 
confir.med by Hungerford and Reinhardt (1950) whilst 
investigating the effects of sodium pentobarbital and ether on 
the flow rate and cell content of rat thoracic duct lymph. Lee 
(1965) investigated the effect of a number of drugs on 
intestinal motility and lymph flow using in vitro rat intestine 
preparations, and found that sodium pentobarbital (15mg/100ml) 
abolished motility and produced a sustained reduction in lymph 
flow (49%) with no observable' changes in lymph contractility. 
Evidence from this literature suggests that low lymph 
• 
flow rates could be expected in the present study since sodium 
pentobarbitone (Sagatal) was the anaesthetic agent used. Turner 
and Barrowman (1977) found that in conscious rats 
intra-duodenally dQsed with O.Sml LeT (olive oil) and 0.5ml 
0.9% saline the lymph flow increased from a resting rate of 
approximately 1.3ml/hr to a peak flow rate of 5.1ml/hr after 
40-80 minutes. Similarly in rats intra-duodenally dosed with 
0.5ml MeT and 0.5ml 0.9\ saline, the lymph flow rose to a peak 
of 3.5±0.3ml/hr over the same time period. Experimental peak 
lymph flows of 1.2±0.29ml/hr after 4.5 hr and O.73iO.07ml/hr 
-102-
after 5.5 hr were recorded following dosing with 1ml arachis 
oil and Miglyol 812 respectively (see figue 3.4). The delay in 
the time of peak lymph flow rate compared to the literature 
data will be due in part to intra-gastric and not 
intra-duodenal administration of the oil, and in part to the 
anaesthesia reducing gut motility. The experimental lymph flow 
rates were, as anticipated, lower than in the conscious animal 
but were in good ageement with the values obtained by Nakamoto 
et al.(1979) whilst investigating lymphatic absorption of 
1-(2-tetrahydrofuryl)-5-fluorouracil fram the rat intestinal 
loop. These rats were anaesthetised with sodium pentobarbitone, 
and 2ml saline was given intra-peritoneally each hour. Lymph 
flows of 0.6 to 0.8ml/hr were recorded following administration 
of an aqueous solution and sesame o/w and w/o emulsions. 
As anaesthesia and the surgical procedures have such a 
marked effect on absorption and lymph flow it is not possible 
to compare directly the results fram this study with those 
obtained in unanaesthetised animals. 
• 
In anaesthetised rats peak plasma levels were higher 
<p(0.05) following administration in 1ml arachis oil than the 
other two oils but there was no difference between the peak 
levels following administration in Miglyol 812 and liquid 
paraffin (see figure 3.3). However, the liquid paraffin 
f o ~ u l a t i o n n gave earlier ( ~ . 0 5 ) ) peak plasma levels due to the 
faster 9ut transit of this oil in comparison to the other two 
oils (section 4.5). Thus, under conditions of anaesthesia the 
difference in the extent of DDT absorption from Miglyol 812 and 
liquid paraffin is abolished but is maintained with respect to 
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arachis oil. 
Comparison of the lymph flows in the presence of the 
different oils (see figure 3.4) shows that arachis oil and 
liquid paraffin stimulated lymph flow whereas Miglyol 812 
caused inhibition. Both LCT and MCT have been shown to exert a 
lymphagogue effect. Simmonds (1955) observed that although 
tributyrin did not appear in the lymph it produced an increase 
in lymph flow accompanied by a fall in protein concentration. 
More recently Barrowman and Turner (1977,1978) showed that 
intra-duodenally administered MCT caused a lymphagogue effect 
75% that of LCT over approximately the same time period, and 
the total protein moved was also 75% that of LCT. On the basis 
of these reports the lymph flow in the prescence of Miglyol 812 
should only have been slightly less than that with arachis oil, 
whereas the experimental lymph flow profile (see figure 3.4) 
suggests that initially lymph flow is being severly inhibited 
and that this effect then gradually decreases. The only 
indication of such an inhibitory mechanism in the plasma level 
• 
data in unanaesthetised rats following administration of DDT in 
Miglyol 812, is at the hour one data point when the plasma DDT 
concentration was less (P(O.05) than in the presence of the 
other oils (see figure 3.2). It is suggested that by some ' 
unknown mechanism Miglyol 812 initially inhibits lymph flow but 
that the effect is only short-term in conscious animals. In 
anaesthetised animals due to the depression of blood flow in 
the intestinal region and the reduction in gut motility, 
recovery is not as rapid resulting in the gradual rise in lymph 
flow and in pla.ma DDT levels observed,during the experimental 
-104-
period. 
The experimental data showed that liquid paraffin 
exerted a lymphagogue effect almost equal to that of arachis 
oil. There is no literature data available with which to 
campare these results. As liquid paraffin is not comprised of 
fatty acids and is not digested the mechanism for this effect 
cannot be the same as for triglyceride materials. Unemulsified 
liquid paraffin is absorbed in very small quantities from the 
gastro-intestinal tract of rats (Albro & Fishbein 1970) and is 
then oxidised in the mucosal cells to-long chain fatty acids 
(McWeeny 1957) which are presumably incorporated into 
chylomicra in the normal way. In conditions of excess 
absorption liquid paraffin may be transported unchanged in the 
lymph and oxidised in the liver. In either situation liquid 
paraffin or its metabolites are transported in mesenteric lymph 
and this may be the means by which liquid paraffin enhances 
lymph flow. 
Fo.llowing dosing approxi'mately 1.5 hours elapsed before 
• 
the thoracic duct lymph flow was interupted. DDT absorbed into 
the lymph during this period would pass into the general 
circulation. To compensate for this time delay the DDT 
concentration in the first plasma sample was s ~ t r a c t e d d from 
that in the subsequent s a m ~ l e s . . On this basis the maximum 
plasma concentration of DDT in rats dosed with DDT in arachis 
oil-o.29,:tO.47uq/ml, Miglyol 812 = O.18±<).09ug/ml, and liquid 
paraffin - O.03±O.19uq/ml (mean ± S.D.). It is possible that 
lymph containinq DDT was by-passinq the cannula and enterinq 
the plasma by way of vena-lymphatic anastameses as suggested by 
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other workers (Rothe et al.1957,Pocock & Vost 1974), or a small 
fraction of the dose was absorbed directly into the portal 
vein. In either situation it can be concluded that in the 
presence of all three oils the major, if not the only route for 
DOT absorption was via the lymphatic system. This is in 
agreement with the findings of Sieber et al.(1974), Pocock and 
Vost (1974) and Rothe et al.(1957). 
The peak lymph levels of DDT following administration in 
arachis oil were higher (P<O.05) than the other two oils. There 
was no difference between the levels following administration 
in liquid paraffin and Miglyol 812 (see figure 3.5). This 
suggests that there is some facet of arachis oil digestion and 
absorption that enhances the lymphatic uptake of DDT and which 
is absent with the other oils (see section 6). 
The results of these experiments show that DDT is 
largely absorbed via the lymphatic route and that the presence 
of different oils does not alter the route of absorption but 
effects the extent to which DDT absorption into the lymph 
• 
occurs. Thus, the enhanced oral absorption of DDT in the 
presence of arachis oil is due at least in part to increased 
lymphatic absorption of DDT. However this study does not 
explain the difference in the oral absorption of DDT in the 
presence of Miglyol 812 and liquid paraffin. It was shown that 
the plasma levels of DDT may be altered by changing 
gastro-intestinal motility using the drugs metoclopramide and 
propantheline bromide (see section 2.5). It is possible that 
the differences in DDT a b s o ~ t i o n n from Miqlyol 812 and liquid 
paraffin is due in part to the different affect of these oils 
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on gastro-intestinal motility. This was investigated using a 
gamma camera and oils spiked with a gamma emitting nuclide, as 
discussed in the following chapter. 
• 
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CHAPl'ER 4. 
GASTRO-INTESTINAL MOTILITY STUDIES IN THE RAT. 
4.1 Introduction. 
Gastric emptying and intestinal motility may have a 
profound effect on drug activity ·following oral administration 
by altering the residence time of the drug at the site of 
absorption, or at the site of metabolism and deactivation 
(Prescott 1974,Varga et al.1975,Franklin 1977). Pharmacological 
modification of gastro-intestinal motility using therapeutic 
agents such as metoclopramide and propantheline, has shown the 
absorption of a number of drugs to be influenced by the rate of 
gastric emptying and intestinal transit e.g.digoxin (Manninen 
1973), paracetamol (Nimmo et al.1973), L-dopa (Algeri et 
al.1976), phenylbutazone (Consolo et al.1970), and griseofulvin 
(Jamali & Axelson 1977). It follows f r ~ ~ t h i ~ ~ that drug 
absorption may be altered by administration with a fatty meal 
which inhibits gastro-intestinal motility. For example, the 
absorption of griseofulvin is enhanced by oral administration 
in the presence of a high fat meal.(Crounse 1961) or when given 
in a micronised form in corn-oil-in-water emulsion (Carrigan & 
Bates 1973,Bates & Sequeira 1975). Further investigations 
suggested that in the presence of fat the gastric emptying and 
intestinal transit of griseofulvin were inhibited, allowing 
more time for dissolution and absorption (Jamali & Axelson 
1977) • 
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4.1.1 Determination of Gastric Emptying and Intestinal Transit. 
The majority of studies of gastric emptying and 
intestinal transit in rats, have employed the same basic 
technique. The rats are dosed with a non-absorbable marker and 
are then left for the requisite time period before being killed 
and the distribution of the marker along the gastro-intestinal 
tract determined. 
The non-absorbable markers that have been used in these 
studies are of two types:-
a) Non-radioactive - glass beads, small seeds, or inert 
indicators such as carbon, chromic oxide or barium sulphate. 
Various problems are associated with such markers; beads and 
seeds can become separated fram food, dye indicators may not be 
accurately located, and barium sulphate may retard gastric 
emptying (Nimmo 1976). 
b) Radioactive - two types of monitoring techniques have 
been employed with radionuclide markers. Either the gut is cut 
into segments and the activity in each segment counted, or the 
• 
entire gastro-intestinal tract is removed in one continuous 
section, stretched out on a perspex plate and scanned with a 
detector connected to a scaler or ratemeter, to produce a 
profile of t h ~ ~ activity distribution through the gut. 
(Examples of these studies are listed in table 4.1). 
The main disadvantage of these methods is that gastric 
emptyinq ca·nnot be continuously followed in the same animal and 
that a large number of animals have to be sacrificed in order 
to obtain statistically significant results. 
In the study of gastric emptying in humans one of the 
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Table 4.1- Markers Used in Gastric Emptying and Intestinal 
Transit Studies in the Rat. 
1.Non-Radioactive Markers. 
Author Marker Study 
Macht (1930) Charcoal Propulsive motility 
Schurch et al.(1950) Chromic oxide Gastro-intestinal 
transit 
Goodman et al.(1952) Dye T1824 Gastro-intestinal 
transit 
Reynell & Sprey Phenol red Gastric emptying 
• 
(1956) Gastro-intestinal 
transit 
Aberdeen et al.(1960) PEG Gastric emptying 
Bennett & Simmond PEG Gastric emptying 
(1962) 
Brodie (1966) Amberlite Gastric emptying 
pellets 
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2.Radioactive Markers - Gut Segmentation monitoring 
Author 
Cramer & Copp 
( 1959) 
Marcus & Lengemann 
(1962) 
Nygaard (1967) 
Purdon & 'Bass (1973) 
Varga (1976) 
Marke r Study 
Radiostrontium Intestinal transit in 
89srCl fed and fasted rats 2 
Radionuclide Intestinal transit 
PEG 
Phenol red 
133BaSO 4 
85Sr-labelled 
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Intestinal motility 
G a s t r ~ - i n t e s t i n a l l
transit 
Gastro-intestinal 
m::>tility 
3.Radioactive - Monitoring of the I ntact Gut. 
Author 
Derbloom et al.(1966) 
Marker 
51NaCrO + 4 
1251 1 . 1 -po yVl.ny -
Poulakos & Kent (1973) pyrrolidone 
(PVP) 
Patterson et al.(1976) 125I _PVP 
Hinder et al.(1976) 1251 -RI HSA 
Gustavsson et ale 125I _PVP 
( 1979) 
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Study 
Simultaneous, 
independant 
determi na tion of 
gastric emptying & 
intestinal transit 
Intestinal transit 
Gastric emptying 
Calcium absorption+ 
• 
gut motility 
most recent innovations involves the use of technetium-99m 
( 9 ~ c ) ) labelled markers for in vivo imaging using a gamma 
camera with an associated computer (Chaudhuri 1974, Van Dam 
1974, Chaudhuri et al.1976, Meyer et al.1976, Ostick et 
al.1976, Grimes & Goddard 1977). Although several millicuries 
of radionuclide are generally administered during the imaging 
studies, the effective radiation dose is low due to the lack of 
particulate emission (O(orp) and the short half life (6 hours) 
of the radionuclide. In addition, the low energy gamma rays 
(140keV) emitted by 99mrc are at the optimum energy level for 
detection by the camera. 
A full review of gamma camera techniques for determining 
gastric emptying is outside the scope of the present work and 
has recently been carried out by Hardy & Wilson (1981). 
As the methodology for gastric emptying studies using 
the gamma camera is well established and has been successfully 
applied to rabbits (Curt 1977). it was decided. to apply the same 
technique to rats, and if possible, determine the gastric 
emptying rate and intestinal transit of arachis oil, Miglyol 
812 and liquid paraffin. 
4.2 Materials and Apparatus. 
4.2.1 Materials. 
a)Arachis oil B.P.- Evans Ltd.,Liverpool. 
b)Miglyol 812 - Oynamit Nobel, Slough, Berks. 
c)Liquid paraffin B.P.- Shell Ltd., London. 
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d)Oleic acid - B.D.H. Chemicals Ltd., Poole, Dorset. 
e)123I-oleic acid, 123I-arachis oil'- prepared using the 
method descibed by Lubran and Pearson (1958), in the 
Radiopharmacy Department, General Hospital, Nottigham. 
f)99mrc-Sulphur colloid - prepared in a 99MO_99mrc generator, 
from Amersham International Ltd., Bucks. Particle size 
distribution of colloid - 72%:400-600nm, 1 8 % ~ O O n m , , 7 ~ 6 0 0 n m . .
g)Barium sulphate suspension - Baritop 100 suspension, Concept 
Pharmaceuticals Ltd., Rickmansworth, Bucks. 
4.2.2 Apparatus. 
a)Gamma camera - i)Searle U.K. Ltd. 
iiJInternational General Electric of New York 
Ltd. 
These consist of three parts:-
i)camera head and stand consisting of a collimator, a 
detector crystal (sodium iodide, thallium activated) and a bank 
of 37 interconnected photomultiplier tubes. 
ii)operating console • 
iii)display system 
When the nuclidie 99mrc is placed on the collimator 
surface the gamma radiation emmitted by the isotope is 
detected. Gamma radiation p a s s i n ~ ~ perpendicularly to the 
detector face passes into the sodium iodide crystal exciting 
electrons to a higher energy state. The electrons drop back to 
their original energy level and in doing so emit photons which 
I 
are detected by the photomultiplier tube and converted into 
electrical signals. These signals are electronically combined 
to produce a spot on an oscilloscope screen corresponding in 
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position with the site of interaction of the gamma ray with the 
crystal. By photographing the events on the oscilloscope an 
image representing the distribution of radioactivity can be 
obtained. Data is recorded and analysed by computer (Varian 
Data Machines Ltd. and Link Systems Ltd.), the images being 
displayed on a television monitor. Hard copy from the computer 
of the graphs and images is produced using an electrostatic 
printer (Statos, Varian Data Machine Ltd.). Information can be 
stored on magnetic tape for subsequent analysis. 
b)Perspex restraining cages - consisting of a perspex tube 
approximately 5 c m ~ 9 c m , , with a perforated perspex plate at one 
end and a removable pespex restraint at the other. 
4.3 Methods. 
4.3.1 X-ray investigation. 
Three male, Wistar rats were orally d o ~ e d d with 1ml 
barium sulphate suspension. Dorsal, ventral and lateral 
radiographs of the rats in cages were taken at 1, 2 and 3 hours 
after dosinq. 
4.3.2 Radionuclide Imaging Study. 
Each rat was orally dosed with oil plus radionuc1ide 
marker and immediately placed in a perspex restraininq cage at 
the camera face. It was possible to image three rats , 
simultaneously by use of a small rack so that the rats were 
positioned one above the other. For the large oil volume study 
90 one minute images were taken, whereas for the small oil 
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Figure 4.1 - Regions of Interest Constructed For Analysis 
of Radionuclide Computer Images. 
i) stomach region 
ii) intestinal region 
iii) whole body region 
volume study 72 75 second images were taken. In each study the 
first frame was started when the first rat was placed at the 
camera face. 
4.3.3 Analysis of Radionuclide Imaging Study. 
For each rat a series of images taken at 5 minute 
intervals were analysed such that for each formulation the 
images analysed were at the same time period after dosing for 
each animal. On each image regions of interest (BOI) of a 
standard size were constructed around 1)the stomach (30 cells) 
2)the intestine (142 cells) and 3)the whole body (363 cells) 
(see figure 4.1) and the counts within the regions computed. 
The counts for the stomach region and the intestinal region 
were divided by the whole body counts to allow for any 
variation in the activity of each dose. Assuming that the total 
dose is in the stomach on the first image, the ratio 
stomach:whole body counts at t=O will be 1 and the ratio 
intestinal:whole body counts will be zero. Graphs were 
constructed of the decrease in the stomach counts ratio with 
• 
time and the increase in the intestinal counts ratio with time. 
4.3.4 Preparation of Dosage Forms. 
Preliminary investigations were conducted with several 
oil markers to determine the most suitable. In each case the 
oil was either mixed or emulsified with the marker prior to 
adDdnistration. Formulations investigated:-
a ) 9 ~ c - s u l p h u r r colloid in water. 
O.3ml ( ~ S O O u C i ) ) sulphur colloid 
1.2ml oil (arachis oil, Miqlyol 812 
-117-
b) 123I -oleic acid 
O.2ml (-g.60uCi) 
1.3ml 
c) 123I-arachis oil 
O.3ml (1l-190UCi) 
1.2ml 
or liquid paraffin) 
123I-oleic acid 
oil (arachis oil., Miglyol 812 
or liquid paraffin) 
123I-arachis oil 
arachis oil 
9 ~ c - s u l p h u r r colloid was found to be the most suitable 
marker (see discussion) and was used in all further 
investiga tions. 
Formulation for large oil volume study:-
O.Sml (8-S00uCi) 
1.0ml 
99mrc-sulphur colloid 
oil (arachis oil, Miglyol 812 
or liquid paraffin) 
Formulation for the small oil volume study:-
1 Sul (&.'ISO uCi) 
30ul 
9 ~ c - s u l p h u r r colloid 
oil (arachis oil, Miglyol 812 
or liquid paraffin) 
4.3.5 Total Gut Transit Time Study. 
Usinq the same animals and continuing directly fram the 
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radionuclide imaging studies with 9 ~ c - s u l p h u r r colloid and the 
large oil volumes and small oil volumes, each rat was imaged at 
hourly intervals for 100secs (large oil volume study) or 75secs 
(small oil volume study) and the faeces collected and counted. 
A standard dose was counted simultaneously so that radioactive 
decay could be compensated for by expressing the whole body 
counts in terms of a ratio with the standard. The study was 
continued until the mean standardised whole body count for each 
formulation had fallen by 60% from its highest value. 
4.4 Results. 
Statistical comparison of parameters was made using the 
Student's "t" test or the Mann Whitney "U" test. 
4.4.1 X-ray investigation. 
The radiographs of the rats showed that the right 
lateral view gave the best single plane discrimination of the 
• 
stomach and the intestinal regions (see Figure 4.2). This view 
was subsequently used in all the gamma camera studies. 
4.4.2 Radionuclide Imaging Study. 
The high activity present in the stomach region masked 
any loss of activity into the intestinal region so the grAphs 
showing the change in the stomach counts ratio with t ~ e e did 
not clearly illustrate gastric emptying (see figure 4.3). 
However, the rise in intestinal activity as gastric emptying 
occured was shown clearly by plotting the intestinal counts 
ratio against time (see figure 4.4). Gastric emptying was 
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Tigure 4.2 - Lateral Images of a Rat One Hour After a 
Barium Meal and Following Administration 
9 9 ~ c - S u l p h u r r Colloid. 
a)Lateral radiogram of a rat one hour after a barium meal. 
b)Lateral scintogram of a rat immediately after dosing with 
9 ~ c - s u l p h u r r colloid in water (O.5ml) • 
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Figure 4.3 
EFFECT OF DIFFERENT VEHICLES (lml volumes) ON THE lOSS 
OF (99"1c)-SUlPHUR COllOI D FROM THE RAT STOMACH 
( Mean values, n=6 per group). 
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Figure 4.4 
EFFECT OF DIFFERENT VEHICLES (1 ml volumes) ON THE 
APPEARANCE OF (99mTC '_ SULPHUR COllOID IN THE RAT INTESTINE 
( Mean values, n=6 per group'. 
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Figure 4.5 
THE APPEARANCE OF (123 1 )-ARACHIS OIL IN THE RAT INTESTINE 
FOLLOWING ORAL ADMINISTRATION IN ARACHIS OIL U.5mU 
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Figure 4.6 
EFFECT OF DIFFERENT VEHI CLES (1. 3 ml volumes) ON THE 
APPEARANCE OF (1231)_ OLEIC ACID IN THE RAT INTESTINE 
(Mean values, n=3 per group'. 
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Figure 4.7 
EFFECT OF DIFFERENT VEH ICLES (3{)JJ1 vol umes)ON THE 
APPEARANCE OF (99mTc )_SULPHUR COLLOID IN THE RAT INTESTINE 
(Mean values, n=6 per group). 
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90 
therefore detemined in terms of the activity entering the 
intestinal region. 
Determination of gastric emptying in groups of 6 rats 
using 99mrc-sulphur colloid (O.Sml) dispersed in each oil 
(1.0ml) showed there to be no difference (p>O.OS) between the 
oils as determined from the difference in the intestinal counts 
ratio at t=Smin and at t=80min, although the mean values had 
the rank order liquid paraffin> Miglyol 812 > arachis oil. All 
three oils significantly inhibited (p O.OS} the gastric 
emptying of 99mrc-sulphur colloid compared to water (see figure 
4.4) • 
With the smaller volumes of oil (30pl) the difference in 
the intestinal activity at t=Smin and at t=8Smin was lower 
( ~ . O S ) ) following administration in arachis oil compared with 
water, liquid paraffin and Miglyol 812 (see figure 4.7), but 
there was no difference (p>O.OS) in the gastric emptying of 
9 ~ c - s u p l h u r r colloid in the presence of water, liquid paraffin 
and Miglyol 812. 
• 
4.4.3 Total Gut Transit Study. 
As all the rats did not receive an identical dose of 
radioactivity the whole b o ~ : s t a n d a r d d dose ratios were 
expressed as a percentage of the highest ratio value for each 
rat (see figures 4.8 & 4.9). The time taken for the mean 
standardised whole b o ~ ~ count to fall to 60% of its highest 
value was taken as an index of total gut transit time (see 
table 4.2). As the faecal samples were not homogenised and made 
up to equivalent volumes the counting efficiency was not the 
same for each sample and in addition a standard count was not 
-126-
en 
-C 
:::l 
0 
u 
~ ~
.8 
Q,) 
(5 
.c: 
3: 
l/!. 
Figure 4.8 
EFFECT OF 0 I FFERENT VEH I CLES (1 m I volumes) ON THE 
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Figure 4.9 
EFFECT OF DIFFERENT VEHICLES ( 30 ~ I I volumes) ON THE 
EXCRETION OF (99mTCJ _ SULPHUR COLLOID FROM THE RAT 
(Mean values, na 6 per group). 
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Table 4.2 -Time Taken for Standardised Whole Body Counts to 
Fall to 60% of the Original Value Following Oral Administration 
of 9 9 ~ c - S u l p h u r r Colloid in Different Vehicles to Rats. (Mean ± 
S • D ., n =6 pe r gr ou p ) • 
Formula tion t 60 % (h. ) 
1ml 30).11 
Arachis oil 13.33 + 1.1 9.23 + 1.4 
Miglyol 812 14.83 ± 2.1 9.26 ± 1.6 
• 
Liquid paraffin 9.22 ± 3.4 12.42 + 1.8 
Water 6.05 ± 2.1 7.01 + 1 .6 
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made. The standardised whole body counts were therefore used to 
determine the total gut transit time of the 99mrc-sulphur 
colloid. 
In the rats dosed with 1ml oil, the total gut transit 
time of 99mrc-sulphur colloid as determined fram the t 60% 
values was faster (P<O.05) in the prsence of liquid paraffin 
and water than in the presence of arachis oil and Miglyol 812 
(see table 4.2 & figure· 4.8). With the small volumes of oil 
(30pl) the total gut transit time of 9 9 ~ c - s u l p h u r r colloid was 
slower (P(O.05) in the presence of liquid paraffin than the 
other f o ~ u l a t i o n s s (see table 4.2 & figure 4.9). 
4.5.Discussion. 
Preliminary studies were p e r f o ~ e d d to determine first 
whether gastric emptying in rats could be monitored using the 
gamma camera technique and second, which of the radionuclides 
available would be the most suitable oil phase marker • 
• 
Radiographs of restrained rats orally dosed with barium 
sUlphate suspension showed that the lateral view of the animal 
was the most suitable for the present studies as it gave the 
best single plane discrimination of the areas of interest, 
namely the stomach and the intestines. By combining a lateral 
radiograph and a scintigram, taken immediately after dosing a 
rat with 99mrc-sulphur colloid, it was seen that initially all 
the activity was in the stomach and the mouth (see figure 4.2). 
With time, activity moved out of the stomach region into the 
area corresponding to the intestines, and by computer analysis 
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it was possible to follow the the decrease in stomach counts 
and the increase in intestinal counts as this occured, and thus 
monitor gastric emptying. As clearer results were obtained from 
the intestinal counts, these were used to determine gastric 
emptying. 
The requirments for an ideal radionuclide marker for the 
oil phase were that:-
alit was not absorbed, as activity passing into the general 
circulation 'would cause errors in the analysis. 
b)it was attached to or at least miscible with, the oil so that 
gastric emptying of the oil and not the marker alone was 
monitored. 
c)it exerted no independant effect on gastric emptying which 
would alter the results. 
As no radionuclide marker with all these properties was 
available a suitable compromise had to be found. 
Attaching a marker to the molecules of the oil would 
ensure that it was the gastric emptying of the oil that was 
• 
being monitored and that the marker was not altering the 
gastric emptying rate. Unfortunately arachis oil was the only 
oil to which a radionulcide could be added due to the presence 
of. unsaturated bonds. 123I-arachis oil was prepared, orally 
administerd to rats and the results were used for comparison 
with the other markers (see figure 4.5). 
123I-oleic acid was prepared as this is miscible with 
each oil. The studies with 123r-oleic acid + arachis oil gave 
the same gastric emptyinq profile as was obtained with 
123r-arachis oil (see figure 4.6) suqgestinq that the presence 
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of oleic acid was not altering gastric emptying. As the energy 
of the 123I-iodide emmdssions is not optimal for detection by 
the collimator available a relatively large scatter of activity 
was detected, resulting in a high background count. This made 
it difficult to establish the regions of interest on the 
scintiqrams correctly, giving rise to inaccurate counts for 
each region. 
9 ~ c - s u l p h u r r colloid has been widely used in human 
gastric emptying studies (Hardy & Wilson 1981) being non 
absorbable, and as it was readily available it was examined as 
a potential oi.l phase marker. The gastric emptying prof ile for 
99mrc-sulphur colloid in the presence of arachis oil was very 
similar to that for 123I-arachis oil and 123I-oleic acid + 
arachis oil. However, the emptying of the colloid in the 
presence of Miglyol 812 was greater than for 123I-oleic acid + 
Miglyol 812, suggesting that the oleic acid had inhibited the 
emptying of Miglyol 812. Oleic acid is a long chain unsaturated 
fatty acid and may therfore be expected to inhibit gastric 
• 
emptying. This would not have been seen with the arachis oil as 
there was virtually no emptying of either marker, 123r-arachis 
oil or 123I-oleic acid, within the experimental period. There 
was, however, little difference in the gastric emptying of 
. 
9 ~ c - s u l p h u r r colloid and of 123I-oleic acid in the presence of 
liquid paraffin. 
9 ~ c - s u l p h u r r colloid would seem to be a more suitable 
marker than 123-oleic acid being less likely to exert any 
pharmacological action, being non absorbable and emitting gamma 
rays at an optimum energy level for detection by the camera. It 
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is, however, immiscible with oil and is a solid, although the 
particles are very small, and it was considered possible that 
it was the gastric emptying of the colloid and not that of the 
oil that was being monitored. However if the gastric emptying 
of the.colloid had been unaffected by the presence of the oils 
the same result would have been anticipated for each 
formulation. As this did not occur it was considered that the 
gastric emptying of the colloid was being altered by the 
affects of the oils on gut motility. The effect of each oil on 
gastric emptying could therefore be determined from the changes 
in the gastric emptying of 99mrc-sulphur colloid administered 
with the oil. 
On the basis of these investigations 99mrc-sulphur 
colloid was selected for use in all further gastric emptying 
studies. 
Having shown that it is possible to monitor gastric 
emptying in rats using the gamma camera and 99mrc-sulphur 
colloid as a marker the effect of 1 ~ 1 1 and 3 0 ~ 1 1 volumes of 
• 
arachis oil, Miglyol 812, liquid paraffin and water on gastric 
emptyinq in the rat were investiqated. 
With 1ml volumes, 99mrc-sulphur colloid emptied faster 
(P(O.OS) in the presence of water than the oils, and there was 
no siqnificant difference (p>O.OS) in the intestinal counts 
ratios for the oils after 80minutes, although the mean values 
had a rank order of liquid paraffin> MiqlyoI 812 > arachis 
oil. Within each qroup of rats there was a wide variation in 
the rate of gastric emptyinq due in part to biological 
variation and in part to analytical difficulties (see later), 
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such that, although possible differences in gastric emptying 
were observed, the values were not different (p>O.OS). The 
preliminary study using 123I-oleic acid gave the same ranking 
of the mean values for the intestinal counts ratio after 80 
minutes as this experiment, in that liquid paraffin exhibited 
faster emptying than the other oils. It is therefore suggested 
that 1ml volumes of liquid paraffin emptied from the stomach 
faster than the 1ml volumes of arachis oil, but that due to 
large intra-group variation and analytical errors a 
statistically significant (P<O.OS) effect was not observed. 
With the smaller volumes of oil (30pl), arachis oil 
inhibited (P(O.OS) the gastric emptying of 99mrc-sulphur 
colloid compared with water, Miglyol 812 and liquid paraffin, 
there being no difference (p>O.OS) between the latter group. 
The results obtained for the small volumes of oil may be 
anticipated from the literature data. Miglyol 812 contains 
CS-C 12 fatty acids which are unlikely to inhibit gastric 
emptying to the same extent as the long chain unsaturated fatty 
• 
acids of arachis oil (Hunt & Knox 1965b,Cooperman & Cook 1976). 
Liquid paraffin is unlikely to inhibit gastric emptying as it 
is non-digestible so there are no intra-luminal digestion 
prodUcts to stimulate the inhibitory responses. Thus, only 
arachis oil is likely to delay gastric emptying with respect to 
water. For the larger volumes of oil it is difficult to draw 
any conclusions as to the underlying mechanisms as the 
experiment was not condUcted over a· long enough time period to 
deter.mine any significant (P(O.OS) differences in the gastric 
emptying of the oils. The lower (P(O.OS) gastric emptying rate 
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of the oils in comparison to water may be due in part, to a 
viscosity effect. Following mixing with chyme the low volumes 
(30Pl) of oil would not have significantly altered the 
viscosity of the stomach contents, but the large volumes (1ml·) 
of oil probably markedly increased the viscosity of the stomach 
chyme t h e r e ~ ~ retarding gastric emptying (Yamahira et 
al.1978,Levy & Jusko 1965). 
Comparison of the gastric emptying profiles for 1ml and 
30ul volumes of oil suggest that with the larger volumes of oil 
there was an initial delay before gastric emptying started; for 
Miglyol 812, liquid paraffin and water this was approximately 
20 minutes whereas for arachis oil it was approximately 30 
minutes. In addition, comparison of figures 4.4 and 4.7 
suggests that for the larger volumes of oil the rate of gastric 
emptying was slower. Oil volume would therefore appear to have 
a marked effect on gastric emptying. 
As previously stated a number of problems were 
encountered with the computer analysis of the radionuclide 
• 
imaging studies which gave rise to error in the counts 
recorded:-
a)The analysis was done in two dimensions and it was not 
possible to allow for activity which moves through the 
intestinal region lying in the same horizontal plane as the 
stomach and all the activity was attributed to the stomach. 
b)Lonqtitudinal movement of the rats durinq the study 
could be canpensated for by movinq the R:>I correspondinqly, but 
rotational movement could not be accounted for and gave rise to 
errors aa the view presented to the camera changed. In addition 
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any movement of the rat during an image could not be allowed 
for and caused errors in the counts from that frame. 
c)As the 99mrc-sulphur colloid passed along the 
intestinal tract its distance fram the camera face changed 
causing errors as the nearer a c t i v i t ~ ~ is to the camera face the 
higher the counts that are reccorded. 
d)Standardisation to allow for-the slight variation in 
the dose received by each rat was based on the assumption that 
in the first complete image all the activity would be in the 
stomach. I f the rat did not swallow the whole dose the 
stomach:whole body count ratio was not equal to 1. In a later 
frame if the rat swallowed the activity remaining in the mouth 
or oesophagus the stomach count ratio suddenly increased. The 
intestinal counts ratio did not always start at zero due to 
background activity in the ROI. 
e)Errors caused by incomplete resolution by the camera 
of the anatomical structure being examined. 
• 
As 99mrc-sulphur colloid is not absorbed it was possible 
to determine the total gut transit of the colloid by whole b o ~ ~
gamma scintiqraphy and faecal analysis and relate this to 
qastro-intestinal motility in the presence of each oil. The 
time taken for the standardised whole b o ~ ~ count ratio to fall 
to 60\ of its highest value was used as an index for total gut 
transit time. Variations in the whole b o ~ ~ counts were seen 
throughout the experiment due to movement of activity towards 
and away from the camera face and it was considered that a 60\ 
fall in whole body activity would only occur when the colloid 
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was excreted in the faeces. 
For the large volumes of oil the colloid was excreted 
faster (P(O.OS) in the presence of water and liquid paraffin 
than arachis oil or Miglyol 812 (see table 4.2). As gastric 
emptying is an important factor in intestinal transit these 
results correlate with the faster gastric emptying of the 
colloid in the presence of water, and the suggestion that 
liquid paraffin causes faster emptying of the colloid from the 
stomach than arachis oil. With such large volumes of oil it may 
be anticipated that the laxative properties of liquid paraffin 
would markedly increase intestinal transit, resulting in a low 
total gut transit time. 
With the smaller volumes of oil and water there was not 
the same correlation between gastric emptying and total gut 
transit time. 99mrc-sulphur colloid was excreted faster 
(p(P.OS) in the presence of arachis oil and Miglyol 812 than 
liquid paraffin but slower (P(O.OS) than in the presence of 
water, whereas with the gastric emptying study arachis oil 
• 
Significantly inhibited (P(O.OS) emptying compared to the other 
formulations. This suggests that the intestinal transit of the 
colloid in the presence of arachis oil is faster than with the 
other two oils reducing the time available for its. absorption 
and, conversely, in the presence of liquid paraffin i n ~ e s t i n a l l
transit of the colloid is slowed allowing more time for 
absorption. Unemulsified liquid prarffin is absorbed in small 
quantities from the gastro-intestinal tract of rats (Albro & 
Fishbein 1970) and metabolised to long chain fatty acids within 
the mucosal cella (McWeeny 1957) which are then transported in 
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the chylomicra of the lymph (section 1.2). It is possible that 
although liquid paraffin itself does not initially inhibit 
gastro-intestinal motility the LCFA produced within the mucosal 
cells following absorption do stimulate an inhibitory response. 
With 1ml volumes this effect would have been negligible with 
respect to the laxative action of the relatively large 
proportion of liquid paraffin remaining within the intestinal 
lumen. However, with the smaller oil volume it is possible that 
gut motility was inhibited by this mechanism, especially as the 
liquid paraffin moved further along the gastro-intestinal tract 
when less remained in the intestinal lumen. Also liquid 
paraffin absorption may have continued along the length of the 
small intestinal tract causing a continued suppression of 
motility. The other two oils are completely absorbed within the 
upper regions of the intestine and so would only inhibit 
motility for a relatively short time. In this way it is 
possible that following rapid gastric emptying, the intestinal 
transit of liquid paraffin was slowed c a u s i n ~ ~ the observed 
delay in total gut transit of 9 ~ c - s u l p h u r r colloid in the 
presence of this oil. 
Transit of material through the colon is an important 
consideration in total gut transit, being the region through 
which food takes the longest time to pass (Cumming & Wiggins 
1976). In the present studies arachis oil, Miglyol 812 and 
water would have been absorbed within the small intestine so 
that in each experiment the same material, 99mrc-sulphur 
colloid, was entering the colon. Thus the colonic transit was 
not dependant on the vehicle in which the colloid was 
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originally administered and the differences in total gut 
transit could be related to the influence of the vehicle on the 
small intestinal transit of the colloid. The same arguament can 
probably be applied to small volumes of liquid paraffin as it 
is likely that most, if not all, is absorbed within the small 
intestine. With the larger volumes of this oil the laxative 
effect would have caused rapid transit of the colloid 
throughout the entire intestinal tract. 
The present study has shown that the gastric emptying 
rate and intestinal transit of lml volumes of arachis oil and 
Miglyol 813 are similar (p>O.05), whereas the gastric emptying 
rate and intestinal transit of lml liquid paraffin is faster 
(p<O.05) than that of arachis oil and Miglyol 812. The 
differnce in the oral absorption of DDT from lml volumes of 
Miglyol 812 and of liquid paraffin may therefore be partially 
explained in terms of differences in the gastro-intestinal 
residence time of DDT in the presence of the two oils (see 
section 6). 
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CHAPTER 5. 
ORAl. ABSORPTION OF PREDNISOLONE. 
5.1 Introduction. 
The preceeding studies have shown that it is possible to 
enhance the lymphatic absorption of a model compound, DDT, by 
co-administration with arachis oil. On the basis of these 
findings the study was extended to examine the lymphatic uptake 
of the glucocorticoid, prednisolone. Although prednisolone is 
extensively used clinically plasma levels and total drug 
absorption (calculated as the area under the plasma level-time 
profile) exhibit wide inter-subject variation following oral 
administration. This has been attributed to poor water 
solubility and to first-pass metabolism (Pickup 1979,Thiesen 
1976). It is possible that elevated, more uniform plasma levels 
may be achieved by enhancing the lymphatic absorption of the 
steroid. • 
A number of steroids, namely oestradiol and testosterone 
(Sieber et al.1974), 17-methyl-14c-oestradiol (Blockage et 
al.1953), 17-k-methyl-14C-testosterone (Hyde et al.1954), 
cortisone-4- 14C-acetate (Blockage et al 1955) and testostereone 
and hydrocortisone (Hellman et al.1956), have been shown not to 
exhibit selective lymphatic absorption, being preferentially 
absorbed into the portal vein. I t was suggested that these 
compounds are not sufficiently lipophilic to be absorbed into 
the lymph (see section 1.5.3). However, a study by Lowimore 
(1977) showed that in doq.s, prednisolone concentrated in the 
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lymph preferentially to the portal blood during the first 20 
minutes after intra-gastric administration of an aqueous 
radiolabelled drug solution; the lymph concentrations were 2.9 
and 2.2. times those of the portal plasma 5 and 15 minutes 
after dosing. It was also shown that prednisolone and its 
metabolites preferentially distributed into the lipid rather 
than the aqueous phase of the lymph. 
It was concluded fram the literature review (see section 
1.5) that the absorption of a drug into the lymphatic system 
may be increased by the introduction of a lipophilic grouping 
into the molecule and by stimulation of lymph flow by 
co-administration of oil. The lymphatic absorption of 
ethynyloestradiol in rats was enhanced by synthesis of the 
cyclopentyl ether ester and by administration in sesame oil 
(Gianina et al.1966). Similarly, Coert et al.(1975) showed that 
the biological activity of testosterone in rats, was enhanced 
by esterification of the steroid to testosterone undecanoate 
and by administration in arachis oil. Absorption of the ester 
was demonstrated to be via the lymphatic route. In a number of 
studies B ~ n i i and his co-workers (1966,1970) showed in man that 
the oral absorption of several ~ - 3 - k e t o s t e r o i d s s could be 
increased by administration of the enol ether derivative and by 
administration in oily solution (see section 1.1). Although no 
investigations were conducted to determine the underlying 
mechanisms enhanced lymphatic absorption was suggested. 
It may therefore be possible to enhance the partitioning 
of prednisolone into the lymph by co-administration of the drug 
with oils and by the introduction of a lipophilic grouping into 
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the molecule. In the present study the plasma and lymph 
radioactivity following oral administration of 3H-prednisolone 
and 3H-prednisolone-21-palmitate (198nM/kg body weight) in 30pl 
arachis oil, Miglyol 812, liquid paraffin and water were 
determined in rats. 
5.2 Materials and Apparatus. 
5.2.1 Materials. 
a)Prednisolone B.P. - M.S.D., Cramlington, Tyne & Wear. 
b)Pyridine - B.D.H., Poole, Dorset. 
c)Octanol - B.D.H., Poole, Dorset. 
d)Palmitoyl chloride -'Aldrich Chemical Co., Gillingham, 
Dorset. 
e)Chloroform - Cambrian Chemicals, Croydon, Surrey. 
f)Methanol - East Anglia Chemicals, Hadleigh, Sulfolk. 
g)Ether ":- May & Baker Ltd., Dagenham, Essex. 
h)Acetronitrile - Fisons, Loughborough. 
i)Fisoflor - Fisons, Loughborough. 
• 
j)Brij 97 (polyoxyethylene oleyl ether) - Honeywell Atlas Ltd., 
Carshalton, Surrey. 
k)Miqlyol 812 - Dynamit Nobel, SlOUgh, Bucks. 
l)Arachis Oil - Evans Ltd.', Speke, Liverpool. 
m)Liquid Paraffin - Shell, London. 
5.2.2 Apparatus. 
a)TLC plates - Kieselgel 60 F254 , Merck, Germany. 
i)analytical - 5 c m ~ 1 0 c m x O . 2 5 m m m
ii )preparative - 20cnut20cnuc5mm 
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b)Rotary evaporator - Buchi, Switzerland. 
c)Peristaltic pump - Watson-Marlow Ltd., Bucks. 
d)Cannulae - (see figure 5.1) Teflon tubing - Portex Ltd., 
Hythe, Kent. 
Silicone tubing - Esco Rubber, 
Teddington, Middlessex. 
e)Homogeniser - Ultra-Turrax, Janke & Kunkel KG, Staufen, 
Breisgau. 
f)Agla m i c r o ~ e t e r r syringe - Wellcame Reagents Ltd., Beckenham, 
Middlessex. 
i)HPLC - Varian Model 5000 Liquid Chromatograph, Model 
5020/5030 Column Heater, Hewlett Packard Model 3390A 
Integrator, UV 50 Detector at 245nm, Zorbax ODS Column. 
Operating conditions - a)prednisolone - Temp.=400. Flow 
rate=1.0ml/min. Mobile phase= 45%acetronitrile and 55% water. 
Rt = 4.2 minutes. 
b)prednisolone-21-palmitate -
Temp.=40 0 • Flow rate 1.5ml/min.',Mobile phase=96% acetronitrile 
and 4% water. Rt = 10.8 minutes. 
5.3 Methods. 
5.3.1 Synthesis of Prednisolone-21-Palmitate. 
Prednisolone (4q,11.1mM) was dissolved in dry pyridine 
(25mls) in an ice bath, under nitroqen. Palmitoyl chloride 
(6.1q,22.2mM) dissolved in ether (15mls), was added through a 
4ra,ppinq funnel over a 30 minute peroid whilst the reaction 
mixture was atirred continually. After a further 30 minutes the 
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ice-bath was removed. TLC analysis of the reaction mixture on 
silica gel F254 using chloroform:methanol (8:1 v/v) as the 
solvent system, showed that after two hours there was no 
unreacted prednisolone. The reaction mixture was poured into 
150mls iced water and the precipitate produced was extracted 
twice with chloroform. The chloroform phase was collected and 
washed with excess hydrochloric acid (1.0M) to remove the 
pyridine, .and with sodium bicarbonate solution to remove excess 
hydrochloric acid and palmitic acid. The organic phase was then 
dried over sodium sulphate •. Rotary evaporation in vacuo, of the 
filtered chloroform yielded a "glass" from which the product 
was crystallised by the addition of ether (approximately 10mls) 
and scratching of the flask surface. The crystals were 
collected and recrystallised from aqueous ethanol using 
charcoal to decolourise the solution. The purified crystals 
were dried to constant weight and the character and purity of 
the product was determined using NMR, IR, HPLC, TLC and 
mi cro-analys is. • 
The preceeding method was modified when ~ y n t h e s i s i n g g
3H-prednisolone-palmitate from 3H-prednisolone due to the small 
quantities of starting material used. 3 ~ ~ p r e d n i s o l o n e e
(13.6pg,2mCi,37.7nM) and prednisolone (1.42mg,3.94pM) were 
dissolved in dry pyridine (O.8ml) and palmitoyl chloride 
(approximately O.002ml) was added. The reaction flask was left 
shaking for 48 hours when TLC analysis indicated that the 
reaction of prednisolone was complete. The pyridine was removed 
by rotary evaporation at 350 in vacuo and then left for 12 
hours under vaCUUlll in a vacuum oven. The residue was dissolve4 
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in methanol (approximately 1ml) to remove unreacted palmitoyl 
chloride and then evaporated to dryness by rotary evaporation 
in vacuo before being redissolved in chloroform. This solution 
was'spotted onto a preparative TLC plate which was developed in 
chloroform:methanol (8:1 v/v) solvent system. The silica at the 
Rf corresponding to prednisolone palmitate (0.7) was collected 
and washed with 3x20ml aliquots of chloroform. These washings 
were collected and rotary evaporated in vacuo at 350, to 
dryness and then the residue was redissolved in a known volume 
of chloroform. The purity of the product was determined by TLC 
and the yield was calculated fram the activity in known 
aliquots of the solution. 
5.3.2 Solubility Determinations. 
Prednisolone or prednisolone-21-palmitate (100mg) was 
added to each oil (6ml) contained in 10ml glass screw capped 
bottles and the bottles were vigoroursly shaken at 20° for 4 
days. The oil was centrifuged at 2,000rpm for 15 minutes to 
sediment the undissolved drug and an aliquo_ was taken for 
analysis. Drug concentrations in Miglyol 812 and arachis oil 
were determined by HPLC following dilution of each oil sample 
with ethanol (1 in 10w/v for Miglyol 812 and 1 in 50w/v for 
arachis oil). Diluted ethanolic.solutions of liquid paraffin (1 
in lOw/v) were assayed by UV spectroscopy at 245nm. 
5.3.3 Partition Coefficient Determinations. 
The octanol:water partition coefficient for prednisolone 
and for prednisolon-21-palmitate and the ether:water partition 
coefficient for prednisolone were determined. 5ml aliquots of 
drug 8olution8 (1.g/lI1) in water saturated octanol were shaken 
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with 25 ml octanol saturated water in stoppered glass 
centrifuge tubes for 10 hours at 20 0. The tubes were 
centrifuged at 2,000rpm for approximately 20 minutes to 
separate the phases. The aqueous phase was filtered through a 
0.47um Millipore filter and a sample of the filtrate taken for 
analysis. Aliquots of the octanol phase were diluted with 
ethanol (1 in 10v/v) prior to analysis. 10ml samples of 
prednisolone in water saturated ether (1.5mg/ml) were shaken 
with 20ml ether saturated water in stoppered glass centrifuge 
tubes at 200 for 6 hours. The mixture was allowed to settle and 
the phases separated. 1ml aliquots of each ether layer were 
evaporated to dryness under nitrogen and then re-constituted in 
acetonitrile (1ml) prior to analysis. Samples of the water 
phase was taken directly for analysis. All the samples were 
assayed by'HPLC. 
5.3.4 Preparation of Dosage Forms. 
Each rat was orally dosed with 39.6nM prednisolone or 
prednisolone-21-palmitate containing 20pCi la-prednisolone or 
3H-prednisolone-21-palmitate dissolved or suspended in 30ul 
vehicle. Solutions containing the tritiated and the cold 
material were evaporated to dryness under nitrogen, the 
required volume of vehicle adde4 and a solution or suspension 
. . 
of the drug produced by sonication. F o ~ u l a t i o n s s containinq 
prednisolone in arachis oil, Miqlyol 812, liquid paraffin, 
aqueous ethanol (20% ethanol in water) and water, and 
prednisolone-21-palmitate in arachis oil ~ e r e e prepared in this 
way. A solution containinq 20pCi 3H-prednisolone-21-palmitate 
plus 0.25mq cold druq (-0.0042mM predniso1one-21-pa1mitate) in 
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1ml arachis oil was also prepared. 
Solutions of prednisolone and prednisolone-21-palmitate 
for the in situ gut loop study were prepared using the 
non-ionic surfactant Brij 97. 10mg drug was dissolved in 19 
Brij 97 by warming and made up to 100mls with 0.9% saline. 
5.3.5 Oral absorption Study. 
Groups (n=6 per group) of male, Wistar rats in the 
weight range 195-200g were starved for 18 hours with free 
access to water. 30ul volumes of the formulations were orally 
administered to the rats using an Agla micrometer syringe.unit 
fitted with a dosing needle. Following oral dosing tail tip 
blood samples were taken, (see section 2.3.3), at 0.25, 0.5, 
1.0, 1.5, 2.0, 3.0, 4.0, 6.0, 8.0, and 24.0 hours after dosing. 
After 4 hours the rats were given free access to food. Weighed 
plasma samples were added to 10mls Fisoflor containinq 5 0 ~ l l
water to solubilise the plasma, and the activity determined by 
liquid scintillation counting. 
The oral absorption of 3H-prednisolone from 30pl Miqlyol 
812 , arachis oil, liquid paraffin, aqueous ethanol and water, 
and of 3H-prednisolone-21-palmitate from 30pl arachis oil, was 
determined. 
5.3.6 Lymphatic Absorption Study. 
Starved male, Wistar rats as in section 5.3.5 were used 
for each formulation (n=4 per qroup). Followinq oral dosinq the 
rats were anaesthetised, and juqular vein and thoracic duct 
cannulations performed as previously described (see section 
3.3.1). Rats dosed with 30pl volumes were anaesthetised 
immediately whereas rats dosed with 1ml volumes were left for 5 
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minutes to allow the dose to be swallowed. Tail tip blood 
samples and lymph samples were collected at half-hourly 
intervals between 0.5 and 4.0 hours after dosing and the lymph 
flow was determined from the weight of the lymph collected. The 
lymphatic absorption of ~ - p r e d n i s o l o n e e from 30ul arachis oil, 
Miglyol 812 and liquid paraffin, and of 
3H-prednisolone-21-palmitate from 1m! and 30ul volumes arachis 
oil were determined. 
During the studies with prednisolone-21-palmitate, 100ul 
aliquots of lymph were collected at intervals between the 
samples taken for scintillation counting, and extracted with 
chloroform. The phases were separated by centrifugation at 
3,000rpm for 10minutes, and the chloroform layer collected and 
evaporated to dryness under nitrogen. Each sample was 
reconstituted with SOpl chloroform and 10pl was spotted onto a 
TLC plate. Standard solutions of prednisolone and 
prednisolone-21-palmitate were also spotted onto each plate. 
The plates were developed in chloroform:methanol (8:1 v/v) 
• 
solvent system, and uniform areas of silica around each spot 
were removed and the activity determined by scintillation 
counting. 
5.3.7 In situ Gut Loop Study. 
Starved male, Wistar rats as in section 5.3.5 were used 
(n-3 per group). Each rat was anaesthetised and the abdomen 
opened by a mid-line incision along the linea-alba. The stomach 
was exposed and a small plastic cannula inserted through a slit 
• 
in the wall of the pyloric region, and passed into the small 
intestine. It was secured in place with a ligature placed 
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Figure 5.2 
THE RECIRCULATION PERFUSION SYSTEM 
Silicone tubing 
Cannula (.' 
(distal end) 
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I. 10 m I. plastic 
syringe 
... 1 Drug solution 
... Water at 370C 
behind the bulge in the cannula. A slit was made in the small 
intestinal wall just proximal to the ileo-caecal junction. The 
gut segment was cleaned by infusing with warm saline and the 
fluid removed by displacement with air. A second cannula was 
then introduced into the distal end of the gut segment and 
secured in place with a ligature, taking care not to damage the 
mesenteric blood vessels. The proximal cannula was fitted to 
the perfusion circuit, the pump started and the loop filled 
wi th drug solution. The loop was perfused through a 
recirculating system at a rate of 2ml/min using 25mls drug 
solution (see figure 5.2). 0.5ml samples were taken from the 
resevoir at time zero (the time at which the drug solution 
appeared at the distal end of the gut loop) and thereafter at 5 
minute intervals until 35 minutes. Throughout the experiment 
the rats were kept on a heated table at 450 and anaesthesia 
maintained by administration of phenobarbital. At the end of 
the experiment the gut loop was excised, blotted dry and 
weighed. The absorption of prednisolone and 
• 
prednisolone-21-palmitate from 0.9% saline containing l' Brij 
97 was determined in this way. Control experiments were 
performed to determine the ad$orption of both drugs to the 
tQbing of the re-circulating system. 
S.3.a In vitro Hydrolysis of Prednisolone-21-Palmitate. 
Starved male Wistar rats as described in section 5.3.5, 
were orally dosed with O.Sml arachis oil containing Sudan Black 
and left for 30 minutes before being anaesthetised. The abdomen 
was opened and the section of the small intestine 
(approximately 33cm) containing Sudan Black was excised. The 
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luminal contents were added to 10m! 0.1M phosphate buffer pH7.4 
and mixed using a homogeniser. The gut wall was cut into 
sections and homogenised with 10m! 0.1M phosphate buffer pH7.4. 
3ml aliquots of homogenised gut wall or luminal contents were 
added to flasks containing 5 mg prednisolone-21-palmitate 
suspended ~ n n 4.5ml 0.1M phosphate buffer+O.5m! arachis oil or 
5.0ml 0.1M phosphate buffer respectively. The flasks were 
shaken at 35° for 1 hour and then the reaction mixture was 
extracted with 10ml chloroform. Samples of the chloroform layer 
were analysed by TLC using the solvent system of 
chloroform:methanol (8:1 v/v). Control experiments without 
either drug or rat tissue were performed. 
5.4 Results. 
5.4.1 Synthesis of Prednisolone-21-Palmitate. 
The identity of the reaction product as 
• 
prednisolone-21-palmitate was confir.med using NMR, IR, and 
micro-analysis. The product had a melting point of 138-140°. 
HPLC and TLC showed the presence of a low concentration 
impurity with slightly greater Rt and Rf values than 
prednisolone-21-palmitate, which was not removed by further 
recrystal1sation of the product. It is likely that this 
impurity was prednisolone-21-stearate for.med due to 
contamination of the palmitoyl chloride with stearoyl chloride. 
A final yield of 66' was obtained from the large scale 
preaparation and ~ ~ 29.3' yield of 3a-prednisolone-21-palmitate, 
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this product being 88.9% pure as determined by TLC. 
5.4.2 Solubility Determinations. 
The solubility of prednisolone and 
prednisolone-21-palmitate in arachis oil, Miglyol 812, and 
liquid paraffin is shown on table 5.1. The concentration of 
both drugs in liquid paraffin was below the detection limit of 
the UV spectrophotometer. 
5.4.3 Partition Coefficient Determinations. 
The ether:water partition coefficient for prednisolone 
was 1.06 and the octanol:water partition coefficient was 40.22 
(mean of two detenninations). The octanol water partition 
coefficient for prednisolone-21-palmi tate was> 3.05 X 103 , the 
exact value could not be detennined as the drug concentration 
in the water phase was below the limit of the detector. 
5.4.4 Dosage Forms. 
The solubility data suggested that prednisolone would 
not fonn a solution in Miglyol 812 or arachis oil at a 
concentration o ~ ~ 14.3ug/30pl. However microscopic examination 
• 
of both preparations made in exactly the same manner as the 
original fonnulations but containing no radioactive material, 
failed to detect any drug particles. Prednisolone also f o ~ e d d a 
solution in aqueous ethanol but formed a suspension in liquid 
paraffin and water. Prednisolone-21-palmitate formed a fine 
suspension in the 30pl arachis oil f o ~ u l a t i o n n and a solution 
in the 1ml arachis oil f o ~ u l a t i o n . . Microscopic examination of 
the prednisolone and prednisolone-21-palmitate suspensions 
showed the particles to be conqlomerates of needle shaped 
crystals. The individual crystals were of the order of 2-100pm 
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Table 5.1 -Solubility (roM/gram) of Prednisolone and 
Prednisolone-21-Palmitate in Arachis Oil, Miglyol 812 and 
Liquid Paraffin at 20°. (Mean of 2 determinations). 
Arachis Oil Miglyol 812 Liquid 
Paraffin 
. 
Prednisolone 5.16x10- 4 1 . 83X1 0-4 <1.57x10-4 
Prednisolone-21- 31.73X10-4 12.67 X1 0-4 < 0.95)(10-4 
Palmitate 
Prednisolone solubility in water at 25 0 = 6.74 mM/gram (Hayton 
& Grisafe 1975). 
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in size but this varied considerably and the true particle size 
distribution could not be determined. 
5.4.5 Oral Absorption Study. 
The plasma activity versus time profiles for the various 
formulations are shown in figure 5.3 and. 5.4. The plasma 
activity was expressed in terms of the fraction of the total 
activity administered to allow for the difficulties in 
administering the exact dose of a suspension. From the data the 
peak plasma activity (Cpmax ) annd the time of peak plasma 
activity (Tmax) were determined and the area under the curve 
between 0 and 24 hours (AUC O_24h ) calculated using the 
trapezoidal method (see table 5.2). A comparison of these 
parameters for the different formulations was made using the 
unpaired Student' s lit II test. 
5.4.6 Lymphatic Absorption Study. 
To show the comparative effects of the different 
vehicles on the uptake of activity into the lymph it was 
necessary to allow for the differences in lymph flow in each 
• 
rat. The lymph activity at the end of the cannula in the 
thoracic duct, at the same time interval after dosing for each 
rat, was interpolated from the experimental data and the 
lymph:plasma activity ratio calculated (see table 5.3). 
The activity in each spot from the TLC plates was 
determined in terms of dpm/100pl and the ratio of the 
prednisolone-21-palmitate to prednisolone activity for each 
sample calculated. For the 30pl arachis oil formulation this 
ratio remained ~ . l a t i v e l y y constant being 0.62±0.10, 0 . 5 8 7 ~ . 0 9 , ,
and 0.680±0.16 (mean ~ ~ standard deviation) between 1-2, 2-3, 
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Figure 5.3 
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Table 5.2 -Absorption Data Following Oral Administration of 
Prednisolone (71.5pg/kg) in Different Vehicles (30pl volumes) 
to Rats (rnean±S.D ., n=6 per group). 
Vehicle AUC O_24h Cpmax Tmax 
(h. ) 
Arachis oil 13.34±O .87 2.96±O.47 0.3 8±O . 15 
Miglyol 812 16.05±1.03 3.57±0 .78 o .31 to . 13 
Liquid paraffin 12.87±1.78 2.09±O .58 1.0±0 .55 
Aqueous ethanol 13. 16± 1 .3 1 2.92±0.15 o . 30±0 . 11 
(20% v Iv) 
Water 10.64±1.13 1.47±O.24 O.71±O.33 
AUC O_24 = area under the curve of fraction of dose administered 
against time between 0 and 24 hours, determined by the 
trapezoidal method. 
= maximum plasma activity expressed as the fraction of 
the dose administered. 
Tmax = time of maximum plasma activity. 
For prednisolone-21-palrnitate (118.7pg/kg) in arachis oil 
(30pl), AUC=8.43+0.78, Cpmax=1.06±O.30, Tmax=1.60±O.96. 
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Table 5.3 - Lymph:Plasma Ratios of Tritium Concentrations (dpm/mg) in 
Anaesthetised Rats Following Oral Administration of 3H-Prednisolone and 
3H-Prednisolone-21-palmitate (20pCi) in Different Vehicles 
(Mean ± S.D., n=4 per group). 
-~ ~ 0.5h. 1 . Oh. 1 .5h. 2.0h. 2.5h. 3.0h 3.5h • Formulation 
Prednisolone+ 0.62 0.79 0.73 0.77 0.85 0.70 1.05 
arachis oil 30lll ±0.03 t o • 21 ±O .09 t o • 16 t o • 15 t o .14 / 
Prednisolone+ 0.81 0.77 0.74 0.75 0.77 0.78 0.86 
Miglyol 812 30pl ±O . 18 to.Ol to.l1 ±0.12 t o . 15 t o • 12 ±0.25 
Prednisolone+ 0.79. 0.67 0.76 0.80 0.85 0.77 0.74 
Liquid paraffin 30pl ±0.53 ±0.05 ±0.15 to.14 .i0 • 12 ±0.07 ±O • 18 
Prednisolne-21-palmitate 0.58 0.62 0.76 0.80 0.83 0.85 0.72 
+arachis oil 30pl t.e .33 ±O .24 ±O • 15 ±O.25 +0.21 ±0.12 to .60 
Prednisolone-21-palmitate 0.88 0.99 0.93 1 .03 1 . 18 1.06 0.81 
+arachis oil lml ±O • 11 ±0.19 iO.08 ±0.11 ±0.17 ±0.15 to.37 
-
4.0h 
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Figure 5.5 
ABSORPTION OF PREDNISOLONE AND PREDNISOLONE-21-PALMITATE IN 1% BRIJ 97 
SOLUTION FROM A SMALL INTESTINAL GUT LOOP IN THE RAT (mean values, n-3 per group, 
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and 3-4 hours after dosing respectively. Due to difficulty in 
maintaining a steady state of anaesthesia in the animals dosed 
with 1ml volumes of arachis oil insufficient lymph was 
collected for analysis. 
5.4.7 In Situ Gut Loop Study. 
The drug concentration in the test solution at different 
time intervals was expressed as a percentage of the drug 
concentration at t=5minutes. This allowed for dilution effects 
due to saline remaining in the gut loop. From the log-linear 
time plot of percentage drug remaining versus time, the 
absorption rate constant for each drug was determined (see 
figure 5.5). 
5.4.8 In Vitro Hydrolysis of Prednisolone-21-Palmitate. 
No prednisolone was detected in the extracts incubated 
with homogenised gut wall. Very low concentrations of 
prednisolone were detected in the extracts incubated with 
homogenised luminal contents. 
• 
5.5 Discussion. 
The oral absorption of prednisolone was not enhanced by 
administration in oily vehicles and was significantly reduced 
following esterification to predbisolone-21-palmitate. In 
addition, neither drug was selectively absorbed via the 
lymphatic pathway. 
The plasma activity versus t ~ e e profiles constructed 
represent the concentration of 3H- label in the plasma and not 
the concentration of drug. No attempt was made to follow drug 
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metabolism and therefore the distribution of the 3H-Iabel 
within the plasma. A study by Pickup et al.(1977) showed that 
in human subjects following intra-venous administration of 
3H-prednisolone the total counts in the plasma up to about 1.5 
hours after dosing were almost entirely due to prednisolone and 
its major metabolite prednisone. Later, further metabolites 
such as glucuronides were produced. Thus the total counts do 
not reflect the kinetics of prednisolone alone. In the present 
study the absorption phase is all that is of interest, and as 
the presence of the 3H-Iabel in the plasma represents 
absorption of the drug molecule this can be used to determine 
the effect of different oily vehicles on drug absorption. 
The levels of plasma activity following administration 
of 3H-prednisolone varied considerably with the vehicle in 
which it was adminfstered (see figure 5.3). This did not result 
from differences in the lymphatic absorption of the drug. The 
. 
lymph:plasma activity ratio remained less than one in each 
experiment (see t ~ l e e 5.3) suggesting that there was no 
• 
selective lymphatic uptake and that the activity present in the 
lymph was derived from the plasma. Prednisolone was in solution 
in the three vehicles (Miglyol 812, arachis oil and aqueous 
( 
ethanol) which yielded the highest peak plasma levels and,in 
suspension in the other two formuiations (liquid p a r a ~ f i n n and 
water). The difference in plasma activity levels may therefore 
be due to the physical form in which the drug was administered. 
As dissolution of suspension particles has to occur prior to 
absorption this may also have contributed to the delay in the 
peak activity levels that were observed with the liquid 
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paraffin and water formulations compared with the arachis oil, 
Miglyol 812 and aqueous ethanol formulations (P(0.05 for T 
max 
values) • 
Solubility determinations suggested that prednisolone 
was insufficiently soluble in arachis oil and Mig1yo1 812 to 
form a solution at the required dose level of 14.3pg/30pl (= 
1 . 3 0 ~ 1 0 - 3 / g r a m ) ) (see table 5.1). The formation of prednisolone 
solutions in these oils with the experimental formulations may 
have resulted from differences in the physical form of the 
prednisolone used. The solubility determinations were made 
using prednisolone powder whilst the formulations were produced 
from prednisolone crystallised from toluene/ethanol solution. 
The low oil solubility and octano1:water partition 
coefficient determined for prednisolone suggested that the drug 
was not sufficiently lipophilic to exhibit selective lymphatic 
absorption. By esterification of prednisolone to prednisolone 
palmitate the solubility of the drug in both arachis oil and 
Mig1yo1 812 and the 1ipoophilicity of the molecule as 
• 
determined from the octanol:water partition coefficient, was 
significantly increased. The experimental value for the log 
ether:water partition coefficient for prednisolone (0.027) was 
of the same order as that determined by Flynn (1971), 0.053. On 
the basis of the steroidal ether:water partition coefficients 
determined by Flynn (1971), McGowan et al.(1979) proposed a 
theoretic'al model for the estimation of this parameter for 
other steroidal molecules. Using this model the log ether:water 
partition coefficient for prednisolone-21-palmitate was 
estimated to be of the order of 9.00. As DDT has a log 
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Figure 5.6 
LYMPH AND PLASMA CONCENTRATION OF TRITIUM IN 
ANAESTHETISED RATS FOLLOWING ORAL ADMINISTRATION OF 
3H-PREDNISOLONE AND 3H-PREDNISOLONE-21-PALlV"TATE (2Q.,tCj) 
IN ARACHIS OIL (3QlI) (mean values, n=4 per group). 
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octanol:water partition coefficient of only 6.19 (O'Brien 1975) 
it was anticipated that prednisolone-21-palmitate would be 
sufficiently lipophilic to be lymphatically absorbed. However 
this estimation does not take into account factors arising fram 
the addition of a long chain alkyl group to the original 
molecule, such as micelle formation, which could introduce 
errors into the calculation. 
The levels of plasma activity following administration 
of 3H-prednisolone-21-palmitate in 30pl of arachis oil were 
significantly less than that after 3H-prednisolone 
admdnistration in the same vehicle (see figure 5.4). There was 
no selective uptake of prednisolone-21-palmitate into the 
lymph, the lymph:plasma activity ratio remaining below unity 
throughout the experimental period (see figure 5.6 & table 
5.3). 
There are several possible explainations for these 
results. The difference in the absorption may be due to the 
difference in the physical form of the drugs,administered, 
prednisolone was in solution whereas prednisolone-21-palmitate 
was in suspension. The greater size of the 
prednisolone-21-palmitate molecule may have reduced the rate of 
drug absorption into the plasma., It is possible that hydrolysis 
of the ester had to occur prior to absorption and that this was 
the rate-limitinq step. Hydrolysis of straight chain fatty acid 
esters of several natural and foreign compounds has been shown 
to be essential prior to a b a o ~ t i o n n e.q. cholesterol esters 
(Shiratori et al.1965,Vahouny & Treadwell 1958,1964) Vitamin A 
(Lawrence et al.1966,Yeunq & Veen-Baigent 1972,Mahadevan at 
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.' , 
al.1966) Vitamin E (Gallo-Torres et al.1971,Gallo-Torres 
1970,1973). Chloramphenicol palmitate (Glazko et al.1958).The 
possible mechanisms for prednisolone-21-palmitate absorption 
fram the gastro-intestinal t ract can be represented by the 
following scheme:-
I N T ~ S T I N A L L LUMEN PLASMA 
Prednisolone-21-palmitate - - - - ~ . ~ ~ Prednisolone-21-palmitate 
Hydrolysis in gut lumen or Hydrolysis by plasma 
gut wall esterases 
Prednisolone - - - - - - - - - - - - - - - - ~ . ~ ~ Prednisolone 
The detection of both prednisolone and 
• 
prednisolone-21-palmitate by TLC analysis of lymph samples 
demonstrates that at least a proportion of 
prednisolone-21-palmitate is absorbed in the unhydrolysed f o ~ . .
It is possible that the drug is absorbed only as the ester and 
is then rapidly hydrolysed by ~ h e e plasma esterases, 
prednisolone being detected in the lymph due to redistribution 
fran the plasma. Data derived fran the gut loop experiments 
shows that the rate of absorption of prednisolone is 
signficantly faster than that of prednisolone-21-palmitate 
although the effect of the Brij 97 is unknown. This suqgests 
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that if hydrolysis of prednisolone-21-palmitate does occur 
within the gut lumen the greater portion of the drug will be 
absorbed as prednisolone. Unfortunately, the data from the in 
vitro hydrolysis studies were inconclusive. Janssen et 
al.(1962) demonstrated the in vitro hydrolysis of 
prednisolone-21-monoacetate by homogenised rat intestine, which 
suggests that the prednisolone molecule is liable to hydrolysis 
at the 21 position. 
From the data available it is proposed that the greater 
portion of prednisolone-21-palmitate is hydrolysed within the 
gut lumen and is absorbed as prednisolone into the plasma. 
However, a small portion of the ester is absorbed into the 
plasma unchanged but at a slower rate than the prednisolone due 
the larger size of the molecule. The administration of 
prednisolone-21-palmitate as a suspension may have reduced the 
rate of enzymatic hydrolysis, as has been demonstrated in 
studies with chloramphenicol palmitate (Glazko et al.1958) and 
testosterone undecanoate (Coert et al.1975), thereb¥ limiting 
• 
the absorption of prednisolone and reducing the overall levels 
of plasma activity. Further investigation is obviously required 
to confirm these proposals. 
The lymphatic absorption of DOT was promoted using 1ml 
volumes of arachis oil. The volume of arachis oil and the dose 
of prednisolone-21-palmitate were therefore increased to 1m! 
and 25mq respectively to determine whether lymphatic absorption 
could be promoted by these elevated levels of druq and vehicle. 
Althouqh the mean lymph:plasma ratio rose above 1 betwe.en 2 aneS 
3 hours after dosinq this was not observed in all the 
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experimental animals. Increasing the oil volume and the dose of 
the drug did not therefore promote lymphatic absorption. 
The present study has shown that the absorption of 
prednisolone cannot be enhanced by oral administration in oily 
vehicles nor is there any selective uptake into the lymph as 
suggested by Lowrimore (1977). Esterification of prednisolone 
to form the more lipophilic moiety prednisolone-21-palmitate 
did not enhance lymphatic absorption. 
• 
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ClIAPl'ER 6. 
FINAL DISCUSSION AND CONCLUSIONS. 
In the present investigation the oral absorption of DDT 
in rats was shown to be altered by the presence of lipids. The 
plasma DDT concentration versus time profiles following 
administration of DDT in solution in 1ml volumes of different 
vehicles varied considerably (see figure 2.3), with the rank 
order for total DDT absorption over 0-24 hours being arachis 
oil;>Miglyol 812 = water containing 6% Tween 8Q)liquid 
paraffin. Investigation of the lymphatic absorption of DDT in 
anaesthetised rats, showed the DDT concentration in thoracic 
duct lymph to be highest following administration in arachis 
oil, there being no difference between Miglyol 812 and liquid 
paraffin. Studies on the effect of these oils on 
gastro-intestinal motility showed that the marker 99mrc-sulphur 
colloid, emptied from the stomach and passed through the 
intestinal tract more rapidly in the presence of 1ml volumes of 
• 
liquid paraffin than in the p r e s e ~ c e e of equivalent volumes of 
either Miglyol 812 or arachis oil. Thus increased DDT 
absorption in the presence of arachis oil is due in part to 
enhanced lymphatic absorption, whereas reduced DOT absorption 
in the presence of liquid paraffin is due in part to the 
shorter gastro-intestinal residence time of this oil. 
The variation in these physiological mechanisms may be 
attributed to differences in the chemical composition of the 
oils. As stated in the introduction arachis oil is comprised of 
long chain saturated and unsaturated fatty acids, Miglyol 812 
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Figure 6.1 
DISTRIBUTION OF A LIPOPHILIC DRUG AMONG THE THREE PHASES 
OF A LI PI D DIGESTION MIXTURE WITH THE POTENTIAL FOR DRUG 
ABSORPTION FROM EACH PHASE. 
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(Grisafe and Hayton 1978b) 
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of saturated medium chain fatty acids whereas liquid paraffin 
is a non digestible mineral oil. Such differences in structure 
may also affect the physicochemical processes occuring within 
the gut during absorption. A lipid digestion mixture within the 
small intestinal lumen is a 3-phase system comprised of an oil 
phase, an aqueous phase and a micellar phase. Drug absorption 
can occur from one or more of these phases (see figue 6.1), 
although reports in the literature have suggested that drug is 
absorbed from either the aqueous or the micellar phase; 
absorption from the oil phase being negligible (Armstrong & 
James 1980). Absorption of DDT probably occurs only from the 
micellar phase as it is a highly lipophilic, water insoluble 
structure, with an octanol:water partition coefficient of 
approximately one million. The presence of different lipids 
within the digestion mixture can alter the partitioning of DDT 
between the three phases and hence absorption. 
Following administration of Miglyol 812 the intestinal 
digestion mixture consists of Miglyol 812, ~ i m p l e e bile salt 
micelles and an aqueous phase. As the oil is digested and 
absorbed, DDT molecules partition into the micellar phase from 
which absorption can occur. The capacity of the micellar phase 
to solubilise DDT is limited by the concentration of the bile 
s'alt micelles and the solubi+ity of the DDT molecule within the 
micelle. If this capacity is exceeded DDT precipitates out in 
the aqueous phase from which it is not absorbed and is excreted 
in the faeces. As Miglyol 812 is unlikely to stimulate bile 
flew due to the nature of the constituent fatty acids, the 
absorption of DDT may be limited by the bile salt concentration 
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within the gut. Water containing 6% Tween 80 is unlikely to 
stimulate bile flow so DDT absorption from this vehicle may 
also depend on the bile salt concentration within the rat gut. 
This would explain the similarity in the plasma DDT 
concentration time profiles for the two vehicles (see figure 
2.3). 
The digestion products of Miglyol 812 are sufficiently 
water soluble to be absorbed into the portal vein. Fatty acids 
that are absorbed into the lymph stimulate the formation of 
VLDL rather than chylomicra as they are saturated in structure. 
DDT transported in the lymph has been shown to be present in 
the triglyceride core of chylomicra (Sieber et al:1974). Thus 
neither Miglyol 812 nor its digestion products are likely to 
aid DDT absorption into the lymph. 
Digestion of arachis oil liberates long chain saturated 
and unsaturated fatty acids which are incorporated into bile 
salt micelles forming mixed bile salt micelles. This increases 
the capacity of the micelles to solubilise lipophilic molecules 
• 
such as cholesterol and DOT (see section 1.5). In addition, 
bile flow may be stimulated by the LCFA. Thus the capacity of 
the bile salt micelles to solubilise DDT is increased in the 
presence of arachis oil more than in the presence of Miglyol 
812. It has been suggested that mixed bile salt micelles 
containing long chain unsaturated fatty acids increase mucosal 
membrane per.meability (Muranishi et al.1980), which may further 
aid DDT absorption. The presence of LCFA within the intestinal 
. 
lumen may enhance the lymphatic absorption of DDT due to:-
a)stimulation of lymph flow, although MCFA stimulate lymph flow 
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the effect is only about 75% that of LCFA (Barrowman & Turner 
1977,1978), 
b)stimulation of chylomicra synthesis by unsaturated fatty 
acids, 
c)association of DDT with LCFA as they pass through the mucosal 
cells into the lymph vessels. 
Thus arachis oil, via a series of physiological 
responses to its digestion products, may promote the lymphatic 
absorption of DDT by increasing the capacity of bile salts to 
solubilise DDT , the mucosal membrane permeability and the 
capacity of the lymph to transport DDT. 
Liquid paraffin is non-digestible and a large proportion 
of the oil is retained within the small intestinal lumen. 
However, as a small quantity is normally absorbed (Albro & 
Fishein 1970), DDT may be absorbed directly with the oil phase 
or following partitioning into the micellar phase. As the 
volume of oil absorbed is small and partitioning into bile salt 
micelles is limited, not being enhanced by the formation of 
• 
mixed bile salt micelles, a relatively large proportion of DDT 
is probably retained in the liquid paraffin and excreted in the 
faeces. Similar findings have been reported for cholesterol and 
DDT in the presence of sucrose polyester, a non-absorbable 
lipid (Mattson et a l . 1 9 7 6 , V o ~ e n h e i n n et al.1980). A marked 
increase in DDT absorption was observed following 
emulsification of liquid paraffin. As absorption of liquid 
paraffin has been shown to be enhanced by emulsification 
(Prazer et al.1944) this result shows the dependance of DDT 
absorption on that of the oil. The rapid transit of large 
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volumes of liquid paraffin through the gastro-intestinal tract 
probably further reduced DDT absorption. In anaesthetised rats 
gastro-intestinal motility is reduced and DDT absorption from 
liquid paraffin was found to be equal to that from Miglyol 812. 
This suggests that the difference in oral absorption of DDT 
fram liquid paraffin and from Miglyol 812 is due to the 
difference in the gastro-intestinal transit of the two oils. 
The increase in DDT absorption fram arachis oil as compared 
with liquid paraffin is probably due to a combination of the 
effects of slower gastro-intestinal transit and more favourable 
conditions for lymphatic absorption. 
The chemical composition of a lipid vehicle is therefore 
critical, as it determines the complex series of physiological 
and physicochemical responses occuring within the 
gastro-intestinal tract during lipid digestion, which in turn 
influences drug absorption within the gut. In addition, lipid 
absorption would appear to be essential for significant 
absorption of a lipophlic drug. 
• 
The present investigation also showed that the volume of 
lipid administered is an important parameter in drug 
absorption. Differences were observed in the plasma DDT 
concentration time profiles when the same dose of DDT ,was 
administered in 1ml and 2ml volumes of arachis oil, liquid, 
paraffin and Miqlyol 812 (see figure 2.4-2.6). Reducing the oil 
volume administered from 1ml to 30pl had a marked effect on the 
differences between the plasma profiles for the individual oils 
(see figure 2.3-2.7). 
With the exception of Hori et al.(1977) and Yamahira et 
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al.(1978&1979) the importance of oil volume was not considered 
with respect to either the experimental design or the 
discussion of the results, in any of the investigations sited 
in the introduction. In many animal studies the oil volume was 
large, beyond comparison with a human clinical dose, thereby 
distorting the characteristics of the dosage form. In a series 
of studies in the rat, Yamahira et al.(1978&1979} clearly 
demonstrated that changing the oil volume can have a marked 
effect on drug absorption. It was considered that from 10 to 
100pl MCT/rat the observed decrease in the absorption of SL512, 
a poorly water soluble anti-inflammatory agent, was mainly 
attributable to a decrease in the rate of digestion of the 
lipid after gastric emptying. Above 200pl/rat various factors 
such as depression of gastric emptying rate and intestinal 
motility, and a decrease in the digestion rate of the lipid, 
were considered to contribute to the decrease in drug 
absorption. Thus changing the oil volume may alter drug 
absorption by affecting the various physiological mechanisms 
• 
involved in fat digestion such as, gastro-intestinal motility, 
the rate and extent of oil digestion, bile flow, lymph flow and 
chylomicra synthesis. Reducing the oil volume administered from 
1m! to 30pl was shown to have a marked effect on the gastric 
emptying and total gut transit of 99mrc-sulphur colloid (see 
chapter 4). Delayed gastric emptyinq and intestinal transit, 
caused by increasinq the oil volume from 1-2m1, may account for 
the observed delay in the peak plasma concentration of DDT 
followinq administration in arachis oil and in Miqlyol 812 (aee 
figure 2.4 & 2.6). However, as liquid paraffin haa no 
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inhibitory effect on gastro-intestinal motility, increasing the 
oil volume served only to increase the laxative action of the 
oil. 
Yamahira et al.(1978) considered that the dose volume 
for lipid formulations for human clinical use should be 
restricted to O.Sml/capsule or as an upper limit Sml/human. On 
the basis of this they decided that 20pl/200g rat was a 
suitable dose volume. In the present investigation an oil 
volume of 30pl/200g, 10ml/70kg body weight was u'sed. However, 
such a scaling down of the dose volume on a body weight basis 
is of limited use as it does not take into consideration other 
important physiological factors such as, differences in the 
basic rate of metabolism and the absence of a gall bladder in 
the rat. It is therefore apparent that the effect of oil volume 
on drug absorption should be carefully considered especially in 
the design of experimental protocol. 
The plasma DDT concentration versus time profiles for 
DDT administered in 30pl volumes of arachis oil, liquid 
• 
paraffin and Miglyol 812 did not exhibit the marked differences 
that were observed between the 1ml volumes. However, there were 
still distinct differences in DDT absorption from the oils 
which can not be explained in terms of gastriC emptying rates 
and i n t e s t ~ n a l l transit of the oils. Investigation of the 
lymphatic absorption of DDT from this oil volume was 
inconclusive and further studies are required. 
The oral absorption of prednisolone from 30pl volumes of 
arachis oil, liquid paraffin, Miqlyol 812, aqueous ethanol and 
water was found to be independant of the nature of the vehicle 
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but dependant on the physical form of the drug. Higher levels 
of plasma activity were achieved when the drug was administered 
in solution rather than in suspension. It is probable that the 
drug is sufficiently water soluble to be absorbed directly from 
the aqueous phase of the digestion mixture into the portal 
vein. Therefore drug absorption would only be affected by the 
presence of oils if the prednisolone partitioned more 
favourably into one oil than another. 
The lymphatic absorption of prednisolone was not 
stimulated by the presence of arachis oil, Miglyol 812 or 
l i q u i ~ ~ paraffin. Attempts to promote .selective lymphatic 
absorption of prednisolone by synthesis of 
prednisolone-21-palmitate, a more lipophilic structure, were 
also unsuccessful, even when the ester was administered in 1ml 
arachis oil. Further, the oral absorption of tritium was 
reduced by administration with 3H-prednisolone-21-palmitate 
compared with 3H-prednisolone. It was suggested that this was 
because:-
• 
a)prednisolone-21-palmitate was administered as a suspension 
and prednisolone as a solution, 
b)there is a difference in the intestinal absorption rate of 
the two compounds, the absorption rate constant for 
prednisolone-21-palmitate being iess than that for 
prednisolone, 
c)ester hydrolysis must occur prior to absorption; this has 
been demonstrated for a number of esters of natural compounds 
absorbed via the lymph, as discussed in section 5.5. 
For a druq to be absorbed into the lymph it has to be 
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preferentially taken up against a far higher blood flow than 
lymph flow, even in conditions of fat stimulated lymph flow. 
One of the major criteria for selective lymphatic absorption is 
lipophilicity, as discussed in section 1.5. It is likely that 
lymphatic absorption may only be enhanced by co-administration 
with oil if the molecule being considered exhibits selective 
lymphatic absorption from a non oily environment. In the 
presence of a suitable lipid the partitioning of such a 
molecule into the lymph may be enhanced by lipid stimulation of 
suitable conditions for lymphatic absorption, that is increased 
lymph and bile flow, mixed bile salt micelle formation, 
chylomicra synthesis and possibly increased membrane 
per.meability. DDT absorption was shown to be primarily via the 
lymphatic route and in the presence of arachis oil, absorption 
was enhanced. However, prednisolone was not selectively 
absorbed into the lymph fram an aqueous vehicle and lymphatic 
absorption was not stimulated by administration in arachis oil. 
Modification of drug molecules, for example by 
esterification, may promote selective lymphatic absorption by 
increasing.lipophilicity. Kimbel (1961) suggested that steroids 
esters not hydrolysed by intestinal esterases are transported 
by the lymph to a greater extent than the corresponding free 
compounds. However, Schedl (1965) concluded that except for 
certain configurations these esters are rapidly split by the 
intestinal mucosa. Carbonyl ester hydrolase found in the 
pancreatic juice has been shown to be capable of hydrolysing 
the ester bond of a variety of LCFA, including monoglycerides 
and cholesterol (Barrowman & Borgstrom 1968). In vitro studies 
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with homogenised rat gut showed that the esters of steroid 
hydroxyl groups at 3D(, 3 ~ , , 6fJ, sec 17j.>and 21 positions are 
hydrolysed whereas steroids acylated at 11 ~ ~ and tert 1 7 ~ - a n d - , 6 6
OH groups tend to be stable (Janssen et al.1962). It would 
appear that the lymphatic absorption of drug IIK>lecules may only 
be stimulated if the IIK>dified structure is stable within the 
gastro-intestinal tract. Meli (1963) suggested that the 
biological activity of testosterone propionate in rats was the 
same as testosterone because the ester grouping was hydrolysed 
prior to absorption. When 3H-testosterone-17-undecanoate was 
administered in arachis oil to rats, a large proportion was 
metabolised in the intestinal wall and absorbed into the portal 
vein, but the unmetabolised fraction and two metabolites 
containing the undecanoate grouping, were exclusively absorbed 
via the lymphatic system (Coert et al.1975). The lymphatic 
absorption of ethynyloestradiol was found to be enhanced by 
administration as ethynylestradiol cyclopentyl ether (Gianina 
et al.1966). Similarly the oral absorption, as determined by 
• 
urinary excretion, of androstendione and progesterone was 
enhanced by administration of the 3-cyclopentyl enol ether form 
of each steroid, it being suggested that this was due to 
enhanced lymphatic absorption (Bruni et al.1966,1970). Thus the 
addition of a stable lipophilic ~ o u p i n g g to the steroid 
structure increased the oral/lymphatic absorption. However, the 
biological activity of these modified steroids was not 
investigated. 
The potential for promoting lymphatiC absorption by 
increasing the lipophilicity of the drug molecule would appear 
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to be limited by the following requirements:-
a)the modified drug molecule must be stable within the 
environment of the gastro-intestinal tract, 
b)following absorption the active drug must be rapidly released 
and the pharmacological properties of the drug unimpaired, 
c)the modified drug molecule must not be too large to be 
absorbed across the intestinal mucosal membrane. 
The potential of the lymphatic pathway for drug 
absorption would seem to be limited, being applicable only to 
highly lipophilic drugs or to pro-drugs which are suitably 
modified to increase lipohilicity and are stable within the 
gastro-intestinal lumen. Promotion of lymphatic absorption is 
not due solely to enhanced lymph flow as previously suggested 
(DeMarco & Levine 1969), as liquid paraffin and arachis oil had 
similar lymphagogue effects. Further investigation is required 
to determine whether the increase in lymphatic absorption of 
DDT in the presence of arachis oil was due to stimulation of:-
a)bile flow, 
• 
b)mixed bile salt formation and/or membrane permeability, 
c)chylomicra synthesis. 
Enhancement of drug absorption may be achieved by 
retardation of gastro-intestinal motility following 
administration of oils, and stimulation of this physiological 
response may have far wider application than lymphatic 
a b s o ~ t i o n . .
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